var title_f16_10_16544="Male obstruction";
var content_f16_10_16544=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F58694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F58694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Uroflowmetry obstruction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 319px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This uroflow study demonstrates male obstruction, with an intermittency plateau pattern. The Q max is 8 mL/s.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16544=[""].join("\n");
var outline_f16_10_16544=null;
var title_f16_10_16545="Exposing rectovaginal fistula";
var content_f16_10_16545=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F77833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F77833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Repair of a small rectovaginal fistula through a transvaginal approach",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 415px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGfAVQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKiS4hkuJYI5UaaIKZEDAsmc4yO2cGuC+IOo3Gk61Y6gRKsdmRMjoN37v/AJboRgZUoCepw6xnjjLSuK56FRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRSOwRGZjhVGSfQUAZ+j2cds+oTo2+S7umlkbzN/IAjAHAxhUUY7HPJrE8YQfbZJbTb53mQfLEVyVJJAkX1Izz0OD3HS18PYJIPBekm4YtPPD9qlJOfnlJkb9XNJHd2Gqagtxp1zb3ABwHicOrlSQSCCQcHKnHII5zxio7kS2L/ha6kvfDOk3U67ZprSKR1znDFASPzzWpXPeAJzP4UtN2d0TzW5z6xyvH/7LXQ0mWgooopAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFYXjq4a38I6oY2ZZpoTbRFeoklIjT/x51rdrz3423V2PDmlaXpu5bzWdWttPjkUcxZJcye20Rls+1ADbeLTdf0mfVdduBH4MsAUtLaR9tvPFFwbib++pKnap+XaA2CWG3Fsdb8NfEV5B4REuleL/AA8BLawXVu1rKse7IRl/igkGARzgOpIB203xZ4o8PWPxL8OeBtT2RaNYWP210cjyRKpC26SZ6hQGYD++Yj2p1zeaTB4p0HxxBB5F1dXo0S7dAP30U5xGW/3ZEjOcnAZh2GKJOr+FWow6joeoyW3mCManct5cgw0TSP5rRkDurSMp9wa7OuO8M2MWheOvEtlBEYrfVTHrEeFARpSBFOB75SJj7y12NSNBRRRQMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK429lg1Pxx9ruGCab4XhkkkmZvk+0yx8/jHCSSf+m49DWx4p1ltJtIY7OIXOq3j+RZWxzh5MZ3NjoijLM3YDuSAeN8WWH2XRtL8C6bcPJfa7Mx1C6P3zBnfdTN1wXyUA6fPgcLigR4t4V8Oa98Rdf1zxtYQJDf3l9Jtt7/PkXNmuwRwllBKMPLBDjqQO1W/Ect/4kMujf2D/wAI5bQSG6+yy3Bke5u9pQSPIAAgUk4C8lgGOOAfpQvFY3C5mhs9Nt1EQXCqskjdB7YHQDqW9qo6nbaJ4sttQ0qcSCVoyjOI2hlUH+ONiATg45GRnAPpVXEUEuZvEfhLRPEumRKdVt41ukhBxuJGJ7ckjIz8y8jh1Un7tdXp17BqOn297aPvt7iNZEbGMgjPI7H2rk/Dkn/CPeJ59ButqxagDeWbqu1WlA/fp6Atjzceryf3c1o6bnRfEE2mvn7BqDPc2ZxxHLy0sWffmRfXMnZRSYzo6KKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACs/XdXttFsDc3fmOSwjihiXdLPIfuxxr3Y4/mTgAkUvEPiKPS547GztpdS1qdC8FhAQGK9N8jHiOPPBdvoAxwDh3RsvCVq/ijxtfrdaqR5UZjQssRfpb2sXJJPQnl3xkkAAKCJ/NXQLa88WeL5FS9aIRJBDmQW0ZYbbeIDl5GbbkgZdtoHCqBQ+HunXM91qXjLxLbG31e+yiROd32S1X7kI7HHJJA5ZnI4IqlZaTq3jPWYdT8RQCzjtJM29j5m8WYwOuOGuGUkFwcRhiq5JLG18cfGh8FeCTLZxxS6rfzLZWMchAVZGBPmMP7qAZPbOAcZp7CFvE8Raxrd+2jxi3S1KCK4vXAjY9SsYUEgf3jwxzjcoAFZPiNdT8HfZdXvJ7mW0Vx9pL3MlxHbyk8Soz5dEY/I8ZJUK4ZcFDnr54NZ0HwJbLpk8ep6pYQxvK1yQn2wLgyjcMBGYbtrHgHGcjNWJbKTxN4Ca011YIptRsMXKxrujjZ05wCfmAJ79cU7hYf4i0yLxJoUcllL5V0At1Y3SjmKQfMjjPbsR3BI71WsbiLxn4XDHdY6jDJtkXG6SxvIzyMH0PPONyMOzVS+F+qNdaDaW1yrJN9njuUVznCuoZlB7hWbjBPyMnrWb4k03UvCWuX/jDRY5r+GeWM6pYIctLbBQpeMd5IsFh/eUsh6IQhnY+HtWbUYpoLuNYNUtGEd3bg8Kx6OueSjDlT9QcEEDWrm7y0g8QWthr3hy/ijvfKD2l6g3xzRNz5cgBG+M8HGQQeQQasaLr4u7o6fqdudO1hAWNq77hKo/jhfgSJ7jBGcMFNIDcooooGFFFFABRRRQAUUUUAFFV4b22nu7i1hnje4t9vnRq2THuGVDehIGcemPWrFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVi6hrJgvXjs41vBa/8AH7bxEm4iVgCron8Y65A5PO3JXadquW1fwujXC3lg0qzRyNMgR8SRMxyxic5wGP3o2yjeg5NNCZ0Vld299axXNnMk1vKNySIchhU9ef2l1dWd689ssMN9NJiWE/u7e+f3ByYLgj1yG45fgr2Gkatb6osoiEkNzCQs9tMu2WFj2Yeh7EEqeoJFDVgTNCiiikMKKK5vVfF9ja3c1hpsNzrOqxEK9np6CQxMc4ErkhIun8bD2zQB0lche+JLnW5JLDwV5NxIGMc+rSLvtLU9wuCPOkH9xTgH7zL0LT4e1TxGwfxhcRx2HUaNYu3ksOeJ5eGm6/dAVPUNwah1rxnZ6bMdC8J2cWqatABF9mgYR21n2AmkAIj4HCAFz2XHIYri6zeab8PdFZ7WKS/1zUZBHCkj5uNSucYBd8cKByTjaig4AAArI8H+G9V1PVIdf8U3K32o4IWUKUht1P3o7aM8opPBkPzsAOcHAseFvB9zc65L4g8RXkepXs0YQTeXtUJuJaKOM5EcIwmMEs/JYnIr0GaSO3geWQhIo1LMcdABk09hbjYkhsrRUUiOCFMZZvuqB1JP8zXhPxD0LUPiNpWo61aFHFtA17oqbcuiRkGFlzxmdldif+eYiHrXd6zp+pePdQ+xXcd3pvg1EWRysgjl1UnrGwB3JBj7ykBnz2A56zR9MTStPdbmdZp5GMk9wyhAx7YHRVUYVR2AHXrSWg35GQb9fFnwwlvPDqo51LTH+yxhgoV3jICE8Y2scH0wajdbvwl4GTT/AO0RdX0MYstPuLo5eVtuIzIQMFhgknAGFySOTS+FtJttGnu49M1qF7ee7muDbDayjeBwOcghhk4wCSSRkk1LbeDopNUi1TW72TVdSjAEUk0MapbjAyIVAzGDjJOSx6EkYAegjNtdJu4xay2Mp+12YIgZkwkq85Rh2GcjHVckc4FdXDLaa9pU8U0W+CVWt7m3kHK5GGRh9D+III4INXwiqmxVCqOAF4xXO6za3VpDNqXha3juNRiDh7NpfLS65LbCTwrZPDHpn0OKG0wSaON/sXVfhrrd1d+FbG41DwjdMJp9HhZc2bk/O1spxjOd3l5wfmA2naD3TxaN4y0S3nVlu7Nz5sE0bMkkUgyNysMNHIpyD0YHIPcVY0DWIdZtHYRS29zCxiubWZdskLjqCD1B6hhwwwRwa57XfDN9p+rSa94MmitdQncNf2c+5ra+UDGSo5SQADDqM4GCG4FIZZV/Enh7f5yN4k01fuNEEivoxjoykrHL9QUP+yx5qxaeNtBmuBbXN7/Z14cAW2pRtaSMT/dEgG/6rkVV0Lx5pd9qC6Tqm7R9dzj7DeEKZTnGYX+7KpPQqc+oU8V095aW17A0F5BDcQN96OVA6n6g8UATgggEHINFcpJ4H063lE3h64vPD02/eRpjhInOP4oGDRH67c+4pBc+JtCjnl1RINesI13B7CAxXajnOYixWTjH3SpPZSaQzrKKy/Duv6X4j01b/RLyO7tiSpZMhkYdVdThkYd1YAjuKbr2v2WirEk/mz3k+Rb2duvmTzkddq+g7scKOpIFAGpLIkUTySuqRoCzMxwFA6kn0rkNS159TtGks7ptN0MNtfU2UiS4GPu2ykZOf+emDn+ANkMuN4iu2LRTeLUW4uWXzLTw5avujHzDa9y3RyGwORsB4VZG2k6ej+G73V7pdV8Wv5snWKyxiOIem3sPUHJOAWPRFdhDPBs+o3moRPpNjFpfhSFWwJRumvXbPz5OT15LEkk55bPy91QBgYHSikMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDM1nRrbVEbzFVZihjLFQwdT/A6nhl9j06gg81yM0EljcqmrSXEc0Kk297CxaeCPgnDEHzouASrgsv8AEGGHHoNQXtpBeQ+VcpvXIYHJBUjoykcgjsRyKaYmjFj1yXT44zrix/ZXx5ep23Nu4OMFxyY856klf9rtVvWdfsNJtraW4lMrXTiK1ht18yS4c8hUUdeOSegAJJABNYLNqHhi7xs+0abI2AFwA5J6AcBJST0GEc9NjHDOsPDOiXd0niHwpMlhePE8Ky26AxEFsurQtwp3r823Y+RhjxQBPc6PrWvzj+2b86dpXX7Bp0jLLL04luAQ2P8AZjC+7MK3tH0qw0XTorDSLO3srKIYSGCMIi9zwO5PJPeuU8ZeM73wN4eutX8RaRJe2Nt9+fSmViMsFUtHIVKgkjoz4rjNIvvEXxP0sTay76PpF5GzQ6RYOyyzJjA+0T5V8ZzlECAjGWOcUWuGxo+NvGT+INQPh3w5O8Omb2i1PVo22k4BzbWxHLSHBDOvCAEA7/u9j4S8JWGi6dZxQW0dvDCqtHaxII0ibg5wOrZHJJP49asaPoemeGdEsrWG1hYWarFbhIhv4BVFXPOcEjOe7Enk1ur5jwjf+7kI52nO0+2RzTvZaCsQ3Vy8bCK2iM05wdudqqPVm7D8z7Vg+IdS0zRLf7X4huWuZoka4EKD5VC87gmdoA4+dzwccgkVt6vNb2WlXdxdXYsLaKNpZbnKr5ajlmJYEDjuRXjuipZfEKe+1+9kl07wJYsTbvdMYzfyKQftkruc7AMhAw+XO75SBhICzoPxl1HxffSQ+DfCM09srmMXF/ciDkdSUVWwB7nJ5wODj0Gz0jVr8pP4lurR3SVJYrS0jYRRBecElsyNkZ3EADsvc8DP8WfC3h0G38NaBfX1uCN32CBVeU5wdsZIkZhySWUAgEgnmsa91X4i+MNRfUNAvLjQNOhBYxXEQiSEHAVTmF2mlyDuA+ReFG45NO3YPU93hhEcHlu7SjkkyYJOST9O9Z0nh/S5b9b77NtuFUqGjkZBgnOdoIGffGa8Ej+FM2tXM114o8Q65fWMjedcTtZ3Hm3bZHyhOgRSMKChGDwBninb6Pr+nQDRfDOva1o2hkFJE03T55WBUD5sGIeW7E/P5ThdwY7QeKLMND6PXS7ZclTOCe/2iTI/8eqT7J91hK6zAYMi4Bb03Dofy+mK+aNH034l+FdRvDoHiDU9WhlthNnV4ZI1V94yXWRWZyEySU2k4UHJ4rqtM8X/ABGtryzuhfeF/E9vdS7G0y0D2txFCDgzBWHmcNncux8AcexqGh6H458N6pqlrLdaLqtxp2rImyK4tcBgM5AKt8rDPVTwe2081g/DD4jahql5f6B40sEsde0wR+bd2+Ta3KScI6k8oTgjB4yMZBO0ddpHilZ76Ow1qxl0i/m5tlmcNFdDr+6kHBb1QhXHXbjmuK+JMT+Gdeg8Yxw7hZqY76NMMbzTz/rVK8ZaMnzB67T6mjfcNjuvFPhix8RafLa3cUbRy8SI6hkkHoyng+ueoPIrj7G68SeC7gWWyXxBpDF2ht5JVW+twOfLjZjtmXrtDlW7bm4rt9MnhihtJbGdbrR7xFa2lVt6oGGU2t3RgRj0OByCMX7+0ivIDHMue4I4II5BB7cgUX6MLdjC8PeONB1y9fT7e8Ntq0YzJp16hguV4/uNgsP9pcr710F5dW9lbSXN5PFb28Q3PLK4REHqSeAK5PxJ4bg1nTmttVsrK7wCB9phV1yepXPIJwOQQQenauC+GHhqxsfG+raD4lur3WbyxVNQ0VdTuZJkis3O3CRMxXfG67S+M4KEYBxQ42BSudRdi/8AFesWWp+C1OjxJKDca1cW/F/BsYeWkRw0i5YEO+0ArldwJp17NbeHru4s/D4lv/Ed0Vju9RuR58uSCyp/CGbGWWJSqICWbYv3pvG2u65ql3c+GPABhXV1UC91Of8A1GmKwyOx3zEcqnbIZsAjLfgto02neDbN9XmN3rkRns7m4Z9/zRzOjBTgcFk3EkbmPLEnGEM2PCnhddOdr7UibjU5X81nd/MKtjG4tgbnxxuwAo+VAq8HqaKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAZNFHPC8U0ayROCrI4yGB6gjuK838H6RPoGh3F/wCG4pJm/tO/a9snkJN0BdyjcrMf9cAAASfmACsfusvpdct4JVLW/wDFGnqxJg1V5sHsJo0m49tzuPwNNCZ478YPiHF4zv8AR/CHhIPdWVxexjU7l4WVAygyLb/MASw2bmGOCFHUsB7X4N8M2nhfS4bGy3+VDElvGGOcImQv4kcmvL/DXhtLb4++I0WFBFFcQapE3cLNDNv4xj/Whzn/AGq9wpvRAVI7cyXpuZxzHlIVJ+6O7fU/y9MmrdFZjxz6mrJOklrZ5wU3YklHuR91fbOT3xyDIHm/xWlk8XX+h+E7F2ax1K7zdbQcSW8BDysWH8OQkY9Wdv7nPDeLFbxXqljpVoFXwZp7LFbqjK5ln3lUcAN/rGdWwrgjaQcDcRXYTahPcaD8QvFsbRx20enS2ejSICEihiEybhjnLSZbj+HZivN/hZpFzqXjews9MikvNL0tPtjoLvYsNyB5e13UZUZBwAGYmFefvmrQj17w54FsGs7iZbO3lM7ySSzTDzzNIT1RWwmBjG5gQSMgBeTsaLpkfhq4dLe0vNvl7j5aySgk9yECx568AE/StWaTVZJUa80clUBx9h1Ik591YRg/iaLS5uSkskUmoW+CF8i9tDLsJ6YKcsPU7mx7UXEZc9nayPNdzpG1yHMiyJpVwZhznAO7cTj0/AVgTadcILqe70W9vbOcqUMdxLZuAeTuD3BORx2X6enWzW/iDUJ4wuqWsFqqbnRLKWJ5GyQMsXyF45C4bocgHBy5tBVJVW/uytw3zt5Nm1wrN/e3SrIc/jQmJo5iGx8JDTo49Wsr+23ylRaJqt3cyEg8NiORuDnvUh0TRbyKCy8PW1za3Udwkkf2qGaR4QG+Z0imXaDz94+x54rtrRrwJEsVy1ym/bLLLFJGyrgnooVT2HQfWmo2qyam0WnXdlGpTzGW6Rpm3dyB52QOVGMCnsB5X421Q6RJ4i03U9RuIo7JI715iVBlLuqR3SYxhldNjA8KxjcFeRXrlrdxeIvDVnIqRXD3VnHdRsw+RiQM4PsT+o68188ftBT+JrSHS9ZkXTGv7e6lszc2LbPMEgOIXjfIdd0asCSckYwrKSfVfgJqJ1H4T+Eb6WUySxK9rKVXaBl2ABAHqI6TGtir4J8Qr4R8WJ4R1KNrfSdQYtpTtHsS3mOWa09ACPmTPfeo6KB69XknxT0UQz6Tq7eZcto1/Hev5jLk23IkLZ+8oVnU9xhM8dfS7WZredLWUtJFIM282d24YztY+oHQ9x7g0mikXJollUhx2xnuK8j+MLzRab/bPhiaQeK9JuY7W1eHaSktxJHD5UisCGjYOpwR1VTkHr6+w3KRkjIxkV5t4ljW41jwk0Lw4uNZiWcg4MnlRTv26nfGp59DRHYTWp2PhDw9aeF9AttLsi8gjBaa4lO6S5lbl5ZG6s7Nkk+/pVTwJE8Wl6hvOQ+q37rx0BuZP65rpKwPAcxuvCen3bDBuw91j08x2f8A9mqRm/RRRQMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKRgSpAO0+vpS0UAArmFJsfiO6EoItV00Oo6HzLeTDH8VnX/viunrlfGUyWet+Ebtkyx1M2hbuFlglGPxdY/ypoRzIeeH9pGWKHcILnw1FLNxlTsuJVHuD8wx+NeoVwmvfZNO+Kei6hcEpNd2D2SEAktiaPjjpzIpyePzru6GCCuG+LviGXRfBWtHTpzDfLaE+eoz9n3nYjf7xY4X3yeimuxvluXtytk8cczEDfICwUdzjucdBXIeO7W0t9G03S3ha6OqarbRv5nzNMyN5xLH/AHYT7AAAYAAoSuDZz3xe06Pwr+z1q2maaFFvaWUNovmEkeX5iIdxAyflJzjmvNf2cr6S88TeKrVItQM5jgZIvPFqnlIZAMAfNwWI4JBOSeuB6t+0Zc28Hwm1eK6QSLcGNAhJG7awkIz2O2NiO2cZr5o8E69J4X+J0sNwdOmsdUmmjLXVyVVGWWRoisn/ACyzuUAnI+fJxnIaE9j69gs7svtWLWbMgbjKL1JlOP4cSM3X6fiK0xZ3jAH+0rtCGIx5cJyM9fu9+tcZca99stgtvrureHZz8oS8skuEOTwySYZWB7EORyMjPFaGmJa6rd+Rd67baxHsPmxlnQsAf7isE6kfw96dmI0imow3qPcW+p3acEFLqJETHqo2Z9/vCsmOXxCs11s0OC0SSViZJbgNu44IWKJiRwPvMCa2rPQ9ANh9o0jStKmjlXdGUjTZJ6fMAePfmuB1e40RfEEtnf6RpEV2Sqxp/Z1w2evzF/IKlSVIDDAOOuacWDOiuTFagDxBeee0jqqqYmhiDk5VVVY8kkr3Yng9siq19JaXN800Sajq800AEGnec0NuijBLSKW5OWGQwZuwXtXMyeNbaCCKHQks7iaUbdlhYGY4Xk9REM4PALD8TwcafWjqXiS1Se88Xu7SlrbT4ZlgguVKZdWCt/CBkZk78c7abEc98V7C2jttDeQ6fPqkWr2pt7Wz08FELOARLgl3UjAAJUtgd1O7uv2TngvPgxDbpgNDeXEUu0/dbcGGPwZa8n+I/if+2vG3hfw14dWwjhivEvri2sHSb97ETtV5PumTarZQZXO35j0XvP2Ub+Ow/tvw6lq9vAjpPDI7/wDHxIF2ynaQNpwI+OehzUvyKR63420qHWdIhNyqrNE7RMSAQQ4KMjA5zG/AIP8Asn+Gsv4I6zd6j4IisdXQxaro8r6bcI0fllhExVH2+6gcjgkNium8TwO2lyvGi7VkWSTjkpjDEcdQOffGO9c/4ShaC41ua1gZLi3vN0qg7vtKtDET6fMcAj3/AN40rXQX1O6rjPGdpHBPot3lEEGtW0gZ+5lJhwD65k/XFdfbzR3ECSwtujcZU+tc78RLFdS8IavbpkXKWzTwso5WSM70I9w6qRSQ2b2o3CWen3VzIdscMTSMfQAEn+VUvCUZh8K6NGQQUsoVwe2EFY+ratBr/wAK7zVbJyLfUNIeeNu6iSIkfiM/nXVQRLDBHEnCooUfQDFAD6KKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5T4j2yT6ZpMrMVNtrWnyrj1NzGn8nNdXWB43UNokORkDULE/ldxGhCZm/EWF4zoGpQRB5bPUFUkDLbJFZcD6v5XHfFdgDkA+tc58RY5H8I3kkLbZLeSG6U46eVMkn/sldGOg70+gdRa4K4mfWvjBb2iNEbLw/p5uJME7hcznaox04iRueeJDXY6ldm2REhUSXUuViQnjPdm9FHUn8OpAPE/BywxpWpa3NNJc3OsXst01w5yXQs3l49FCbQAOBjA6ULuDON/a2ubZ/CGgaTcEk3uqxsUH8SIrbv1dB1Gc9a+bvippmn6J4jWEP55msxJIpUrI8gnKGN2JPA8pjvHJ9cEY+hPjTpknin4vaHYPOtvp+j2C3N1I7EArPKUZeo2/LF973HtXkf/AAhep/G3xvqniKwji0fwwJxbWz+Sd7RIpC7Ixjc3ALZPBc4JximloK5U0H4v6joFrbrOjXMOCfNs5mtDOQSuWV1aN1OAC3loxIb0JroZP2g1lsJ1im8QRXKxh4cG34bJJjZ8fcGTtbbuGcYbgj0nwp8CPB2mIJL/AEp7yYx4zqVwRj5eTsBUZ/PHAGDkjWPwk8Mm6Mtv4V08TyIylWjjaKMHoQvPPoT6/lVmK6PF5Pj1bSWclpcaf4h1fzgF23WqmD5uoI8tfXtjBBwenOJqPxfN/DJLdaE80QfzEI1NsiTJ2knZkDqdo25I3DBBNe2n4BeFtolXwy0uADsF9Km8ggdC4xnBOT0B6E/KK8/wA0g3PkQ6NZLZDYS26TzM8lsEyEkdMDIzzkgYWkrhdHznefELVJLyG+iW781fnfztTnlRzk7TjcPm55x15OF5rM1jxxrOqLcRyrbLMxfdMm53Cn7wUszBQSM5XB684yK+q7P4OeGLC3kN5oAdDKdqJa+Y/ByCWKMTkY+VQFyCOauL8PvDNzvt7fQ/D90WUlbaewitpwPXAjjfjnndRyhzHyD4U1W08O634f1WSxun+yXIlujnAmQn7qeh2568Enngc/QchuvBOt6drlvcPc28UEV0XVtomh4RGbIIJ2bl3A4H2hefSp49/Z5trrTH1HwT5lpqce7do92SEmA/55MxJB9izZz1HFcr8LfFU58Kx6BrWnnUv7FvwTbXCHelrIds0K9MH77YY/eVRg8AG2g9z7LuLlZ4ontnE9vdQMYnUgoxwCuD7jPtxWP4MkA1TXYFk3IHglRNoG1WiUdRzjKHryMVX+Gkv2v4dafGUkEdqJLSLzRiTbBI0aFh2b92D3q1YxDTfGZTKhL22ZOepaNiyqPweQ/gfSjoLqdQABwAAOvFYvjJmi8MavKoyUspiBnGDsPetusDx1OsHhLWWchR9huDubgf6tuKlblMwJ7B9O+FtlYWypH56WVvsRAADLJEknT1LMfxrvq5bxGywaf4ctFGFl1C1jAPYJmT/wBp11NDBBRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWB44lSHQ4mk6NqFig+rXcQH6mt+ub+IEXm6JaLjONV05vyvYT/SmhMm8ekjwP4hK/eXT7hh9RGxFbUBZoIy/wB4qCfrisXx/wD8iL4j4J/4l1xwDjP7pq3UGEUe1HQOpxXxPuTZaDcW2nzJFreuEaXZyOwzGzg5ZckfdXe+O7ADuK6Tw7YR6bo9raQJ5cUSBEXuFAwM++AK5sWg1/x/d3cryi30PbZwpj5TM6LLI49TtaEZ7bWHeuzhjEMSRqWKooUFjknHqe9PoLdnyL8atWk+0/EW/s5PKnnvV0mUuQwaFY7dVUAn5RkXB3Yxk464x9JeA9HHhzwjpelaZZxmK1tYkEjTD96cZJ3KOepOcDrXzVpMI1jV7iWSwFxO0zibT52HmXkUshlWWFydpPmK+OQD0bbtBr6m8L2X9naXb20H2cW6IAI4ovK8sgAbdgJVcei4A7Cm9gNdMsPnQKfrmq7X8CXwsyJ/OK7uIHK4/wB8Db+tWGcjpGx+mP8AGklkZIS6RPIwHCKQCfzIH61IzNu9YaAP5Wl6lclW24ihAzzjI3Mox71E+rmexn86wv7NmUqBPamUcjqRGWyPbIq9LFFdwIbm0dxncY5MHafpnHc9PwqjDZaSZN8JltJH42LLJb5/4BkfninoIyLqBrezV9K06yvo55MqsAaBtigYG4nBYHPBKCq0ElnqWoPbxWtwmpxsJRbXjSROq9N6sd6sOvKH2JrbutHtoZTd/a9XfdhfLjvp2GB/dQNjNZulRoviJoIdbuQjgs1jc3heTgfwqw3r2P3iOOlVcmw0T22mX8n2/UJ7Hz3UMLmZZITJ0VRuU9cdNw/OvE/iNF/wgXxg03xiFsr7RteB068EDFcSZUhn3E8napyOvltnk5P0VcTSrOrW0UlzEBhxHMhbH0br78g/WvMP2kdPtfEXw0vprRVbU9JK6lFkiOWMRH95kH5gNjMeB1xQ2ETufAV3bXMWtWVpg29pqD+U4wVljkVZgwI4IJkYZ/2T3p/i5Vs2tr4YHkXMdxu/ujISTnsCjH8frWZ8KDbrp9wlmkItSA9u0Tlswl5PLBz6KAB7Y5rd8Xr9o0q8sQgaW5tJhEWHyhgB39eQw/3TS6j6G/XI/FeNW+H3iAyS+TD/AGfcpJJuwI1aJhv98HafzrodDuJrzRdPublVWea3jkkC9AxUE4/E1jfEoRP4A8RxXDIsT6bchi/AA8tsnJ446/hUrcp7GQq6jPonw/TWVK6ot5ELvp80qWs29hjsSpI9jXe1zepxJDqvhhFXBa8kc/X7LKCf1/WukoYIKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK53x5MtvoMUjkYGo2A/E3kIH6muirO8Q2n23R7iIEB12yoW6B0YOufxUUIGU/Hf8AyJWven2GbP8A3wa3ayvE9ub7wtq0EOGaezlRMcgkoQKsTzSyaJJNAQJmty6HGfm25H60xHN/DWCObQItTbeLjUZ5tTZWbOBO5KfgECgfSusd8XMaZ5ZWP5Y/xrm/AkyW/gPSLieMI8NlFDL5fIHljaSB2HBOO3vW5qA2y2c/ygRy4YnjhgV/mVp9RdD5Q+CzWmq3Oj3ZvoojpN/tMrJ++jULtQSEAfIYwEPY7Mk19ZwiREzI3mDqHUYY/Ud/88V4LpHhdvD/AMSvE1jYRRrcLqKaxCJnCxyWVwCJFCAElFkWRGGMDcrcYw3tGlWs9oqx2M5+yqObW5y7w57K4PK+gOfY44pvYXU1ZJQFGJY0J/vjH6ZFKCwAMkiYLcYGM+g5NLHvIYTKM57DjFNk81SohjiKY53OVx9Bg1IxzyxrkO6qeM5OOvSqUmmaZfOZLiyguHX5N08W88HP8Q9assLsyAqYFjHVSCS348Y/I1la01xAFnuLy4trVWw3kfPnJ7gRFh9QR9aEgbINbjh023+0NZQvFvA5VfLt17ufkyB/nIqDw6VklkvJNRtJ2miIV7WIrGuD1GXYMfw/wqXW/In06HN5GUZgRDcbiJSQcAjGemTjB+lULGFPN820g0y1TAR2gsmMjKO2SgwOnUGrJNSC4eeV7S1e4WdQp82ZAUOQf7rD/GptXt7u502SK50+xv8AMZUo3IY47KwIx7E1X0e0ZCxiv7qZ2Vik9xCvCnHygiNflzzjNGp3UemW4kv9U1C4jkYqsdrb7y3H3cxoSPrkfWk9xo5j4V2xsr2bELWsM9v5ItnBDRvBNInI7ZUqfpiu71mKOazdZozIoViAuM52nv2yMj8a83+FFnFH4p1qeBr1I5doSCe8+1BEiURrmTc2Xy0qnBIBXbk7Mn0vUyptzGwyGBJBGQRxkenfil1G9g0aGK30exhti5gjgjSMucttCgDJ7nFc/wDEqwudY8LX2mWE8UU92i2xaTJCrJIqEkd/lLiuphwYk24C7RjHpWO4+16v5FzFDIscgZGXOVKfMCe3GUH4nihbgytqjtN480C1UgpDa3d249CDFGv5+Y/5GukqtDh7y4fuu2P6cbv/AGYflVmpKQUUV83fGbUdWg8fa+bK41KK2tbOyc3NteyxjTw0mGm8pCBJxwR75oA+kaK8R8XfEPX7Lxm1pp19p8Gmxpay2ZuQoTU43ALsrdT1IAToRznNM1Dxbrmq6X4qhPiJdN1uKO/SHQ4bI+fGkSOUdZAdwYhQQ/3csMc4oA9xorwCf4ga3ZeHdHMHiK3aM6G15Devaeb/AGheq237Hkk/MOASPmJOexro5/GfipfHem+G3t0gn1Q2l7ETDnyLby3N0jH+8rJgf7w/EA9corwTTfih4gm8V3EFnKuowSQak0WnzQrHPHLbqWRCqfMu4gLhiSRzgcVk6r8QtUvvC+tRS6rYa1EPD8GoyD7KEWG4e5VWiIByQo455z1oCx9I0V4z4m8ZeJ7PWvENxZ6happ2j6tZ2Ys2tAxmSYR7syZyMF+MD8ayD8RdYvvGt1pK3qyabdHU7drWaFI57fyopHThfmX7oGWJLDJwKAPfaK8c1C4vYv2X4bizu5Le5XRomMq5LEYUMM5yCQSM1kJqN94Ni8SWejyaZBcWGmae0dzPGUUmV3LlskgdTjdwCeeKAPeqK+fbLxjrmp6h4J1C58QXVhYy6jeWk8s1uiwylYhsBMbeXKrElVbpuyRyObj/ABM1C+t7PSJriIanLd6jaahB5BVo40jlMXsCQqn35oA92or5t1H4hax4Z8EeGIdIvxbzxaDBeGO6iQx3BzghWbLO2Byq4wOSfT6NtJTPawykYMiK2B2yM0AS0UUUAFFFFABRRRQAUUUUAVLCLyLb7KWLeV8gPT5f4fyHH4Vn+Epp7vwxaLeLsuo1a1mA/vxsY2I9iVJ/GtYx4uRKDjKbCPXnI/r+dUrILa6peW4UKsxFyh3E7ieHGO2CAf8AgVMRT8FW8EPhqCOAP5byTOyyDBVmldmXHYBiRitgCO5tQGXdG64Kt/Kq2mQJZy3NsjEhpGuFBHQSMWIz3+bcfbIq1bqiowi27NzH5emc8/rmhged/GHTprJ9F8aaYk5vdAmJuVtxl5bKT5Zl2/xbflkweytjBOa7Oyl2WMNxYq15FIBhYyo2jHJXJGBx0z37VfnEcubaeISRSowYMMqw6FT9Qen1rzn4epq2g6zqPhy6u2u4rOTFubgFna3bJiYyADJwChyCcocnkU1tYTPQ/t0IjDyCSIHg742GPrx+vSqu60u2eSyTz2Y7XkhkKL6csDzj8TV52YxkPCxPGQpH6HIqC4soXKs0HnOgLIZHJ2ntjOcfWhWAyoPKju7+e/SeC004Bt0lw7xMQu4vg/3Qfp3615npnxO8ceI7G58Q+GfCmmnwxEXeFL+7aK7u4k6sgUFVJxgA55I6jk+n31nHr3hjWNHBnt/tEEtm7PuLxmSP1PXAccgkV5B4S1jxdaeBbTwRZ+D9e07xNHYfZU1FoY0sbdtmBKZdxU9iQAW4OBngnqK+mhuatqGo6nP4T8b+GtY1pdJ1Zo4JdKk2eWBKCqNtIO0hiMsNxwOMiu3x4gEEIhjsppzjzBIGQD1w2z5j6ZAryjV9JmtdW8BeALDWp7200sRT6hO0sY8sRqdu3oy8rxgkgMBkd+nt9A8G218Fnnn+3XA3kz3t2JG4xnJl/D61a2E7HpdjaQ+RsnthvOd3mhWLevc1n+IpNKttMmWWGycMpBjeVIVI/wBokj5fUVQtvAHhrO+fSRNK3LSXMzzM3TqzMSenc1zvxMsdG8MeGJotK0K1E+oulnFHDCB50krhFVsD1fPXJ6DqSJ6ldCh8NvGOiST3V8b+yb7VMlhbC3YgMke9twTAIU5zwO49a7bxL4itItOfat86SKV/c2cxcMeEK/L/AHiPzFSeDtOXSrSHSY2Mh06NVnlwAJZ3UMSAAOgPTA4YDtV4IdQ1ezuChEMMBk+//G5GBjvgAnP0x3peYMLbVi8Ki20vUnRQAC0Ii7ejsp/SsnSp7oanql9a6BLGLuQbp5p4kDbFCc7WY8bSOnaurnk8qJnIJwOAO57CqUtusOnx2UKhRLmLjkDIJY8+2fxpDMzTrjWprBLq10/T1a6Pnnzrx+jYx0i7LtH4VfWPWmUFrnToyeoFu74/HeM/kK01AUAAYA4ApaLhYyrOz1RZ1e+1WOVAc+XBaiNW+uWY/kRSa5rKaXd6TA6xMb+6Fsu+XYQdpb5Rg7jx04rWrn/FHhz+3dR8P3X2ryP7Jvhe7fL3ebhGXbnI2/eznnp0pDItI8d+GNZ1aPTNM1q1ub6RWZIkJy23O4A4xkYJx1xz0qXXfGfh7QbxrXV9VgtbhUWRo3zlUY4DHA4XIxk8DvXPeHfhx/Yx8H/8TTzj4elvpf8Aj32+f9p38feO3bv9847Vm+LfA2teI/HOtNFdrp2iahpMNlNceSkzygSOXjQFwUOCPmKkc8c0AdrN4w8Pw67Ho0uq266i7KixZP3mGVUtjaGI5Ck5PasrWfiZ4W0q01KZ9R+0GwV2kjt0LFipwVRjhGbJAxu69cVlyfC+P+1y9vqzxaK9/b6lJYmAM7TQqqqBNuyFO1SRtJ9CKzx8IS13rUkmutDBqNtcQNBZ2xhRjL/HIvmFGK9tqpnvQB09x8QfCTaVaT3mrQw2+oQGRFfcGEeShLbfuANldxwMjrWRBqHgfwdd6v8A2TdWr67HATNFc38kkzIieZtLyFyqAHPHFUtV+FE+pSWVzca1bS30dgunXJm08tDPGrMUIjEoKsA2D8xBxnFaw+HYGkeL7FdSAHiCNI94tsfZ9sIi6bvm6Z7envQBty+NdAtryzsr3U7aC+uUjdYtxYL5n3AWAwM9s4z2q1pninQ9U1i50rT9TtrjUrbzPOtkfLx7GCNkdsMQK43Uvhb9subpV1l4tO1BbIajb/ZgzzNahQhjk3fuwdq5GG9sZrqvB3hv/hG01lftX2n+0dUuNSz5ezy/NYHZ1OcY68Z9BQBOPFOhm4WD+0rcTNetp4QnBNwBkx/XBB/GqF38QPC1paW91Pq8QtpwxjmVHZCFYoSWCkABgRk4HBrmfEvwmj1nxHq+rRazLZyXapLbIkOfsl2piP2hTuGTiFRjjq3PNVtf+D51HR9M0u01029lZ6X/AGcYZrUzIX6m4VfMULISTkndx0x1oA2tR+JEFp4hutLWwaYQ6pp+miZZhtf7Wm8SDjovp39RXUeIfEWk+HYIpdZvY7ZZmKRggszkDJwqgk4HJ44ri2+F27VTef2x11HTL/Z9m/584hHszv8A48Zz/D6Gui8YeF59b1LR9U03Uhp2qaWZhBK9uJ4ysqBXDJuXJ4BBzxjvmgDPuPiLpz+MtG8P6Skd/JqFuLr7Qs4WNIieCvB3kjJxxwOtdxXC+D/h5b+F9Y0q8tL+SWGw0dtKEUkfzOWmEpk3Z45BG3HfrXdUAFFFFABRRRQAUUUUAFFFFAEN2dsJkyq+WQ5JHQDr+mR+NNvEJjEsS7pYssgBxn2/Gp2AZSrAEEYIPeq2nGRYPJuNpmi+UlQQGHYjJPb365poTQ9WS4SC4hclMb1K9HUj/wDUfwp8RUM6ooXBzwOue9EEYhXYiqsY+4qjAA9KbOSjpJk7B8rD2Pf8P5E0C8x8qF0IB2t/C2M7T61wvjm1uo5bPxDYx41HSwUvI4wSZLZvvMvrtI3jg9HHU13tRzu0cZZF345Kjrjvj3oTG0ZukzjVtMt7211CVoZkDq8YjKsCOoO0gj3FaaK64DNvGMZIwc+vHFcBeWtv4O1uPU7eS4Tw9fsEkVbgrb2cjEYbZkAK5wAR0Y46MMddaz2d9F5unanvWQZDRTLIPqAcim0Sht9JdRzLLHbT7gMFoSrqRnoykg/lWFrVx4muQ8Ql0zRrQnas5d553/4AAAmf94n6dK6pI7lUjX7SrFfvM0fLcexAB/CqkOnMbqS6mu5HmkQLtSWRYgR3Ee8gHpQmgd+hy3h9NE8OLssoL6Z5m2yTmCR2LE88kZC5x3I6eldXbXHnuzxW91+7JCF3Kq/HoTz9cUKkikee9nJMu7ymwQVXt1JP15qdTLLFtW5jWfHzbAGC+mB/jTYkh3nTrt322QSB+7cNtz3OccD2zXnthOvi7xzPrs827w74cLw20QUgS3nIeQ5+9sTAXjrIccir/irUtad7fR9Hurd7qRxE86PiRmxubIUfuwAOTndjJAzjO/p2kiwi0/ToAPssGbid9pHmyk5HtyxZz6YHrUlE9wn2HRr+4RRFczK8zlcAmQrgd8EjCqPoKuaXA9vp9vHKcyqihycZJwBzjr9fao7yOO9uI7Z13RxMs0npkHKD65Ab8B61PczMuI4VDzt0B6KP7x9v50DGKTcXTZH7qA4H+0+Ov0GcfXPpSlfNvVP8MIP/AH0f8B/6FSqFs7RV3M+3Ayx+Z2P9ST+tSQRmNDuO52O5j7n+nagCSiiikMKKKKACiiigAqtqi3T6bdpp0iRXrROIHddyrJg7SR3GcVZooA8LsPiZr2oeDda1u432EFl9k0/clsrFbwlftDNvOFQZC5PAznnGDBpHxK1+60eyGoarZWVu2uXGn3GtiBZI44o4Ukj4wFy5YqGwBgdK97rL1/QrHX7WO31Jbho0bevkXUtu2cEfejZSRgnjOKBnimleO9XvbC01uf7JJqK+G9Wu1nEOPngnZU4zjGFXI71bufH3iTR4bz+1tTS5WfQbTV4ZbawVWtWlmEZXBbBXqSzHjrjjB9o0fTLLRtMt9P0u3S2soF2xxIOFGc/zJOferlAjzv4MeKdT8TaXrP8Aa9zb3ctlftbx3EGNsibFYHKgA/ePIABr0SiigAooooAKKKKACiiigAooooAKKKKACiiigAqKZSCJIxl17f3h6VLRQA1GV0DIcqeRTqy2gmsL+e7heWa1nwZbcDd5bDgun1GMr3xkc53aMUqTRrJE6vGwyGU5BFAhFyhIYjbnC/4GpKOtFAzPvNPtb+xvNM1CFLiyukdHikGQ6NkMp9uf1Fc9obTeFpU0jVMnSUCx2F91Ur0Ecxx8rjoGPytxyDxXWzRLMoDZyDuBHUH1FUzFcIjoypcxMCDG+ACMdB/gePcdKpEtChba4nkW2naK4T76xtgjnqUPBz6kc9jVaYXUUjy/bLSS2jByotsupHUk7+3piuY8Q+GredFa01LUNKkjYOBLC08SYXHB6qBx9x1wQKyLfwzdXMks2qeJRqjRW4RlgMuwgEYfyAWbeOzbznPSmhM7HUdW+xW3nS3rsDGGYgRwKo/vAOCfTjmsvV9Z/tDT0g02WZRcfuXureVt+SfmWA4AZ+OvAHXoCRFp/hNrifzmtVhRgVaWYMrSKR3jDEk9eXYYyflrr9P0m0sZTLFHunKhDK/LbR0UdlHsAB7UNpAkzP8ACfh6DRbbctvDBM4OIouVhUnJUHqzE8s5+Z25PYDXvLkQBVQb55OI48/ePr9B3NJM915qpbwoE/ikkfp9FHX8SKdb26wszljJM/33bqfYeg9v65NSULaw+RCFJDSE7nfGNzdz/ntxQjwgSyoVAJ+d+xwPXvUNw+2dFd3kJBIgjUfMM9Wz2/EDr16U6O3Z2SS525jPyRoTsX0Puf5dvWgBYo2lmE8uQF/1aHt/tH3P6D6mrNFFIYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVdh9ncui/unOXA/hP8Ae/x/P1qxRQBC7uu1o18yM9dp5A9R6/561KrBhwc0zygGyhKewPH5dKpXd/FY3MSXMUo80H/SEiJTIIwpIyQTnjt1pi1NGopbiKKRUdwHb7q9z9BUTXDybWs/ImX+IFypH5A/lxT4I3z5krMHbqm/Kr9OBn8aLBfsT0VE2PtCcHdg89sf5xUtIAooooGV4LlZmwGj6kY3c/kQKsDPeqUtqj3JlZdzZBHGCMdORg4z65q6KbJTCiiikUFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABSEAjBGQaWigDJ1HSbeVkmit4EkTPzhSrDIxwysuPep9IsobOJgir5r8u4JYv75PPrVi8nNvbvKInl2j7qYz+tVLC8Se0EgjMbMwB2tuyc9Nx6+/p7VWrRDsmXY0/evIRhj8o57Cpaa7qi7nYKvAyTiqeo6nb2IYMfMmVd/lJy23OCxHYD19jS3K2L1Fc94g8TwaTYyTeTLI6SwRMGRlVfNdVBLYxgBsmt+ORJEDRsrqehU5BosO449uaKRgSODg+tRRTq8rRHCzIqsyZzgHOD9Mgj8KQiSWRIYnlmdY40UszscBQOpJ7CuBtvFviHxSzy+B9Js10dWATV9XldI7nk5MEKDc69MOxQHtnrVn4lwjXf7K8IB3WPWpWa9KFlb7FDtaYBgRjeWiiPtKa7SCKO3gjhgjSKGNQiIigKqgYAAHQAUDOPbR/HMs2+TxdpMSgcR2+hkLn3LXDE/hipi3jTSxudNI8QRBSSsIawmB9AGaRG/FkrraKAMPQ/Eltql1JYTwXGnavEnmSWF4FWUJ03qVJWRM8bkJAPBweK3KxvFGhprdinlv9n1K2bzrG8UfNbzAcMPVT0ZejKSDwam8NaqNa0S1vjGYZXBSaE9YZVJWSM+6uGX8KANOiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGuiyIySKGRhhlYZBHpVGEGXUpV27YLZVVFA+XcRkn8BgfjWgTgGsi+uns/DtxchLiebyXkVIAoldipIVc8bugGeM4poTOf+KHilvDuhefaWrahfPcRW1rp8f8ArLyZmUlF69E3sTjjGe1c4vhHxX4n0aXTdQNp4R0O6DLcW9rJ9t1GdHLb0edgI485/hD+man+DhfxTZ23jS9nmuWmR7TTjcgB47ZGKu5A4EksilmI/hVB259TptiSPItd+CNvrGif2ZdeOfG0tsNu2OfUEkjypBXcvljdggEc9RnrWF4oj8Z/DqGyuLy/0/WdKu721tLvVjC1pLbI0m3dMiloyuCAHG07iMg5r3qs3xJo1p4h0DUNH1JC9nfQPBKBjIDDGRnoR1B7ECknYbRPpYggsoLW3OFgjEYVmywC/Lz69OtKY5BqiSrt8loWV+OSwYFefTBb868q+AviDVNRtrvSPEkER1PRJZdMN/FNn7S0TbHDqed4ARt3IYNnIO4V6rqt9BpemXmoXbbLe0heeVvRFUsx/IUMEefW+oPL4p8d+KkiWWPRLT+ybJSxAd408+b6Zd40JH/PKtf4badPpa6xaz3ZupEuI/tEhdn3XJgjaZsknALMCFGAO1c3Y/6F8HtBXVpmhuNXuIb67ZlwQZZjeXAP+7H5oPstd34Jh2+HLa5fJmvy1/KSu07pTvwR/shgv0UUAbtFFFIYhOASAT7DvXnUWvw6Tr2tWehR2t3c6rNDcWMKy7Ve4cPHMWwCVVPs5d8AkZPG4gH0auCvdCtNL+MGleIYkZW1Wxn0yQKo2+cNkyv7MUhkUnvtX0oEajaJ4keEyHxY8d4Wztj0+H7MB6BDmT/yJTBH4ztFGy+8P6syEbo3tpbJiP8AfDygH/gNM1nxfI3iCbw54WtItU16CNZbsSymK3sUYfI0zhSdzdRGoLEcnaOal8MeEv7N12/8QapcxXuv30SQSzw2ywRpGpyERRliM/xOzNwBnAApgP03xhbyalBpet2V1omqzj9zBeBTHcHuIplJRz325D45Kiunqhrmk2euaVcadqUImtZxhlyQVIOQykcqwIBDDkEAjkVj+DtTuhNeeH9amM2r6Zt/fsu37Zbtny5xxjJwVcDgOrcAFaQzp6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqtqV/aaXYz3upXMNrZwLvlmmcIiD1JPApdQvLfTrC5vb6ZILS2iaaaVzhURQSzH2ABNcFa6ZeeKLZvFWt2peSONrjQ9IuF+S2+UmOaVDwZ24PP8Aqwdo53EgGkni/U9XKnwp4ZvLy2YjF9qT/wBn27AjOVDK0zD38vB7E0R6R4z1GRn1XxLa6XEcgW+jWasy/WaffuP0jWum0QqdGsDHLJMhgjIlkbczjaPmJ7k9c1doEcWPA93ksfG3iwuepM9v/LycD8BT18G6hGcw+OfFKHvuNpID/wB9W5/SuxoouFji5dH8cW7t9g8W6bcxdVXUdH3v9C0UsYx9FFKfEev6IA3ivQhJaAfNf6Iz3Sp7vAVEqj/cEnviuzooAo6Lq+na5p8d9o97b3to+QJYHDrkdQcdCO4PI71erm9Z8FaLql5NfeTPYanKu1r7Trh7WdvTc0ZG/Ho2RVb7P4q0IA2tzH4ks1HMN1st7wAD+GRQI3Psyp/vUAdbWJ4quzYaakuFFsjlrht23ZEiM7MD2xtqvovjHStU1VtJdptP1tF3tp18nlTlefmTkrIvB+ZCw96wfj3OsPwm8TBrjyN9jKu4PtYgqRtHBzuJCkdwxHHWmtwZp/CTTY9K+GPhS0RQGTTYGb/eZAzf+PE111cRfeIz4f8ADuj6fp9sL3WJbWFILVTgD5QAW9BkHA74PIVWZZ7TTvFb6fENW1hXun+9HYRJCqZyfmkcMSO2VUH+dFgudhRWV4dsbuxtZ1vrhpXkmMiIZmlES4ACh2+ZuhbnoWIHAFOk8QaNEzCXVtPQqcENcoMH86QzzT4elLH4wfEDTLee13Nfx3jW5P70CS3hZnA/u5bBPriuj+MbvdeGbbw9A0guPEV7DpeY+WWFjunbHoIUl/SuQ0HVdPsv2g/F/kz2002pWFjdxMhDF40Ro2VWHuYmI9BntWlZ6lbeM/jwi22423g/T3JZgVJuroAYwewiUjPqxFUyTqviiijwZdoiKXnaKwUHoFuJUgbHvtkIzXS3l5bWEcRuZY4VkkWGMMwXe7HCqPUk9q574o21zceA9UNhD591bCO8jiBOXMMiy7Vx/EfL498VBY3dn4m8Z2t3bTJc2Om6fHd25AyDJchgsg9xEhA9pj60hnYKSVBIKkjoe1LRRSGMDneVZGA3YB6huM546enNef8AxI8V2em+HdK8SWMiX1tZaiCViOSzmKWMR+zb3VcHoTzXodeWfGfR5IYdN1PT0iWG41jTYtVRh8rxi6iKS4/vqwVM90cg52rhoTO58HaIugaBbWbMJbs5mu5+89w53SSE9yWJ+gwOgFbVZniDX9L8O2IvNbvobO3Z1iVpD95mOAAByT9OwJ6A1p0hhXC/Eye50WbRfEOlWv2rUYrj+zRFnaJVucIqs3ZRMIGJ7BT613Vc58QFZvDgKBfMW+smTcMgMLqIg/nQgZmR+ENdjiNzF431cas6hpGeGGS0Z++ICuVT/ZVw2OrE5JuaD4hvU1n+wPFMFvbau0ZltZ7bd9nv4x94x7uVdf4oySQCCCwyR1VY/ivRI9f0eS1LeTdIRNaXIHzW0652SL3yCefUEg8EigRsUVl+F9UOtaBZ38kLQTyKVnhYYMUqkrIh/wB11YfhWpQMKKKKACiiigAooooAKKKKACiiigAooooA5b4lW4vPC4spCRDd39lbzY7xvdRK6/QqSv411NZ/iDS4ta0e6sJ2KLMvyyAZMbghkce6sFYe4rm9P8cxWW+y8ZW82jalBIYnnkgk+xT8ZEsU+CgVhztZgynII4yQRdEF34XZmtt13oO4n7KqZmswT/yzx9+PJ+5jcOi5GErobK6gvbWK5s5o57eVdySRtlWHsaoCbSvE2lSJZ30F5aSY/fWdwG2kEEMroeGBAII6ECuet7fUPD2uQG5nWS0u59j3QQKsrNwomRcBJScYlUBX+6yqdhp7gdtRRVLR7t72zM0qqrCaaPC9MJIyj9FFIZW8S3z2dikdvKsNzcv5UcrYIiGCzyYPB2orNjuQB3qLwZDNB4ZsRcz3U7urSh7py8oV2LKrk8khWA/CsnxKf7R1yKwDr5UhWxKnjO8ebNz1z5UYUY/56V2NMQUUUUhlDWNIsNatBbanax3EQYSJuyGjcdHRhyrDswII7GvM/il4I8Yar4J1HQ/D2r2eo29xHsCasGFyicEqs6EBycADeueTljXrdFFxWOO+Gdza3OilXaT+3YSi6rHcReVNFPsAwU/hTHCYJUrjBbknsT0ODg+tYXiLwza6xNFexTT6frEC7YNRtG2yoM52tnKyJnqjgr3wDg1nWPie50u7TTfGUMdlcO4jt9Sj4srwnoAxJMUh/wCebnk8Kz0wJ5vBem3xkOvS3useYcvFeXDNbn28gERY+qn3JqzD4N8MQFDD4c0WMou1SljENo9B8vSt6ilcdjzrxR8GvBevN58WljRtRXPl32kH7LKhPU/L8pJ/2getYfh/winhTWfsWmlNH8RzoTb6gjO9rrQTLFbiN2J80AsTht2CWViNyr7DWfrulW+tabLZ3RdA2GjljO2SGQcrIh7MpwQfancVit4b1xdZgnSa3ey1K0fyryzkOWhfGRg9GRhyrjgj0IIHAfA23u9I1fxz4evJEkj0nUkitPmy6WrRBoUIx0CYAP1Haui0xrzVf9JUwQ+K9Hk+x3q8pHcpw2D32OpEiHnYxI5w4NfS7Yad8b9eMaYj1fRrW5kb+9JDLJGf/HXSgDtbW+trqa4hglDTQNskQghlP0POD2PQ9qs1n6xpaalblRNLa3IH7q6gO2SI9iD0I9VOQehBqDw7qc17HPa6iiRarZMI7lI87WyMrImf4HHI64OVJJU0hmvXDfG6Rofhlq86TCFoWt5hIcALtuI2yc9uOfau4ByOhH1rkfi1p39r+Ar/AEwttS9ltrZznHyPcRq3P+6TQBJ4fsI9dmfxDqsKzm5BWwhlXKwWuQVIUjhpNqux6/cX+CurpFUIoVQAoGAAMACloApSarYRavDpcl5AuozxNPHbFwHdFIBYD0BIrE8eK9wPD1jG2PtOsWxYeoi3XBH/AJBrL+Kmi3s1hF4h0CDz9c0gGaKADLXCj5ii+j8cdchnT+MkSzX1v4g8W+CZ7SXMH2O51dAD1BjjiXP4XDfkaYjt6KKKQylp1jDYzXv2eMotzMbl+eC7ABsDPH3cngDJ9c1doooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOf1XwX4a1WQyX+habLOTu877OqyZ9d4Ab9ao33gS0mtZ7ez1fXbGKaIwsi3zXCbSMcJP5ij8AK66igVjkFTxZoMcOJIfE1kgCyKyrbXuMgbgciKQ4ySCI/qelTeA/EFlrcOqw2fmxzWV7Ik0E8TQyxl/wB6N0bAMPv4zjBwcZFdTWF4g8KaRr1zBdX9s639uMQ3ttM9vcRj0EkZDbec7ScHuDTAYzBvHUVvHGAsVjJcSH1eR0RT+UbD8a1LKeK9kknhdnjjdoAGQAB0Zlcg4z1yPT5eK83l0PxP4L8Vf8JBDqGpeK9D+yG1nspQhvbZNwcSRlVHn4+b5Th8HgseK6v4Z6zY6/4Qt9Q0ubzraWe4wxBByJnzkHBB74IB5oA6miiikMKKKjuJoraCSa4lSKGNS7ySMFVVHUknoKAJKjubeG6gkguYo5oJBteORQysPQg8EU6KRJokkidXjcBlZTkMD0IPcU6gDkD4L/s1t/hHVrrQxnP2QAXFmec/6l/uD/rmyU2LWvFOlRn/AISDw/HfxKCTdaHL5mR6mCTa4+iNIa7GigDB0vxdoWpXRtINRijvxgGzuQbe4GfWKQB/0reqlq2ladq9uLfVrC0voM58u5hWVc+uGBFc4/gKyt1/4kGp61ocgbcv2O9Z4gf+uMu+ID2CigRY10nSPFWl6wDttLsDTL084BZs27ntw5ZPrMPSo9TWO3+J+gXDna1zpt7aD/aYSW8gH5LIazNZtfFkWlXWn6tbWnifSp4jC8llizvlBH3gjkxOw6gho8EDArivHnxE0nSofAk97fzx6xp2sW8V6moWxtJ/KkgljmlaNhymG3Fk3LnAB6UwPdK5DxdJ/YviXQNdB2W8s39lXzADHly/6lmP+zMEUennNXX1znxG8P8A/CVeBNc0UKplu7V1hJOAsoG6NvwcKfwpDOhUEZyc88VheOSF8PM7EBY7q0kJIzwtxGT/ACqhp3iVtQ0bwbqaEomqyIk8fdWa3kYofdXUA+hBqb4nbj4D1hY/9a0QWP8A3ywC/qRTEdRRRVTVr5NO0+a6kG4IBhc43MSAqj3JIH40hluvNvANsYfiR4wtmg2W+lpBb2bYHCTtJcOoxwAC6gD0Ue1ek1yngWRbq/8AFl4qgGXWHjz6+VDFD/OM0xHV0UUUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVy+peEY/7QutU8PXs2iatcczSQoJIbhgODNCflY/7S7XxxuxXUUUAcN4X8Y3v9vDwz40sodM8QspktJYCTaamij5mgY8hl6tE3zAEH5hkjuaztd0aw17T2stVt1ntywcclWRxyrowIZGB5DKQQehrkoNX1LwTqNrp3ie6m1HQbl1gs9blVfMgkPCxXW0AcnAWUAAkgNg/MwI7e3uVnluERXHkyeWWPRjtB4/PH1BrndS3aqq3DIJIjL5WnwSLlHk5/fuO4ADMoPGFzySu21Gog0K5RZGhe5u5UD91aSdlyPpu4+lXra2UakSiKlvawrBCoH3SeW/DAQD8adgLdnbpaWcFtDkRQosa59AMCpqqateLp+nXF0wDGNflTON7HhVHuSQB7mrEAkEEYmYNKFAcgYBOOaQx9FFFABRRRQAVl+I/D+k+JdLl07XtPt7+zkGGjmTOPcHqp9CMEdq1KKAPP7O28ReBIFiQy+JPDMOVSKOP/T7GID5VHOLlVAx2k9N54rstE1fT9d0uDUdHu4byymGUlibIPYg+hB4IPIIIODV6uS1nwf8A8TOXWfC17/YmtyEGZlj3215g9LiHIDnGRvUq4/vY4oEL/wAIpNH4gt7i3v1XR0vG1E2LxbmW4ZHUmN93yoxkLlSD82SCN2A3xXcrq2uaZ4bs2Z5luIdRvyoyILeJ96bj2MkiKoXqQHPRTXlnj7xh8T0+26Wr+HfC15tAtZZjI4viFJIt7l18kOxGBG4VxkHPeu/+A0dufhlpN2sUg1G6Vm1GWfcZ5bpWKStKzfMW3KRz0AA6AUwPQqwPErG4v9F0xCuZ7oXMoK5/dQ/Pkf8AbTyR/wACrfJABJOAO9cx4Xc6zql74hI/0SVRa6d1+aBTlpcf9NH5B7okZ70hnT1yfwwMcvhVrqI5W81C+ugfUPdSsP0Irpry4jtLSe5nYJDCjSOx7KBkn9K574YWr2fw88OxS8Smxikk9ndQ7fqxoEdPRRRQMKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqvqNja6lYz2WoW8VzaToY5YZVDK6nqCD1qxRQB5t8PS2nM3hHUJrmW80TUJGie6ctJcWkgleCXcfvAAmMn+9EeleiQQrC0zAktK+9ifXAH8gK5Tx7oF5dTaf4h8PRRv4j0cu0EbvsW7hYfvLZmPA3gDax+6wU9M5t2vii31nwedY0TzPMlHkpFLERJBcFtnlyp1Vlc4YdsHtzTEWMnWNc4OdO02TnjImuMdPogP/AH0exSt2qmlWEOmadBZ2wxHEuMnqx6lj6knJJ7kk1bpDCiiigAooooAKKKKACiiigCK6t4bu2lt7uGOe3lUpJFKoZXU9QQeCK4uPwGPD7TT+AL3+w2kcyPp7oZrCVj1JiyDGTgDMbL7hsYruaKAPOda8QW8ttHp3xG0+80OHzAZLiKVpNNuhyNr3CgbUPUrKI89PmGc+gWU1tcWkMtjJDLaugMTwsGRl7FSOCPpUpAIIIyDxzXKy+BNJiu2u9De70C6dtztpUghSQ+rwkGJz7shPvTER/E26D6CmgQSAX/iCT+zIUHLbHB86Qf7kQkbPTIUdxXWxRpFEkcahY0AVVHQAdBXnY8DeJ4vEf9sxeNvPulgNrGb7SYpCkRbcVHltGASQCSACdq56CtiXSPGcibR4s02I92i0U7v/AB6cj9KTGddRWVZaVKpgk1S9k1GaJE2+ZGiIsgGDIFUdSeeScZOMZNatABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXl/ji0m8LeM9F13TmZNH1nUYLPWrcIWTzSQLe5H9xtwWN26MGTIyAa9QrI8XeH7PxV4Y1LQ9SBNpfQNCxABKE9HXPG5Thh7gUAa9FeefCrXNWRr3wh4xlEniXRwCtyT/yEbQ8R3K56/wB1uuGHJy2K9DoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAwfFXhyLXUtJ4Z3sdWsJDLY30a5aFiMMpH8cbDhkPBHoQrA8Oa89/NPp2qQLZa7aqDcWwYlXUnAliY43xt2PUH5WAIIrerD8VadNc2sN9pyj+1dPfz7btv4+eIn+665X2O1uqigDcoqtpl7BqWn217asWguI1kQkYOCM8jsfUVZoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAw7O3k0fVpY4kZtLvZDKu0cW0zcsMf3XOWz2Yt/eGNyiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The surgeon places the nondominant index finger into the rectum to demonstrate the fistula.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16545=[""].join("\n");
var outline_f16_10_16545=null;
var title_f16_10_16546="Patient information: Borderline personality disorder (The Basics)";
var content_f16_10_16546=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/57/12179\">",
"         Patient information: Depression (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/32/32257\">",
"         Patient information: Generalized anxiety disorder (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Borderline personality disorder (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/borderline-personality-disorder-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H21278802\">",
"      <span class=\"h1\">",
"       What is borderline personality disorder?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Borderline personality disorder is a mental disorder. People with this disorder have unstable relationships and extreme mood changes, such as sudden shifts to anger or sadness. They sometimes do things that seem extreme and can even be violent. Plus, they act without thinking about the consequences.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21278817\">",
"      <span class=\"h1\">",
"       What are the symptoms of borderline personality disorder?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with borderline personality disorder often have:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Unstable relationships",
"       </li>",
"       <li>",
"        Sudden shifts in how they see themselves or others",
"       </li>",
"       <li>",
"        Extreme mood changes, such as sudden feelings of rage, deep sadness, or total emptiness",
"       </li>",
"       <li>",
"        Problems with risk-taking (For example, they sometimes take illegal drugs or have unsafe sex, and they can be violent with themselves or others.)",
"       </li>",
"       <li>",
"        Trouble thinking clearly or logically when overcome by emotion",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Part of the reason that people with borderline personality disorder have unstable relationships is that they tend to see people in their life as all good or all bad. At one moment, they might feel close to a loved one; at the next moment they might feel disgusted by that person. People with borderline personality disorder can also misunderstand the reactions of others. For instance, they might think a person who likes them actually hates them.",
"     </p>",
"     <p>",
"      People with borderline personality disorder often think about suicide. Roughly 1 in 10 people with the disorder actually kill themselves. For this reason, it&rsquo;s very important that people with borderline personality disorder be treated by a professional who has experience with the disorder.",
"     </p>",
"     <p>",
"      Many people with borderline personality disorder have other mental problems, too. For example, they might have depression, anxiety or eating disorders, or they might abuse drugs or alcohol.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21278832\">",
"      <span class=\"h1\">",
"       Is there a test for borderline personality disorder?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. There is no test. But a mental health expert, such as a psychologist or psychiatrist, should be able to tell if you have it by learning about your symptoms, your relationships, and your experiences.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21278847\">",
"      <span class=\"h1\">",
"       Should I get help?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have thoughts of harming yourself or others, call 9-1-1 or go to your local emergency room. If you have the symptoms described above and they make it hard for you to have a normal life, talk to a therapist who has experience treating borderline personality disorder.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21278862\">",
"      <span class=\"h1\">",
"       How is borderline personality disorder treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The main treatment for borderline personality disorder is talk therapy (also called psychotherapy). There are different types of talk therapy that can help. In general, they all focus on helping you learn new ways of thinking and behaving, so that you have less extreme mood changes and feel more at ease. &nbsp;",
"     </p>",
"     <p>",
"      Many people with borderline personality disorder also benefit from medicines to help with mood changes, anger, and other symptoms",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21278877\">",
"      <span class=\"h1\">",
"       What will my life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Experts used to think that borderline personality disorder was something you had for the rest of your life. New studies suggest that many people get much better over time. If you have borderline personality disorder, seek help and follow through with treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H21278892\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=see_link\">",
"       Patient information: Depression (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/32/32257?source=see_link\">",
"       Patient information: Generalized anxiety disorder (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?16/10/16546?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16579 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-F8E45503D2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16546=[""].join("\n");
var outline_f16_10_16546=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278802\">",
"      What is borderline personality disorder?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278817\">",
"      What are the symptoms of borderline personality disorder?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278832\">",
"      Is there a test for borderline personality disorder?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278847\">",
"      Should I get help?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278862\">",
"      How is borderline personality disorder treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278877\">",
"      What will my life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21278892\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=related_link\">",
"      Patient information: Depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/32/32257?source=related_link\">",
"      Patient information: Generalized anxiety disorder (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16547="Centruroides antivenom: Patient drug information";
var content_f16_10_16547=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Centruroides antivenom: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/50/22307?source=see_link\">",
"     see \"Centruroides antivenom: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/44/39619?source=see_link\">",
"     see \"Centruroides antivenom: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13215077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Anascorp&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F13185739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3509416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat scorpion stings.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F13185738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3509415",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to antivenin (",
"       <i>",
"        centruroides",
"       </i>",
"       ) or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to horses or horse serum, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F13185743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F13185744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F13185746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699037",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle or joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F13185741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F13185747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F13185748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16768 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9662981F41-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16547=[""].join("\n");
var outline_f16_10_16547=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13215077\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185739\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185738\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185743\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185744\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185746\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185741\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185747\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13185748\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/50/22307?source=related_link\">",
"      Centruroides antivenom: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/44/39619?source=related_link\">",
"      Centruroides antivenom: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16548="Triamcinolone (nasal): Patient drug information";
var content_f16_10_16548=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Triamcinolone (nasal): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/32/5637?source=see_link\">",
"     see \"Triamcinolone (nasal): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/56/16260?source=see_link\">",
"     see \"Triamcinolone (nasal): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9606519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Nasacort&reg; AQ",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9606520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Nasacort&reg; AQ;",
"     </li>",
"     <li>",
"      Trinasal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness. It may take 2 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to triamcinolone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699040",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad nose irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698688",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been exposed to chickenpox and have not had chickenpox or had a chickenpox vaccine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694916",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the nose only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694567",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blow your nose before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your spray use with your doctor at each visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12327 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-5368725AE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16548=[""].join("\n");
var outline_f16_10_16548=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606519\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9606520\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024643\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024642\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024647\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024648\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024650\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024645\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024646\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024651\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024652\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/32/5637?source=related_link\">",
"      Triamcinolone (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/56/16260?source=related_link\">",
"      Triamcinolone (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/55/8052?source=related_link\">",
"      Triamcinolone (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/31/19955?source=related_link\">",
"      Triamcinolone (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/36/16963?source=related_link\">",
"      Triamcinolone (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31768?source=related_link\">",
"      Triamcinolone (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/49/5910?source=related_link\">",
"      Triamcinolone (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/11/27831?source=related_link\">",
"      Triamcinolone (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/30/32229?source=related_link\">",
"      Triamcinolone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/46/36580?source=related_link\">",
"      Triamcinolone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/10/14500?source=related_link\">",
"      Triamcinolone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16549="Famotidine: Patient drug information";
var content_f16_10_16549=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Famotidine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=see_link\">",
"     see \"Famotidine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/61/29655?source=see_link\">",
"     see \"Famotidine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Heartburn Relief Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Heartburn Relief [OTC];",
"     </li>",
"     <li>",
"      Pepcid&reg;;",
"     </li>",
"     <li>",
"      Pepcid&reg; AC Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Pepcid&reg; AC [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F169928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Acid Control;",
"     </li>",
"     <li>",
"      Apo-Famotidine&reg;;",
"     </li>",
"     <li>",
"      Apo-Famotidine&reg; Injectable;",
"     </li>",
"     <li>",
"      Famotidine Omega;",
"     </li>",
"     <li>",
"      Mylan-Famotidine;",
"     </li>",
"     <li>",
"      Novo-Famotidine;",
"     </li>",
"     <li>",
"      Nu-Famotidine;",
"     </li>",
"     <li>",
"      Pepcid&reg;;",
"     </li>",
"     <li>",
"      Pepcid&reg; AC;",
"     </li>",
"     <li>",
"      Pepcid&reg; I.V.;",
"     </li>",
"     <li>",
"      Ulcidine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691503",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat GI (gastrointestinal) ulcers caused by infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691849",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat gastroesophageal reflux disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691875",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heartburn and sour stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692103",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat syndromes caused by lots of stomach acid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to famotidine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697354",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you need Pepcid&reg; AC for more than 14 days in a row, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698643",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing or speaking.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695856",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime if you are taking once a day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022914\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) at room temperature. Throw away any part not used after 1 month.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12462 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-89.32.226.102-9F539080E8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16549=[""].join("\n");
var outline_f16_10_16549=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169927\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169928\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022904\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022906\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022905\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022910\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022911\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022913\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022908\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022909\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022914\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022915\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/45/728?source=related_link\">",
"      Famotidine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/61/29655?source=related_link\">",
"      Famotidine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16550="Anorexia nervosa in adults: Evaluation for medical complications and criteria for hospitalization to manage these complications";
var content_f16_10_16550=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anorexia nervosa in adults: Evaluation for medical complications and criteria for hospitalization to manage these complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16550/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16550/contributors\">",
"     Philip Mehler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16550/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16550/contributors\">",
"     Joel Yager, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16550/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16550/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/10/16550/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 24, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H86791750\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorexia nervosa (AN) is associated with numerous medical complications that are directly attributable to caloric restriction and weight loss (",
"    <a class=\"graphic graphic_table graphicRef67080 \" href=\"UTD.htm?29/44/30413\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/1\">",
"     1",
"    </a>",
"    ]. A medical evaluation is necessary to assess patients for these complications and determine whether hospitalization is necessary. &nbsp;",
"   </p>",
"   <p>",
"    Medical complications account for more than half of all deaths in patients with AN, and the rate of mortality is high [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/2\">",
"     2",
"    </a>",
"    ]. A review of 119 case series (5590 patients) found the crude rate of all-cause mortality was 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/3\">",
"     3",
"    </a>",
"    ]. Standardized mortality ratios show that the rate of death in AN is 10 to 12 times greater than the rate in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation for medical complications and criteria for hospitalization of patients with AN is reviewed here. The medical complications of AN and their management; the epidemiology, pathogenesis, clinical features, treatment, and outcome of AN; the refeeding syndrome in patients with AN; and the medical complications of bulimia nervosa and binge eating disorder are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=see_link\">",
"       \"Anorexia nervosa in adults and adolescents: Medical complications and their management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=see_link\">",
"       \"Eating disorders: Treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30982?source=see_link\">",
"       \"Anorexia nervosa in adults and adolescents: The refeeding syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=see_link\">",
"       \"Bulimia nervosa and binge eating disorder in adults: Medical complications and their management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86794444\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF ANOREXIA NERVOSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AN are not able to maintain a minimally normal body weight of at least 85 percent of that expected for age and height [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/7\">",
"     7",
"    </a>",
"    ]. AN is also characterized by intense fear of gaining weight and a disturbed perception of body weight and shape (",
"    <a class=\"graphic graphic_table graphicRef75110 \" href=\"UTD.htm?9/7/9339\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    There are two subtypes of AN [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Restricting &ndash; marked by weight loss through dieting, fasting, and excessive exercise",
"     </li>",
"     <li>",
"      Binge eating and purging &ndash; marked by episodes of binge eating and inappropriate compensatory behaviors to prevent weight gain, including self-induced vomiting and misuse of laxatives, diuretics, or enemas",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of AN are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link&amp;anchor=H3#H3\">",
"     \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\", section on 'Anorexia nervosa'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793536\">",
"    <span class=\"h1\">",
"     MEDICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AN should be evaluated for medical complications (",
"    <a class=\"graphic graphic_table graphicRef67080 \" href=\"UTD.htm?29/44/30413\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. The complications and their signs and symptoms are secondary to caloric restriction and weight loss. The evaluation of all patients with AN should include a history, physical examination and laboratory testing.",
"   </p>",
"   <p>",
"    Patients with medical complaints due to AN often attempt to mask their thinness and conceal their eating disorder from clinicians by wearing bulky clothes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/9\">",
"     9",
"    </a>",
"    ]. In addition, patients may inflate their body weight by hiding objects in their clothes and drinking water.",
"   </p>",
"   <p>",
"    Findings from the medical evaluation help determine whether the patient requires hospitalization. (See",
"    <a class=\"local\" href=\"#H86793887\">",
"     'Treatment setting'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793543\">",
"    <span class=\"h2\">",
"     Medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common medical symptoms of AN are [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/2,9\">",
"     2,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Amenorrhea",
"     </li>",
"     <li>",
"      Infertility",
"     </li>",
"     <li>",
"      Exertional fatigue",
"     </li>",
"     <li>",
"      Weakness",
"     </li>",
"     <li>",
"      Cold intolerance",
"     </li>",
"     <li>",
"      Palpitations",
"     </li>",
"     <li>",
"      Dizziness",
"     </li>",
"     <li>",
"      Abdominal pain and bloating",
"     </li>",
"     <li>",
"      Constipation",
"     </li>",
"     <li>",
"      Swelling of the feet",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Irritability is often present as well.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793550\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Within the context of a complete physical examination, key portions include weight and height; vital signs including heart rate, blood pressure both supine and standing, and temperature; cardiovascular assessment; and skin examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793557\">",
"    <span class=\"h3\">",
"     Common physical signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common signs in patients with AN are [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low body mass index (&lt;17.5",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      Emaciation (body weight less than 70 percent of ideal body weight)",
"     </li>",
"     <li>",
"      Hypothermia (core temperature &lt;35&deg;C or 95&deg;F)",
"     </li>",
"     <li>",
"      Bradycardia (pulse &lt;60 beats per minute)",
"     </li>",
"     <li>",
"      Hypotension (systolic blood pressure &lt;90 mmHg",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a diastolic blood pressure &lt;50 mmHg)",
"     </li>",
"     <li>",
"      Hypoactive bowel sounds",
"     </li>",
"     <li>",
"      Xerosis (dry, scaly skin)",
"     </li>",
"     <li>",
"      Brittle hair and hair loss",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other signs that are often present include brittle nails, pressure sores, yellow skin (hypercarotenemia, especially palms), lanugo hair, cyanotic and cold hands and feet, edema (ankle and periorbital), and heart murmur from mitral valve prolapse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793564\">",
"    <span class=\"h2\">",
"     Laboratory assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tests should be guided by the symptoms and findings on the physical examination. Laboratory tests indicated for all patients with AN include [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/2,8,11-13\">",
"     2,8,11-13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Serum electrolytes",
"     </li>",
"     <li>",
"      Blood urea nitrogen",
"     </li>",
"     <li>",
"      Serum creatinine",
"     </li>",
"     <li>",
"      Serum glucose",
"     </li>",
"     <li>",
"      Serum calcium, phosphorous, and magnesium",
"     </li>",
"     <li>",
"      Thiamine",
"     </li>",
"     <li>",
"      Serum albumin",
"     </li>",
"     <li>",
"      Liver function tests (aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase)",
"     </li>",
"     <li>",
"      Internationalized Normalized Ratio (INR)",
"     </li>",
"     <li>",
"      Complete blood count (CBC) including differential",
"     </li>",
"     <li>",
"      Thyroid stimulating hormone (TSH)",
"     </li>",
"     <li>",
"      Electrocardiogram (ECG)",
"     </li>",
"     <li>",
"      Urinalysis for specific gravity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with a body mass index &lt;14, we also suggest an echocardiogram. Patients amenorrheic for greater than six months warrant dual-energy X-ray absorptiometry (DEXA). Patients with atypical features, an unremitting course, or significant cognitive impairment warrant magnetic resonance imaging (MRI) of the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793571\">",
"    <span class=\"h2\">",
"     Excluding medical disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;AN is the most common cause of substantial weight loss in young adolescent females in western countries, and the diagnosis is usually clear because patients present with emaciation in conjunction with self-induced starvation and intense fear of fatness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/11\">",
"     11",
"    </a>",
"    ]. However, if the diagnosis of AN is not clear, the evaluation should account for other nonpsychiatric medical illnesses that can present with weight loss, malabsorption, or secondary amenorrhea. These include (",
"    <a class=\"graphic graphic_table graphicRef69495 \" href=\"UTD.htm?8/61/9181\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef59801 \" href=\"UTD.htm?1/19/1340\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef73995 \" href=\"UTD.htm?25/25/26012\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neoplasm",
"     </li>",
"     <li>",
"      Chronic infections (eg, tuberculosis or acquired immunodeficiency syndrome)",
"     </li>",
"     <li>",
"      Uncontrolled diabetes mellitus",
"     </li>",
"     <li>",
"      Hyperthyroidism",
"     </li>",
"     <li>",
"      Malabsorption syndromes (eg, celiac disease)",
"     </li>",
"     <li>",
"      Inflammatory bowel disease",
"     </li>",
"     <li>",
"      Pregnancy",
"     </li>",
"     <li>",
"      Primary ovarian failure",
"     </li>",
"     <li>",
"      Polycystic ovary disease",
"     </li>",
"     <li>",
"      Pituitary prolactinoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Findings from the medical evaluation of AN overlap with findings obtained from the evaluation of other illnesses that cause weight loss. However, there are a few important differences. As an example, most starving patients describe lethargy and inability to exercise, whereas patients with AN may exercise excessively in an attempt to lose weight. Patients with AN are often not concerned about their marked weight loss, whereas patients who lose weight from other causes usually express concern. In addition, weight loss due to malabsorption usually presents with diarrhea or symptoms of adrenergic excess, such as diaphoresis and rapid pulse, which are typically absent in AN (purging may lead to dehydration and tachycardia, and laxative abuse to diarrhea). Further, the diet of patients with AN usually contains protein and vitamins even though their total caloric intake is very low. Thus, patients are often spared the starvation-related complications of malnutrition observed in developing countries (eg, kwashiorkor and marasmus).",
"   </p>",
"   <p>",
"    Illnesses other than AN can be diagnosed or excluded through the history, physical examination, and laboratory screening tests. The guiding principle is that a complex and expensive workup to rule out numerous medical disorders is rarely, if ever, indicated. The etiology and evaluation of weight loss; clinical features and diagnosis of malabsorption; and etiology, diagnosis, and treatment of secondary amenorrhea are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2617?source=see_link\">",
"     \"Approach to the patient with weight loss\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=see_link\">",
"     \"Clinical features and diagnosis of malabsorption\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34697?source=see_link\">",
"     \"Etiology, diagnosis, and treatment of secondary amenorrhea\"",
"    </a>",
"    .) See other topics for a review of individual illnesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793887\">",
"    <span class=\"h1\">",
"     TREATMENT SETTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon our clinical experience, most medical complications of AN are managed as inpatients or outpatients. Other treatment settings that may be available include intensive outpatient (two to three hours per weekday), partial hospitalization (six hours of outpatient per weekday), and residential care (",
"    <a class=\"graphic graphic_table graphicRef73092 \" href=\"UTD.htm?9/54/10094\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793895\">",
"    <span class=\"h2\">",
"     Outpatient",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most medical complications of AN can be treated in an outpatient setting if they are correctly diagnosed and responding to treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/1\">",
"     1",
"    </a>",
"    ]. The clinician treating these complications should have expertise in managing them and is often part of a team that includes specialists in psychiatry and nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793902\">",
"    <span class=\"h2\">",
"     Hospitalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some medical complications require inpatient treatment on an internal medicine, psychiatric, or combined unit. The choice depends upon the patient&rsquo;s medical and psychiatric status, and available resources.",
"   </p>",
"   <p>",
"    There are no evidence-based criteria indicating which patients need hospitalization. Based upon systematic reviews and clinical practice guidelines, we suggest hospitalization for adult patients with any one or more of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/2,8,9,12\">",
"     2,8,9,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unstable vital signs",
"     </li>",
"     <li>",
"      Bradycardia less than 30 beats per minute",
"     </li>",
"     <li>",
"      Bradycardia less than 40 beats per minute and hypotension or symptoms of lightheadedness",
"     </li>",
"     <li>",
"      Hypothermia (core temperature &lt;35&deg;C or 95&deg;F )",
"     </li>",
"     <li>",
"      Cardiac dysrhythmia other than sinus bradycardia",
"     </li>",
"     <li>",
"      Weight less than 70 percent of ideal body weight, especially if weight loss was rapid",
"     </li>",
"     <li>",
"      Marked dehydration",
"     </li>",
"     <li>",
"      Acute medical complication of malnutrition (eg, syncope, seizures, cardiac failure, liver failure, pancreatitis, or electrolyte disturbance)",
"     </li>",
"     <li>",
"      Moderate to severe refeeding syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Marked edema",
"     </li>",
"     <li>",
"      Serum phosphorous &lt;2",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The refeeding syndrome is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30982?source=see_link\">",
"     \"Anorexia nervosa in adults and adolescents: The refeeding syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians treating patients treated on an internal medicine unit should obtain consultation from the psychiatry service. A clinical practice guideline from one institution for treating patients with restrictive AN during medical hospitalization is available [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86793909\">",
"    <span class=\"h3\">",
"     Follow-up care",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no empirically tested guidelines that direct the frequency of followup visits for medical complications or the time intervals for testing. Based upon clinical experience, we suggest outpatient followup within three to five days for patients discharged after an acute care hospitalization for severe emaciation and nutritional rehabilitation. These patients are at risk for the refeeding syndrome for the first few weeks after consistent weight restoration and weight gain have started. Weekly to monthly primary care followup is prudent to examine patients for signs of the refeeding syndrome; check phosphate, other electrolyte levels, and liver function tests; and to monitor weight gain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30982?source=see_link\">",
"     \"Anorexia nervosa in adults and adolescents: The refeeding syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who remain ill with AN, we suggest a repeat DEXA scan every two years to monitor bone mineral density and response to treatment for osteoporosis. Repeat ECG and echocardiograms are not required unless cardiac symptoms persist despite weight restoration, or if new cardiac symptoms develop, or if there were significant abnormalities present on the initial tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/16/25858?source=see_link\">",
"       \"Patient information: Anorexia nervosa (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H253123970\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anorexia nervosa (AN) is associated with numerous medical complications that are directly attributable to caloric restriction and weight loss (",
"      <a class=\"graphic graphic_table graphicRef67080 \" href=\"UTD.htm?29/44/30413\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16550/abstract/1\">",
"       1",
"      </a>",
"      ]. A medical evaluation is necessary to assess patients for these complications and determine whether hospitalization is necessary. (See",
"      <a class=\"local\" href=\"#H86791750\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history and physical examination that occur as part of the medical evaluation should be accompanied by laboratory blood testing. &nbsp;All patients with AN should receive an initial set of serum electrolytes, blood urea nitrogen, creatinine, glucose, calcium, phosphorous, magnesium, thiamine, albumin, liver function tests, INR, CBC, TSH, ECG, and urinalysis. (See",
"      <a class=\"local\" href=\"#H86793543\">",
"       'Medical history'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H86793550\">",
"       'Physical examination'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H86793564\">",
"       'Laboratory assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients presenting with atypical features of AN, clinicians should consider other illnesses that can cause weight loss, malabsorption, or secondary amenorrhea. These include (",
"      <a class=\"graphic graphic_table graphicRef69495 \" href=\"UTD.htm?8/61/9181\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef59801 \" href=\"UTD.htm?1/19/1340\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef73995 \" href=\"UTD.htm?25/25/26012\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H86793571\">",
"       'Excluding medical disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medically unstable patients with AN require hospitalization. Criteria for hospitalization include unstable vital signs, bradycardia less than 40 beats per minute and hypotension or symptoms of lightheadedness, cardiac dysrhythmia other than sinus bradycardia, weight less than 70 percent of ideal body weight, acute medical complication of malnutrition (eg, syncope, seizures, cardiac failure, liver failure, pancreatitis, or electrolyte disturbance), and moderate to severe refeeding syndrome. (See",
"      <a class=\"local\" href=\"#H86793902\">",
"       'Hospitalization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/1\">",
"      Mehler PS. Diagnosis and care of patients with anorexia nervosa in primary care settings. Ann Intern Med 2001; 134:1048.",
"     </a>",
"    </li>",
"    <li>",
"     Eating Disorders: Core Interventions in the Treatment of and Management of Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders. National Institute for Clinical Excellence, Clinical Guideline 9. file://guidance.nice.org.uk (Accessed on December 22, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/3\">",
"      Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002; 159:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/4\">",
"      L&ouml;we B, Zipfel S, Buchholz C, et al. Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psychol Med 2001; 31:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/5\">",
"      Keel PK, Dorer DJ, Eddy KT, et al. Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003; 60:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/6\">",
"      Herzog W, Deter HC, Fiehn W, Petzold E. Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study. Psychol Med 1997; 27:269.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/8\">",
"      American Psychiatric Association. Treatment of patients with eating disorders,third edition. American Psychiatric Association. Am J Psychiatry 2006; 163:4.",
"     </a>",
"    </li>",
"    <li>",
"     Mehler, PS, Birmingham, LC, Crow, SJ, Jahraus, JP. Medical complications of eating disorders. In: The Treatment of Eating Disorders: A Clinical Handbook, Grilo, CM, Mitchell, JE (Eds), The Guilford Press, New York 2010. p.66.",
"    </li>",
"    <li>",
"     Mehler, PS, Anderson, AE. Eating Disorders: A guide to medical care and complications, 2nd ed, The Johns Hopkins University Press, Baltimore, MD 2010.",
"    </li>",
"    <li>",
"     Andersen AE, Yager J. Eating disorders. In: Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 9th ed, Sadock BJ, Sadock VA, Ruiz P (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2009. Vol 1, p.2128.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/12\">",
"      Golden NH, Katzman DK, Kreipe RE, et al. Eating disorders in adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health 2003; 33:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16550/abstract/13\">",
"      Sylvester CJ, Forman SF. Clinical practice guidelines for treating restrictive eating disorder patients during medical hospitalization. Curr Opin Pediatr 2008; 20:390.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15777 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-05EE575892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16550=[""].join("\n");
var outline_f16_10_16550=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H253123970\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86791750\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86794444\">",
"      DIAGNOSIS OF ANOREXIA NERVOSA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86793536\">",
"      MEDICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86793543\">",
"      Medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86793550\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86793557\">",
"      - Common physical signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86793564\">",
"      Laboratory assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86793571\">",
"      Excluding medical disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86793887\">",
"      TREATMENT SETTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86793895\">",
"      Outpatient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H86793902\">",
"      Hospitalization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H86793909\">",
"      - Follow-up care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H253123970\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/15777\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/15777|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/44/30413\" title=\"table 1\">",
"      Medical complications of anorexia nervosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/7/9339\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for anorexia nervosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/61/9181\" title=\"table 3\">",
"      Major causes of weight loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/19/1340\" title=\"table 4\">",
"      Causes of amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/25/26012\" title=\"table 5\">",
"      HPO axis and amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/54/10094\" title=\"table 6\">",
"      Level of care guidelines for patients with eating disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/62/38890?source=related_link\">",
"      Anorexia nervosa in adults and adolescents: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30982?source=related_link\">",
"      Anorexia nervosa in adults and adolescents: The refeeding syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2617?source=related_link\">",
"      Approach to the patient with weight loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/1/33816?source=related_link\">",
"      Bulimia nervosa and binge eating disorder in adults: Medical complications and their management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=related_link\">",
"      Clinical features and diagnosis of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44023?source=related_link\">",
"      Eating disorders: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/56/34697?source=related_link\">",
"      Etiology, diagnosis, and treatment of secondary amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/16/25858?source=related_link\">",
"      Patient information: Anorexia nervosa (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16551="EP study tracings AF";
var content_f16_10_16551=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74286%7ECARD%2F67363&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74286%7ECARD%2F67363&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study in a person with atrial fibrillation (AF)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three surface ECG leads (I, aVF, V1) and intracardiac recordings from the atrioventricular (AV) junction region (HBE1-2, HBE3-4), and the right ventricular apex (RVA3-4) in a patient with atrial fibrillation. The patient has extremely symptomatic, medically refractory atrial fibrillation with rapid ventricular rates and recurrent heart failure. The mapping catheter (HBE) has been maneuvered from the area of maximal His bundle activity to a more proximal position, where a larger atrial (A) and smaller His electrogram (H) are recorded.",
"    <div class=\"footnotes\">",
"     V: ventricular electrogram.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 581px\">",
"   <div class=\"ttl\">",
"    Intracardiac and surface ECG recordings during electrophysiologic study and radiofrequency catheter ablation of the AV junction in atrial fibrillation (AF)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 561px; height: 389px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three surface ECG leads (I, aVF, V1) and intracardiac recordings from the region of the atrio- ventricular (AV) junction (HBE1-2, HBE3-4), and the right ventricular apex (RVA3- 4) in a patient with atrial fibrillation (AF). Application of radiofrequency (RF) energy from the tip of the mapping catheter (HBE1-2) causes complete AV nodal block; pacing (P) is initiated from the right ventricular apex. A permanent VVIR pacemaker was implanted, and the patient has noted a marked improvement in symptoms.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16551=[""].join("\n");
var outline_f16_10_16551=null;
var title_f16_10_16552="Chapter 6B: Antidiuretic hormone and water balance";
var content_f16_10_16552=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 6B: Antidiuretic hormone and water balance",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16552/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/10/16552/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antidiuretic hormone (the human form is called arginine vasopressin) is a polypeptide synthesized in the supraoptic and paraventricular nuclei in the hypothalamus (",
"    <a class=\"graphic graphic_figure graphicRef60578 \" href=\"UTD.htm?5/13/5328\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/1\">",
"     1",
"    </a>",
"    ]. Secretory granules containing ADH migrate down the axons of the supraopticohypophyseal tract into the posterior lobe of the pituitary, where they are stored and subsequently released after appropriate stimuli. In addition, some of the secretory granules produced in the paraventricular nuclei enter the cerebrospinal fluid or the portal capillaries in the median eminence (",
"    <a class=\"graphic graphic_figure graphicRef60578 \" href=\"UTD.htm?5/13/5328\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/1\">",
"     1",
"    </a>",
"    ]. The latter effect probably accounts for the observation that lesions of the posterior pituitary or supraopticohypophyseal tract below the median eminence do not usually lead to permanent diabetes insipidus (ADH-lack), since ADH produced in the hypothalamus still has access to the systemic circulation.",
"   </p>",
"   <p>",
"    ADH is rapidly metabolized in the liver and kidney, with a half-life in the circulation of only 15 to 20 min.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;ADH is the primary physiologic determinant of the rate of free water excretion. Its major renal effect is to augment the water permeability of the luminal membranes of the cortical and medullary collecting tubules, thereby promoting water reabsorption via osmotic equilibration with the hypertonic interstitium. A review of the mechanism by which ADH promotes urinary concentration is available elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/44/29384?source=see_link\">",
"     \"Chapter 4B: Countercurrent mechanism\"",
"    </a>",
"    .) The ADH-induced increase in collecting tubule water permeability occurs primarily in the principal cells, as the adjacent intercalated cells are mostly involved in acid or bicarbonate secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33352?source=see_link\">",
"     \"Chapter 5B: Collecting tubules\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are two major receptors for ADH: the V1 and V2 receptors. Activation of the V1 receptors induces vasoconstriction and enhancement of prostaglandin release (see below), while the V2 receptors mediate the antidiuretic response as well as other functions (",
"    <a class=\"graphic graphic_figure graphicRef79887 \" href=\"UTD.htm?19/7/19571\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/4\">",
"     4",
"    </a>",
"    ]. A third receptor, the V3 or V1b receptor, appears to mediate the effect of ADH on the pituitary, facilitating the release of ACTH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Activation of adenylyl cyclase by ADH via the V2 receptor initiates a sequence of events in which a protein kinase is activated, leading to preformed cytoplasmic vesicles that contain unique water channels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. The principal ADH-sensitive water channel, called",
"    <strong>",
"     aquaporin-2",
"    </strong>",
"    , is normally stored in the cytosol [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]; under the influence of ADH, they move to and fuse with the luminal membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/3,10\">",
"     3,10",
"    </a>",
"    ], thereby allowing water to be reabsorbed down the favorable osmotic gradient [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. This process results in the formation of intramembranous particle aggregates that are visible on electron microscopy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80176 \" href=\"UTD.htm?37/57/38814\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/10,13\">",
"     10,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once the water channels span the luminal membrane and permit osmotic water movement into the cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/13\">",
"     13",
"    </a>",
"    ], water is then rapidly returned to the systemic circulation across the basolateral membrane, which is both water permeable (even in the absence of ADH) and has a much greater surface area than the luminal membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/14\">",
"     14",
"    </a>",
"    ]. When the ADH effect has worn off, the water channels aggregate within clathrin coated pits from which they are removed from the luminal membrane by endocytosis and returned to the cytoplasm [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/10,13\">",
"     10,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A defect in any step in this pathway, such as attachment of ADH to its receptor or the function of the water channel, can cause resistance to the action of ADH and an increase in urine output. This disorder is called nephrogenic diabetes insipidus. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hereditary nephrogenic DI is usually transmitted in an X-linked fashion, with the genetic defect involving a number of different mutations (or deletion) in the V2 receptor gene that can lead to decreased hormone binding, impaired intracellular transport or coupling to the adenylyl cyclase system, or diminished synthesis or accelerated degradation of the receptor (",
"      <a class=\"graphic graphic_figure graphicRef59621 \" href=\"UTD.htm?36/48/37640\">",
"       figure 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/15,16\">",
"       15,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A second, autosomal recessive form of hereditary nephrogenic DI has been described in which there appear to be mutations in the aquaporin-2 gene (",
"      <a class=\"graphic graphic_figure graphicRef78055 \" href=\"UTD.htm?6/25/6552\">",
"       figure 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/9,17-19\">",
"       9,17-19",
"      </a>",
"      ]. These mutations may lead to impaired trafficking of the water channels with lack of fusion with the luminal membrane",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      decreased channel function [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/9,18\">",
"       9,18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/2/21545?source=see_link\">",
"     \"Clinical manifestations and causes of nephrogenic diabetes insipidus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Electrolyte handling",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to increasing water permeability, ADH appears to affect a variety of other processes in the cortical collecting tubule, enhancing the reabsorption of Na+ and the secretion of K+ [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. The physiologic role of these effects is uncertain, since ADH does not appear to be important in the maintenance of electrolyte or acid-base balance.",
"   </p>",
"   <p>",
"    However, the stimulation of K+ secretion allows ADH to regulate water transport without interfering with that of K+. The rate of distal urinary flow is normally an important determinant of the rate of K+ secretion and subsequent excretion (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11657?source=see_link\">",
"     \"Chapter 12B: Renal potassium excretion\"",
"    </a>",
"    ). ADH-stimulated water reabsorption should, by lowering distal flow, inappropriately diminish K+ secretion; this is prevented by the direct stimulatory effect of ADH on K+ handling [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Vascular resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the antidiuretic effects of ADH are mediated by the V2 receptors which, in the kidney, stimulate adenylyl cyclase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/23\">",
"     23",
"    </a>",
"    ]. In comparison, the V1 receptors promote phosphatidylinositol turnover and primarily act to increase vascular resistance (hence the name vasopressin) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/24\">",
"     24",
"    </a>",
"    ]. ADH release is markedly stimulated in the presence of effective circulating volume depletion (see below). In general, the vasopressor role of ADH is relatively minor, as the blood pressure is maintained primarily by the renin-angiotensin and sympathetic nervous systems (see Chap. 8) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Renal prostaglandins",
"    </span>",
"    &nbsp;&mdash;&nbsp;ADH stimulates the production of prostaglandins (particularly prostaglandin E2 and prostacyclin) in a variety of cells within the kidney, including those in the thick ascending limb, collecting tubules, medullary interstitium, and glomerular mesangium [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. The prostaglandins that are produced then impair both the antidiuretic and vascular actions of ADH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. The former effect is in part due to a reduction in ADH-induced generation of cyclic AMP; stimulation of the inhibitory regulatory protein Gi and of protein kinase C formation appear to contribute to this response [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings have suggested that a short negative feedback loop may be present in which ADH enhances local prostaglandin production, thereby preventing an excessive antidiuretic response. It is of interest, however, that the effect of ADH on prostaglandin synthesis is mediated by the V1, not the antidiuretic V2, receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/25,27\">",
"     25,27",
"    </a>",
"    ]. Activation of the V1 receptors promotes phosphatidylinositol turnover, leading to the formation of diacylglycerol, from which arachidonic acid, the precursor of the prostaglandins, can be released via activation of phospholipase A2 (",
"    <a class=\"graphic graphic_figure graphicRef70144 \" href=\"UTD.htm?19/31/19966\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/23,32\">",
"     23,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The renal site of V1-receptor stimulation of prostaglandin synthesis is uncertain. The collecting tubular cells have both V1 (20 percent of the total ADH receptors in the cortical collecting tubule) and V2 receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/33,34\">",
"     33,34",
"    </a>",
"    ] and it is possible that a local negative feedback system is in place [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/25\">",
"     25",
"    </a>",
"    ]. However, stimulation of these V1 receptors appears to occur only at supraphysiologic concentrations of ADH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternatively, the major function of the ADH-prostaglandin relationship may involve the regulation of renal hemodynamics. ADH, acting via the V1 receptors, is a systemic and renal vasoconstrictor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/31\">",
"     31",
"    </a>",
"    ]. The local production of prostaglandins by the kidney (particularly the glomeruli) minimizes the increase in renal vascular resistance, thereby maintaining renal perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other extrarenal effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;ADH has other renal effects of potential clinical importance, including a role in the regulation of cortisol release and of factor VIII and von Willebrand's factor from vascular endothelium [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/4\">",
"     4",
"    </a>",
"    ]. ADH is cosecreted with corticotropin releasing hormone from single neurons in the paraventricular nuclei [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/1\">",
"     1",
"    </a>",
"    ], and promotes the secretion of ACTH by corticotropes in the pituitary via activation of V3 receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cortisol has an inhibitory effect on the secretion of both CRF and ADH from the paraventricular nuclei. Adrenal insufficiency (in which cortisol secretion is reduced) removes this inhibitory effect, leading to a persistent rise in ADH release [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/1,36\">",
"     1,36",
"    </a>",
"    ]. The associated impairment in water excretion can result in water retention and hyponatremia, a common electrolyte disorder in patients with cortisol deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25876?source=see_link\">",
"     \"Hyponatremia and hyperkalemia in adrenal insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ADH, acting through the V2-receptors, also can stimulate the release of factor VIII and von Willebrand factor from vascular endothelium [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/4\">",
"     4",
"    </a>",
"    ]. Although this response is of uncertain significance in normal subjects, the administration of ADH has been effective in transiently improving the bleeding tendencies in a variety of disorders, including hemophilia, von Willebrand's disease, and advanced renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/4,37\">",
"     4,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Control of ADH secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major stimuli to ADH secretion are hyperosmolality and effective circulating volume depletion (",
"    <a class=\"graphic graphic_figure graphicRef65195 \" href=\"UTD.htm?14/61/15325\">",
"     figure 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef58012 \" href=\"UTD.htm?2/33/2589\">",
"     figure 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. These responses are appropriate, since the water retention induced by ADH will both lower the plasma osmolality (Posm) and raise the extracellular volume toward normal. Conversely, lowering the Posm by water loading will diminish ADH release. The ensuing reduction in collecting tubule water reabsorption will decrease the urine osmolality (Uosm), thereby allowing the excess water to be excreted. Since the half-life of ADH in the circulation is 15 to 20 min, the maximum diuresis after a water load is delayed for 90 to 120 min, the time required for the metabolism of the previously circulating ADH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Osmoreceptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The location of the osmoreceptors governing ADH release was demonstrated by the classic experiments of Verney [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/40\">",
"     40",
"    </a>",
"    ]. These experiments utilized local infusions of hypertonic saline, which raised the local Posm without affecting the systemic Posm. Such an infusion into the carotid artery, but not the femoral artery, resulted in enhanced ADH secretion and an antidiuresis. These findings indicated that the osmoreceptors, which are separate from the hormone-producing cells, are located in the brain, not in the periphery&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &dagger; Studies in rats suggest that separate osmoreceptors are located in the upper small bowel [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/41\">",
"     41",
"    </a>",
"    ]. Thus, ingestion of a hypertonic NaCl solution leads to a rapid increase in ADH release that is prevented by lesions in the splanchnic nerves. The physiologic role of these osmoreceptors is unclear; they may contribute to the regulation of water balance or participate in the sensation of satiety.",
"   </p>",
"   <p>",
"    The increment in Posm is perceived by the hypothalamic osmoreceptors as an effective osmotic gradient between the plasma and the receptor cell. It is postulated that the osmoreceptor is activated by changes in intracellular water content, thereby altering intracellular osmolarity. Water channels make the osmoreceptor cell membrane permeable to water, permitting water movement out of the cell with hypernatremia (or other cause of hyperosmolality) and into the cell with hyponatremia. The ensuing reduction in cell volume in hypernatremia increases the activity of stretch-inactivated cation channels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/42,43\">",
"     42,43",
"    </a>",
"    ], leading to depolarization of the cell that in some way stimulates ADH secretion and synthesis. These steps are reversed with hyponatremia.",
"   </p>",
"   <p>",
"    In general, the plasma sodium concentration is the primary osmotic determinant of ADH release, since Na+ salts are the major effective extracellular solutes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/39\">",
"     39",
"    </a>",
"    ]. In contrast, increments in the plasma urea concentration (measured as the blood urea nitrogen or BUN) do not affect ADH secretion, because urea is an ineffective osmole that readily crosses cell membranes and will not induce water movement out of the osmoreceptor cells.",
"   </p>",
"   <p>",
"    The contribution of glucose, the other major extracellular solute, on ADH regulation is somewhat more complicated [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/44\">",
"     44",
"    </a>",
"    ]. In normal subjects, a rise in the plasma glucose concentration increases the release of insulin. Insulin can then promote glucose entry into the osmoreceptor cells, making glucose an ineffective osmole that will not affect the secretion of ADH. In uncontrolled diabetes mellitus, however, hyperglycemia is associated with insulin deficiency. In this setting, glucose acts as an effective osmole that can promote ADH release [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The osmoreceptors are extremely sensitive, responding to alterations in the Posm of as little as 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,39,45\">",
"     38,39,45",
"    </a>",
"    ]. In humans, the osmotic threshold for ADH release is about 280 to 290",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef65195 \" href=\"UTD.htm?14/61/15325\">",
"     figure 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Below this level, there is little if any circulating ADH and the urine should be maximally dilute with an osmolality below 100",
"    <span class=\"nowrap\">",
"     mosmol/kg.",
"    </span>",
"    Above the osmotic threshold, there is a progressive and relatively linear rise in ADH secretion. This system is so efficient that the Posm usually does not vary by more than 1 to 2 percent, despite wide fluctuations in water intake. As an example, a large water load will lower the Posm and essentially shut off the release of ADH. The net effect is the excretion of more than 80 percent of the excess water within four hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Role of thirst",
"    </span>",
"    &nbsp;&mdash;&nbsp;The response to hyperosmolality, as can occur with water loss due to exercise-induced sweating on a hot day, includes a second factor as thirst as well as ADH release is stimulated. The net effect is that both increased water intake and reduced water excretion combine to return the Posm to normal (",
"    <a class=\"graphic graphic_figure graphicRef52686 \" href=\"UTD.htm?32/13/32989\">",
"     figure 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38\">",
"     38",
"    </a>",
"    ]. The osmotic threshold for thirst (which can only be estimated indirectly) has been reported to be either 2 to 5",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    higher than or roughly equivalent to that for ADH release [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. It is not clear whether both of these parameters are controlled by the same or by two different osmoreceptors.",
"   </p>",
"   <p>",
"    Even though thirst is regulated centrally (including cortical areas that influence nonessential or social drinking), it is sensed peripherally as the sensation of a dry mouth [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/36,48\">",
"     36,48",
"    </a>",
"    ]. The cessation of thirst (satiety) is also mediated initially in the periphery by oropharyngeal mechanoreceptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/49,50\">",
"     49,50",
"    </a>",
"    ] that are stimulated by swallowing relatively large volumes of fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It might be expected, for example, that the hyperosmotic stimulus to thirst and ADH release would be attenuated as the Posm returns toward normal. However, studies in experimental animals and humans have demonstrated that drinking leads to a marked, but transient, suppression of thirst and ADH within 10 to 20 min, before there has been any appreciable reduction in the Posm [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. This response can be considered to be appropriate, since there is a 30 to 60 min delay before ingested water is completely absorbed. Thus, water intake would be markedly excessive if it continued until the Posm were normalized, since there would still be a substantial volume of nonabsorbed water remaining in the gastrointestinal tract. The oropharyngeal receptors allow slow repletion of the water deficit to occur in discrete steps as the suppression of thirst and ADH release will be transient as long as the Posm remains elevated.",
"   </p>",
"   <p>",
"    As with ADH, thirst is also stimulated by volume depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/48\">",
"     48",
"    </a>",
"    ]. How this occurs is incompletely understood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Volume receptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with effective circulating volume depletion, as with vomiting, cirrhosis, or heart failure (see Chap. 10), may secrete ADH, even in the presence of a low plasma osmolality [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,52-54\">",
"     38,52-54",
"    </a>",
"    ]. These findings indicate the existence of nonosmolal, volume-sensitive receptors for ADH release (",
"    <a class=\"graphic graphic_figure graphicRef58012 \" href=\"UTD.htm?2/33/2589\">",
"     figure 7",
"    </a>",
"    ). Parasympathetic afferents in the carotid sinus baroreceptors are of primary importance in this response&dagger;. Changes in the rate of afferent discharge from these neurons affect the activity of the vasomotor center in the medulla and subsequently the rate of ADH secretion by the cells in the paraventricular nuclei [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/23\">",
"     23",
"    </a>",
"    ]. (The supraoptic nuclei, in comparison, are important for osmoregulation but do not appear to participate in this volume-sensitive response) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &dagger; Although low-pressure receptors in the left atrium play a contributory role in some animal species, they appear to be less important in humans in whom a moderate reduction in intracardiac filling pressure does not stimulate ADH release unless there is a concomitant decline in systemic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/55,56\">",
"     55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The carotid sinus baroreceptors, as with other \"volume\" receptors, are actually pressure receptors. However, they are able to function indirectly as volume receptors. How this occurs can be appreciated from the formula relating pressure, cardiac output, and vascular resistance&dagger;:",
"   </p>",
"   <p>",
"    &nbsp;Mean arterial pressure &nbsp; = &nbsp; cardiac output &nbsp;x &nbsp;systemic vascular resistance",
"   </p>",
"   <p>",
"    Thus, a fall in cardiac output due to volume depletion or primary cardiac disease will lead to an initial decline in mean arterial pressure, which can be sensed by the carotid sinus baroreceptors. In experimental models of heart failure, for example, there is a fall in urine output and rise in urine osmolality. These changes can be prevented by carotid baroreceptor denervation, indicating that the increment in ADH release is governed by baroreceptor afferents [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &dagger; This product of cardiac output and systemic vascular resistance actually equals the pressure drop across the circulation, i.e., mean arterial pressure minus mean venous pressure. However, the latter is normally so much lower (1 to 7 mmHg) than the former that only a small error results from ignoring the venous pressure.",
"   </p>",
"   <p>",
"    The sensitivity of the volume receptors is different from that of the osmoreceptors. The latter respond to alterations in Posm of as little as 1 percent (",
"    <a class=\"graphic graphic_figure graphicRef65195 \" href=\"UTD.htm?14/61/15325\">",
"     figure 6",
"    </a>",
"    ); in comparison, small, acute reductions in volume that are sufficient to increase the secretion of renin and norepinephrine have little effect on the release of ADH. Acutely, ADH is secreted nonosmotically in humans only if there is a large enough change in the effective volume to produce a reduction in the systemic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. Once hypotension occurs, there may be a marked rise in ADH secretion, resulting in circulating hormone levels that can substantially exceed that induced by hyperosmolality (",
"    <a class=\"graphic graphic_figure graphicRef58012 \" href=\"UTD.htm?2/33/2589\">",
"     figure 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,56\">",
"     38,56",
"    </a>",
"    ]. Acute mild volume expansion generally has little effect of ADH release in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Interactions of the osmotic and volume stimuli",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hormone-producing cells in the supraoptic and paraventricular nuclei receive input from both the osmotic and volume receptors, resulting in positive or negative interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Thus, volume depletion potentiates the ADH response to hyperosmolality, but can prevent the inhibition of ADH release normally induced by a fall in the Posm (",
"    <a class=\"graphic graphic_figure graphicRef59371 \" href=\"UTD.htm?8/41/8862\">",
"     figure 9",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/38,54,59\">",
"     38,54,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These relationships are often clinically relevant. As an example, hypovolemic states are a common cause of water retention and hyponatremia (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=see_link\">",
"     \"Causes of hyponatremia\"",
"    </a>",
"    ). This occurs in part because the nonosmotic stimulation of ADH release prevents the normal excretion of ingested water. On the other hand, chronic volume expansion as in primary hyperaldosteronism can shift the osmotic threshold upward, leading to a mild elevation in the Posm and plasma Na+ concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Other factors affecting ADH secretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;ADH release can also be influenced by a variety of other factors that are not directly related to osmolal or volume balance (",
"    <a class=\"graphic graphic_table graphicRef51900 \" href=\"UTD.htm?33/47/34555\">",
"     table 1",
"    </a>",
"    ). Nausea is probably the most potent, potentially leading to as much as a 500-fold rise in circulating ADH levels; neither the physiologic role of this response nor the mechanism by which it occurs is well understood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some circumstances, these additional stimuli to ADH release can become clinically important. In surgical patients, for example, elevated levels of ADH may persist for several days after the operation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/61\">",
"     61",
"    </a>",
"    ], a stress response that appears to be mediated by pain afferents [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/62\">",
"     62",
"    </a>",
"    ]. If a large amount of free water is given in this setting, water retention, severe hyponatremia, and potentially irreversible neurologic damage may ensue [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnancy, on the other hand, lowers the osmoregulatory threshold for ADH release and thirst [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/46\">",
"     46",
"    </a>",
"    ]. As a result, there is a downward resetting of the osmostat, leading a fall in the normal plasma Na+ concentration by about 5",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    This change, which is rapidly reversed after delivery, may be mediated by increased release of human chorionic gonadotropin (hCG) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/64\">",
"     64",
"    </a>",
"    ]. hCG may act indirectly via the release of relaxin [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16552/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2376?source=see_link\">",
"     \"Chapter 6C: Aldosterone\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/1\">",
"      Zimmerman EA, Nilaver G, Hou-Yu A, Silverman AJ. Vasopressinergic and oxytocinergic pathways in the central nervous system. Fed Proc 1984; 43:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/2\">",
"      Lencer WI, Brown D, Ausiello DA, Verkman AS. Endocytosis of water channels in rat kidney: cell specificity and correlation with in vivo antidiuresis. Am J Physiol 1990; 259:C920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/3\">",
"      Nielsen S, DiGiovanni SR, Christensen EI, et al. Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A 1993; 90:11663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/4\">",
"      Bichet DG, Razi M, Lonergan M, et al. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988; 318:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/5\">",
"      Sugimoto T, Saito M, Mochizuki S, et al. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 1994; 269:27088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/6\">",
"      Sasaki S, Fushimi K, Saito H, et al. Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest 1994; 93:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/7\">",
"      Hayashi M, Sasaki S, Tsuganezawa H, et al. Expression and distribution of aquaporin of collecting duct are regulated by vasopressin V2 receptor in rat kidney. J Clin Invest 1994; 94:1778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/8\">",
"      Deen PM, Verdijk MA, Knoers NV, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994; 264:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/9\">",
"      Deen PM, Croes H, van Aubel RA, et al. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 1995; 95:2291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/10\">",
"      Harris HW Jr, Strange K, Zeidel ML. Current understanding of the cellular biology and molecular structure of the antidiuretic hormone-stimulated water transport pathway. J Clin Invest 1991; 88:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/11\">",
"      Yamamoto T, Sasaki S. Aquaporins in the kidney: emerging new aspects. Kidney Int 1998; 54:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/12\">",
"      Nielsen S, Kwon TH, Christensen BM, et al. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 1999; 10:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/13\">",
"      Brown D. Membrane recycling and epithelial cell function. Am J Physiol 1989; 256:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/14\">",
"      Strange K, Spring KR. Absence of significant cellular dilution during ADH-stimulated water reabsorption. Science 1987; 235:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/15\">",
"      Bichet DG, Oksche A, Rosenthal W. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997; 8:1951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/16\">",
"      Ala Y, Morin D, Mouillac B, et al. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 1998; 9:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/17\">",
"      Oksche A, M&ouml;ller A, Dickson J, et al. Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Hum Genet 1996; 98:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/18\">",
"      Hochberg Z, Van Lieburg A, Even L, et al. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab 1997; 82:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/19\">",
"      Tamarappoo BK, Verkman AS. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 1998; 101:2257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/20\">",
"      Schafer JA, Hawk CT. Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int 1992; 41:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/21\">",
"      Field MJ, Stanton BA, Giebisch GH. Influence of ADH on renal potassium handling: a micropuncture and microperfusion study. Kidney Int 1984; 25:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/22\">",
"      Cassola AC, Giebisch G, Wang W. Vasopressin increases density of apical low-conductance K+ channels in rat CCD. Am J Physiol 1993; 264:F502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/23\">",
"      Abramow M, Beauwens R, Cogan E. Cellular events in vasopressin action. Kidney Int Suppl 1987; 21:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/24\">",
"      Goldsmith SR. Vasopressin as vasopressor. Am J Med 1987; 82:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/25\">",
"      Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 1987; 253:F377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/26\">",
"      Kirschenbaum MA, Lowe AG, Trizna W, Fine LG. Regulation of vasopressin action by prostaglandins. Evidence for prostaglandin synthesis in the rabbit cortical collecting tubule. J Clin Invest 1982; 70:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/27\">",
"      Scharschmidt LA, Dunn MJ. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin. J Clin Invest 1983; 71:1756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/28\">",
"      H&eacute;bert RL, Jacobson HR, Breyer MD. PGE2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation. Am J Physiol 1990; 259:F318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/29\">",
"      Breyer MD, Jacobson HR, Hebert RL. Cellular mechanisms of prostaglandin E2 and vasopressin interactions in the collecting duct. Kidney Int 1990; 38:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/30\">",
"      Stokes JB. Integrated actions of renal medullary prostaglandins in the control of water excretion. Am J Physiol 1981; 240:F471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/31\">",
"      Yared A, Kon V, Ichikawa I. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin. J Clin Invest 1985; 75:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/32\">",
"      Exton JH. Calcium-signalling in cells&mdash;molecular mechanisms. Kidney Int Suppl 1987; 23:S-68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/33\">",
"      Terada Y, Tomita K, Nonoguchi H, et al. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 1993; 92:2339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/34\">",
"      Ammar A, Roseau S, Butlen D. Pharmacological characterization of V1a vasopressin receptor in the rat cortical collecting duct. Am J Physiol 1992; 262:F456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/35\">",
"      Ando Y, Breyer MD, Jacobson HR. Dose-dependent heterogenous actions of vasopressin in rabbit cortical collecting ducts. Am J Physiol 1989; 256:F556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/36\">",
"      Zimmerman EA, Ma LY, Nilaver G. Anatomical basis of thirst and vasopressin secretion. Kidney Int Suppl 1987; 21:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/37\">",
"      Zeigler ZR, Megaludis A, Fraley DS. Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia. Am J Hematol 1992; 39:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/38\">",
"      Baylis PH. Osmoregulation and control of vasopressin secretion in healthy humans. Am J Physiol 1987; 253:R671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/39\">",
"      Robertson GL. Physiology of ADH secretion. Kidney Int Suppl 1987; 21:S20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/40\">",
"      Verney EB. Absorption and excretion of water: the antidiuretic hormone. Lancet 1946; 2:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/41\">",
"      Choi-Kwon S, Baertschi AJ. Splanchnic osmosensation and vasopressin: mechanisms and neural pathways. Am J Physiol 1991; 261:E18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/42\">",
"      Oliet SH, Bourque CW. Mechanosensitive channels transduce osmosensitivity in supraoptic neurons. Nature 1993; 364:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/43\">",
"      Khasar SG, Lin YH, Martin A, et al. A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 1999; 24:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/44\">",
"      Vokes TP, Aycinena PR, Robertson GL. Effect of insulin on osmoregulation of vasopressin. Am J Physiol 1987; 252:E538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/45\">",
"      LEAF A, MAMBY AR. The normal antidiuretic mechanism in man and dog; its regulation by extracellular fluid tonicity. J Clin Invest 1952; 31:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/46\">",
"      Lindheimer MD, Barron WM, Davison JM. Osmoregulation of thirst and vasopressin release in pregnancy. Am J Physiol 1989; 257:F159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/47\">",
"      Thompson CJ, Selby P, Baylis PH. Reproducibility of osmotic and nonosmotic tests of vasopressin secretion in men. Am J Physiol 1991; 260:R533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/48\">",
"      Mann JF, Johnson AK, Ganten D, Ritz E. Thirst and the renin-angiotensin system. Kidney Int Suppl 1987; 21:S27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/49\">",
"      Seckl JR, Williams TD, Lightman SL. Oral hypertonic saline causes transient fall of vasopressin in humans. Am J Physiol 1986; 251:R214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/50\">",
"      Thompson CJ, Burd JM, Baylis PH. Acute suppression of plasma vasopressin and thirst after drinking in hypernatremic humans. Am J Physiol 1987; 252:R1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/51\">",
"      Appelgren BH, Thrasher TN, Keil LC, Ramsay DJ. Mechanism of drinking-induced inhibition of vasopressin secretion in dehydrated dogs. Am J Physiol 1991; 261:R1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/52\">",
"      LEAF A, MAMBY AR. An antidiuretic mechanism not regulated by extracellular fluid tonicity. J Clin Invest 1952; 31:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/53\">",
"      P&eacute;rez-Ayuso RM, Arroyo V, Camps J, et al. Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int 1984; 26:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/54\">",
"      Mettauer B, Rouleau JL, Bichet D, et al. Sodium and water excretion abnormalities in congestive heart failure. Determinant factors and clinical implications. Ann Intern Med 1986; 105:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/55\">",
"      Bie P, Secher NH, Astrup A, Warberg J. Cardiovascular and endocrine responses to head-up tilt and vasopressin infusion in humans. Am J Physiol 1986; 251:R735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/56\">",
"      Goldsmith SR, Francis GS, Cowley AW, Cohn JN. Response of vasopressin and norepinephrine to lower body negative pressure in humans. Am J Physiol 1982; 243:H970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/57\">",
"      Anderson RJ, Cadnapaphornchai P, Harbottle JA, et al. Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. J Clin Invest 1974; 54:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/58\">",
"      Goldsmith SR, Cowley AW Jr, Francis GS, Cohn JN. Effect of increased intracardiac and arterial pressure on plasma vasopressin in humans. Am J Physiol 1984; 246:H647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/59\">",
"      Dunn FL, Brennan TJ, Nelson AE, Robertson GL. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 1973; 52:3212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/60\">",
"      Nausea and vasopressin. Lancet 1991; 337:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/61\">",
"      MOORE FD. Common patterns of water and electrolyte change in injury, surgery and disease. N Engl J Med 1958; 258:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/62\">",
"      Ukai M, Moran WH Jr, Zimmermann B. The role of visceral afferent pathways on vasopressin secretion and urinary exeretory patterns during surgical stress. Ann Surg 1968; 168:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/63\">",
"      Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 1986; 314:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/64\">",
"      Davison JM, Shiells EA, Philips PR, Lindheimer MD. Serial evaluation of vasopressin release and thirst in human pregnancy. Role of human chorionic gonadotrophin in the osmoregulatory changes of gestation. J Clin Invest 1988; 81:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16552/abstract/65\">",
"      Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 1999; 103:525.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7289 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-D3C9B8B2AC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16552=[""].join("\n");
var outline_f16_10_16552=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Electrolyte handling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Vascular resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Renal prostaglandins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other extrarenal effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Control of ADH secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Osmoreceptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Role of thirst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Volume receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Interactions of the osmotic and volume stimuli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Other factors affecting ADH secretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7289\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7289|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/57/38814\" title=\"diagnostic image 1\">",
"      ADH induced aggregates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7289|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/13/5328\" title=\"figure 1\">",
"      Anatomy of ADH release",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/7/19571\" title=\"figure 2\">",
"      AVP and AVP receptor 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/48/37640\" title=\"figure 3\">",
"      Vasopressin receptor mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/25/6552\" title=\"figure 4\">",
"      Aquaporin 2 mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/31/19966\" title=\"figure 5\">",
"      Phosphatidylinositol turnover",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/61/15325\" title=\"figure 6\">",
"      Osmoregulation of ADH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/33/2589\" title=\"figure 7\">",
"      Volume regulation of ADH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/13/32989\" title=\"figure 8\">",
"      Regulation of ADH release I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/41/8862\" title=\"figure 9\">",
"      Regulation of ADH release II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7289|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/47/34555\" title=\"table 1\">",
"      Other factors and ADH release",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/30/3562?source=related_link\">",
"      Causes of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11657?source=related_link\">",
"      Chapter 12B: Renal potassium excretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/44/29384?source=related_link\">",
"      Chapter 4B: Countercurrent mechanism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/36/33352?source=related_link\">",
"      Chapter 5B: Collecting tubules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2376?source=related_link\">",
"      Chapter 6C: Aldosterone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/2/21545?source=related_link\">",
"      Clinical manifestations and causes of nephrogenic diabetes insipidus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/17/25876?source=related_link\">",
"      Hyponatremia and hyperkalemia in adrenal insufficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16553="Approach to the patient with dyspnea";
var content_f16_10_16553=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with dyspnea",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16553/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16553/contributors\">",
"     Richard M Schwartzstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16553/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16553/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16553/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16553/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/10/16553/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A consensus statement of the American Thoracic Society defined dyspnea in the following way [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;\"Dyspnea is a term used to characterize a subjective experience of breathing discomfort that is comprised of qualitatively distinct sensations that vary in intensity. The experience derives from interactions among multiple physiological, psychological, social, and environmental factors, and may induce secondary physiological and behavioral responses.\"",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) statement on the mechanisms, assessment, and management of dyspnea, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Dyspnea, or breathing discomfort, is a common symptom that afflicts millions of patients with pulmonary disease and may be the primary manifestation of myocardial ischemia or dysfunction. Examination of the language of dyspnea suggests that this symptom represents a number of qualitatively distinct sensations, and that the words utilized by patients to describe their breathing discomfort may provide insight into the underlying pathophysiology of the disease.",
"   </p>",
"   <p>",
"    The key elements in the evaluation of the patient with acute and chronic dyspnea will be reviewed here with a pathophysiologic construct to guide thinking about a differential diagnosis for the patient with dyspnea. The basic physiology of dyspnea is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/40/8839?source=see_link\">",
"     \"Physiology of dyspnea\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of patients with chronic dyspnea of unclear etiology have one of five diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Asthma",
"     </li>",
"     <li>",
"      Chronic obstructive pulmonary disease (COPD)",
"     </li>",
"     <li>",
"      Interstitial lung disease",
"     </li>",
"     <li>",
"      Myocardial dysfunction",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Obesity/deconditioning",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with breathing discomfort can be categorized into one of two groups: respiratory system dyspnea or cardiovascular system dyspnea. Respiratory system dyspnea includes discomfort related to disorders of the central controller, the ventilatory pump, and the gas exchanger, while cardiovascular system dyspnea includes cardiac diseases (eg, acute ischemia, systolic dysfunction, valvular disorders, pericardial diseases), anemia, and deconditioning. More than one process may be active in a given patient, and the basic physiology of dyspnea does not always adhere to this structure; for example, stimulation of pulmonary receptors can result from interstitial inflammation (respiratory system) or interstitial edema (cardiovascular system). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/40/8839?source=see_link\">",
"     \"Physiology of dyspnea\"",
"    </a>",
"    .) Nevertheless, this construct offers an organized approach to the patient with dyspnea of unclear etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Respiratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;The respiratory system is designed to move air by bulk transport from the atmosphere to the alveoli, where oxygen is exchanged for carbon dioxide by diffusion across the alveolar-capillary membrane. Carbon dioxide is then removed from the lungs by bulk transport to the atmosphere. Several components must be functioning smoothly for this process to occur; derangements in any of these elements can lead to dyspnea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Controller",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"respiratory controller\" determines the rate and depth of breathing via efferent signals sent to the ventilatory muscles. Factors that stimulate the respiratory centers lead to increased ventilation and breathing discomfort in a variety of settings; these often are secondary to derangements in other parts of the system, such as hypoxia or hypercapnia due to",
"    <span class=\"nowrap\">",
"     ventilation/perfusion",
"    </span>",
"    mismatching in the gas exchanger. In addition, drugs such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (at a toxic dose) or progesterone and conditions such as pregnancy or diabetic ketoacidosis can produce dyspnea through central effects independent of problems in the ventilatory pump or gas exchanger. Typically, dyspnea associated with stimulation of the respiratory controller is described as a sensation of \"air hunger\" or an \"urge or need to breathe\" [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=see_link\">",
"     \"Control of ventilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/40/8839?source=see_link\">",
"     \"Physiology of dyspnea\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To some degree, the breathing pattern may also reflect what are presumed to be attempts by the controller to reduce breathing discomfort. Thus, patients with severe airflow obstruction generally adapt a slow, deep breathing pattern to minimize the pleural pressures needed to overcome airways resistance. Alternatively, patients with interstitial fibrosis or kyphoscoliosis and reduced lung or chest wall compliance have a characteristic rapid, shallow breathing pattern which minimizes the work needed to expand the thorax.",
"   </p>",
"   <p>",
"    When the respiratory controller is stimulated (eg, by exercise), airflow obstruction may heighten the sensation of air hunger. The increase in respiratory rate during exercise in the setting of expiratory flow limitation can lead to exercise-induced air-trapping, a process known as dynamic hyperinflation. Dynamic hyperinflation is associated with a reduced inspiratory reserve and increased dyspnea. For those in whom hyperinflation is substantial, such that inspiratory capacity at rest or during exercise is limited by total lung capacity, dyspnea is further exacerbated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36454?source=see_link\">",
"     \"Dynamic hyperinflation in patients with COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with restrictive lung disease, the adoption of breathing patterns with either an increase or decrease in tidal volume from their average resting tidal volume results in increased dyspnea [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/7\">",
"     7",
"    </a>",
"    ]. Breathing with a rapid, shallow pattern, the patient experiences an increase in the ratio of dead space to tidal volume (since anatomic dead space is relatively fixed), which leads to a need for greater total ventilation (hence, the increase in respiratory rate); this adds to respiratory work-load and may contribute to the development of hypercapnia. In contrast, an increase in tidal volume requires a significant increase in respiratory work due to the stiffness of the lung. Since most patients with restrictive lung disease tend to use a rapid, shallow breathing pattern, we conclude that this pattern ultimately must produce less dyspnea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Ventilatory pump",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"ventilatory pump\" comprises the ventilatory muscles, the peripheral nerves which transmit signals to them from the controller, the bones of the chest wall to which the respiratory muscles are connected, the pleura which transforms movement of the chest wall to negative pressure inside the thorax, and the airways that serve as a conduit for the flow of gas from the atmosphere to the alveoli and back again. The most common derangements of the ventilatory pump result in a sense of increased \"work of breathing\" [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/8-12\">",
"     8-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuromuscular weakness (eg, myasthenia gravis, Guillain-Barr&eacute; syndrome) leads to a condition in which the patient must exert near maximal inspiratory effort to produce a normal negative pleural pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients with reduced compliance of the chest wall (eg, kyphoscoliosis) or lungs (eg, interstitial fibrosis) must perform more work than normal to move air into the lungs. Obstructive lung disease is associated with increased resistance to flow and, in patients with significant hyperinflation, reduced compliance as breathing occurs on the stiff portion of the pressure-volume curve of the respiratory system. When hyperinflation results in an end-inspiratory volume that approximates total lung capacity, patients often complain of an inability to get a deeper satisfying breath [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/11\">",
"     11",
"    </a>",
"    ]. A sensation of chest tightness may also be present in patients in whom acute bronchoconstriction is the cause of airflow obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/8,9,14,15\">",
"     8,9,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Gas exchanger",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"gas exchanger\" consists of the alveoli and the pulmonary capillaries across which oxygen and carbon dioxide diffuse. Most of the common cardiopulmonary disorders leading to dyspnea are associated with some derangement of the gas exchanger due either to destruction of the diffusing membrane (eg, emphysema, pulmonary fibrosis) or the imposition of fluid or inflammatory material between the capillaries and the gas in the alveoli. Diseases affecting the gas exchanger are typically characterized by hypoxemia, either at rest or with exercise, and by chronic hypercapnia in more severe cases. These gas exchange abnormalities stimulate the respiratory centers in the brainstem and lead to a sensation of \"air hunger\" or an increased urge to breathe.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardiovascular system is designed to move oxygenated blood from the lungs to metabolically active tissues, and then transport carbon dioxide from the tissues back to the lungs. For this system to work optimally and avert breathing discomfort, one must have a pump that functions without generating high pulmonary capillary pressures. There must also be sufficient hemoglobin to carry oxygen and appropriate enzymes to utilize oxygen in the tissues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Heart failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure is a clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle(s) to fill with or eject blood. Symptoms of heart failure fall into two major classes: those due to a reduction in cardiac output (fatigue, weakness) and those due to increased pulmonary or systemic venous pressure and fluid accumulation (dyspnea, edema, hepatic congestion, and ascites). When heart failure causes an increase in pulmonary venous pressure, it can lead to dyspnea either by producing hypoxemia or by stimulating pulmonary vascular",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    interstitial receptors (eg, unmyelinated J-receptors, also called C-fibers). Causes of heart failure include ventricular systolic dysfunction, ventricular diastolic dysfunction, and valvular disease. Cardiac tamponade may also lead to dyspnea by increasing pulmonary vascular pressures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/40/8839?source=see_link\">",
"     \"Physiology of dyspnea\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"     \"Evaluation of the patient with suspected heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=see_link\">",
"     \"Cardiac tamponade\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia can severely impair oxygen delivery because the bulk of oxygen carried in the blood is hemoglobin-bound. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=see_link\">",
"     \"Structure and function of normal human hemoglobins\"",
"    </a>",
"    .) Nevertheless, the exact mechanism by which anemia produces dyspnea is unknown. To the extent that the local pH of metabolically active cells decreases due to the inability to sustain aerobic metabolism, there may be stimulation of \"ergoreceptors\" which are believed to be located in the muscles and which respond to such changes in the microenvironment of the cell [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Anemia also leads to increased cardiac output, which may necessitate elevated left ventricular volume and pulmonary vascular pressures. However, the quality of dyspnea is usually quite different in these two clinical situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Deconditioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals usually complain of respiratory discomfort when they engage in vigorous physical activity, even in the presence of a normal cardiovascular and respiratory system and normal hematocrit. More fit individuals experience less discomfort for any given workload; cardiovascular fitness is determined by the ability of the heart to increase maximal cardiac output and by the ability of the peripheral muscles to utilize oxygen efficiently for aerobic metabolism.",
"   </p>",
"   <p>",
"    In contrast, a sedentary existence reduces fitness and leads to dyspnea, often with seemingly trivial tasks. It is common for patients with chronic cardiopulmonary disease to assume a sedentary lifestyle in an effort to avoid breathing discomfort. However, the end result over a span of months to years is that the individual becomes progressively deconditioned and ultimately may be limited more by poor cardiovascular fitness than by the underlying disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/18\">",
"     18",
"    </a>",
"    ]. Dyspnea due to deconditioning is typically described as \"heavy breathing\" or a sense of \"breathing more\" [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/10\">",
"     10",
"    </a>",
"    ], and with careful questioning, one can determine that the patient is actually limited by fatigue rather than breathing discomfort.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LANGUAGE OF DYSPNEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;When eliciting a history from a patient presenting with a complaint of pain, clinicians are taught to always inquire about the quality of the pain. As an example, chest pain may mean very different things if it is described as \"sharp,\" \"burning,\" or \"crushing.\" (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link&amp;anchor=H9#H9\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the 1970s and 1980s a number of pain questionnaires were developed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/19,20\">",
"     19,20",
"    </a>",
"    ], and studies in which they were utilized for headache and facial pain demonstrated that clinicians could draw inferences about the cause of these symptoms depending upon the responses of a given patient [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The notion that pain comprises multiple, qualitatively distinct sensations comes easily to most clinicians because everyone experiences a range of painful sensations as part of normal living (eg, headaches, stomach aches, tooth pain, burns, bruises, etc). However, if one has a normal cardiopulmonary system, the only dyspnea one is likely to experience is that which occurs with heavy exercise. This makes it more difficult for the average examiner to question a patient with breathing discomfort in a way that captures the subtleties of asthma, heart failure, COPD, or pulmonary embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To the extent that dyspnea occurs unexpectedly or cannot be quickly relieved, it may give rise to a range of emotional reactions, which can then lead to further physiological derangements (eg, tachypnea, hyperinflation). For any given gas exchange or mechanical problem with the cardiopulmonary system, the emotional or affective response may contribute to the intensity or discomfort of the sensation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/24\">",
"     24",
"    </a>",
"    ]; questionnaires are now in development that incorporate both qualitative and affective descriptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Questionnaires",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first dyspnea questionnaires were developed in the late 1980s based upon informal data obtained from patients and the systematic questioning of normal subjects made breathless by the imposition of a range of respiratory tasks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/4\">",
"     4",
"    </a>",
"    ]. These tasks included breathing when resistive or elastic loads were added, when end-expiratory lung volume was changed, when tidal volume was restricted, or when carbon dioxide was inhaled. In these settings, the sensations of respiratory discomfort produced by the different causes of dyspnea were different and easily distinguishable.",
"   </p>",
"   <p>",
"    As a result of these studies, clusters of terms emerged that were allied with one or another of the respiratory tasks. Similar dyspnea questionnaires were then presented to patients with breathing discomfort from a variety of cardiopulmonary disorders (",
"    <a class=\"graphic graphic_table graphicRef76579 \" href=\"UTD.htm?32/4/32843\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/8-10,26\">",
"     8-10,26",
"    </a>",
"    ]. Subjects were asked to select the phrases that best described their breathing discomfort, and distinct clusters again emerged. While some clusters of phrases were common to a number of disease categories (eg, increased work or effort of breathing was found with COPD, asthma, and neuromuscular disease), each disease had a relatively unique set of clusters associated with it.",
"   </p>",
"   <p>",
"    These data suggested that the physiologic mechanisms responsible for dyspnea in each patient group are likely to have some elements in common, and some that are unique. Attention to the words that patients use in describing their breathing discomfort may provide insight into the underlying clinical condition as well as the basic physiologic mechanisms producing dyspnea.",
"   </p>",
"   <p>",
"    Research in this area is continuing, and one incompletely resolved issue is the potential role that gender, ethnicity, and cultural context play in influencing an individual's description of dyspnea. In relatively small studies that utilize inspiratory resistive loads to provoke dyspnea, women appear to experience greater breathing discomfort than men [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/27\">",
"     27",
"    </a>",
"    ]. Studies using dyspnea questionnaires in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/8,10\">",
"     8,10",
"    </a>",
"    ] and the United Kingdom [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/10\">",
"     10",
"    </a>",
"    ] have demonstrated similar sensory descriptions across a number of disease states. On the other hand, one study of 32 patients with asthma found significant differences among African-American and white subjects in their use of descriptors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/28\">",
"     28",
"    </a>",
"    ]. However, in this investigation, subjects were not given a questionnaire nor were they asked to describe their breathing discomfort; rather, they offered spontaneous comments about any sensations associated with inhalation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    . Research confirms the utility of studying the qualities of dyspnea in different languages [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. The cross-cultural generalizability of specific dyspnea questionnaires is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Using questionnaires",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies of the language of dyspnea have been performed in patients with known cardiopulmonary disorders or in normal subjects made breathless under experimental conditions. These indicate the following (",
"    <a class=\"graphic graphic_table graphicRef69244 \" href=\"UTD.htm?31/58/32683\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute hypercapnia or restricted thoracic motion produces a sensation of \"air hunger\" [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/5,6,31\">",
"       5,6,31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acute bronchoconstriction leads to a series of sensations from \"chest tightness\" to an increased \"effort to breathe\" to a sensation of \"air hunger\" as the degree of obstruction worsens [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/8-10,14,15\">",
"       8-10,14,15",
"      </a>",
"      ]. The sensation of \"tightness\" appears to be independent of the work of breathing [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One study explored the use of dyspnea questionnaires in evaluating patients receiving treatment for acute bronchoconstriction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/12\">",
"     12",
"    </a>",
"    ]. Patients undergoing bronchodilator therapy in an emergency department reported decreased breathing discomfort in association with relief of their \"chest tightness.\" However, the sense of increased \"effort\" to breathe persisted, as did moderate spirometric airflow obstruction.",
"   </p>",
"   <p>",
"    This study may provide insight into the different components of dyspnea in asthma: chest tightness relieved by bronchodilators may reflect changes in pulmonary receptor activation as bronchospasm diminishes, while the effort of breathing relates to ongoing airflow obstruction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hyperinflation remaining due to airways inflammation.",
"   </p>",
"   <p>",
"    Attention to the use of verbal descriptors in such patients may help the clinician avoid underestimation of the severity of asthma when objective measurements of lung function are not possible.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with COPD complain of an increased \"effort to breathe\" as well as a sensation of \"unsatisfying breaths\" or a sense that they \"cannot get a deep breath\" [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Heart failure is associated with a sensation of \"air hunger\" and \"suffocation\" [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cardiovascular deconditioning is characterized by \"heavy breathing\" [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prospective studies examining the clinical utility of dyspnea questionnaires are underway. We have had extensive experience using these tools in patients referred for evaluation of chronic dyspnea and have found them to be helpful, particularly in patients with more than one cardiopulmonary disorder and in patients in whom dyspnea appears out of proportion to their underlying lung disease. As an example, a patient with sarcoidosis who experienced worsening shortness of breath was increasing her dose of oral corticosteroids on the presumption that her parenchymal disease was flaring, but was found to have superimposed airways reactivity after she selected \"chest tightness\" as the phrase that best described her breathing discomfort. Similarly, a patient with COPD who had significant functional constraints presumed due to his emphysema was found to be limited primarily by cardiovascular deconditioning when he noted that his dyspnea with exertion was best described as \"heavy breathing.\" He denied the qualities of dyspnea most typical of COPD (difficulty moving air in or out of his lungs or a sensation of not being able to get a deep breath).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     EVALUATION OF ACUTE DYSPNEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breathing discomfort arising over the course of minutes to hours is due to a relatively limited number of conditions (",
"    <a class=\"graphic graphic_table graphicRef82700 \" href=\"UTD.htm?5/1/5147\">",
"     table 3",
"    </a>",
"    ). These entities typically have associated symptoms and signs that provide clues to the appropriate diagnosis, eg, substernal chest pain with cardiac ischemia; fever, cough, and sputum with respiratory infections; urticaria with anaphylaxis; and wheezing with acute bronchospasm. However, dyspnea may be the sole complaint and the physical examination may reveal few abnormalities (eg, pulmonary embolism, pneumothorax). In these cases, attention to historical information and a review of this limited differential diagnosis are important. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/16/28938?source=see_link\">",
"     \"Evaluation of the adult with dyspnea in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Plasma BNP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms and physical findings of heart failure (HF) can be subtle; however, establishing HF as the etiology of a patient's dyspnea is extremely important because management will be altered. With chronic and advanced HF, ventricular cells are recruited to secrete atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in response to the high ventricular filling pressures. As a result, the plasma concentrations of both hormones are increased in patients with asymptomatic and symptomatic left ventricular dysfunction, making them useful diagnostic markers. A meta-analysis has shown that the use of BNP testing for patients presenting to the emergency department with a complaint of dyspnea can reduce the length of stay in the critical care unit and the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With the rapid bedside assay for BNP, most dyspneic patients with HF have values above 400",
"    <span class=\"nowrap\">",
"     pg/mL,",
"    </span>",
"    while left ventricular dysfunction without exacerbation, pulmonary embolism, and cor pulmonale should be considered in dyspneic patients with plasma BNP concentrations between 100 and 400",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef82685 \" href=\"UTD.htm?39/28/40397\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. One must be cautious, however, when evaluating a patient with a history of moderate to severe, chronic HF. In these patients, BNP levels may be elevated continuously above 400",
"    <span class=\"nowrap\">",
"     pg/mL,",
"    </span>",
"    reducing the utility of BNP measurement for assessing the role of HF in acute changes in dyspnea.",
"   </p>",
"   <p>",
"    The role of plasma BNP and its precursor, N-terminal pro-BNP, in distinguishing HF from other causes of dyspnea is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link&amp;anchor=H16#H16\">",
"     \"Evaluation of the patient with suspected heart failure\", section on 'BNP and NT-proBNP'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=see_link&amp;anchor=H10#H10\">",
"     \"Natriuretic peptide measurement in heart failure\", section on 'Plasma BNP in heart failure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H435480019\">",
"    <span class=\"h2\">",
"     Chest ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest ultrasound is used in some emergency departments to quickly assess the contractile state of the heart as well as abnormalities in the abdomen. Preliminary data from one highly trained physician suggest a high concordance between ultrasonography of the chest with chest radiographs, particularly for the diagnosis of pulmonary edema and pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     EVALUATION OF CHRONIC DYSPNEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of dyspnea may prove elusive when it develops over weeks to months. Patients commonly have known cardiopulmonary disease, but symptoms are out of proportion to demonstrable physiologic impairments. A majority of patients with dyspnea of unclear cause have one of four etiologies: asthma, COPD, interstitial lung disease, or cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of 85 patients presenting to a pulmonary unit with a complaint of chronic dyspnea, the initial impression of the etiology of dyspnea based upon the patient history alone was correct in only 66 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/2\">",
"     2",
"    </a>",
"    ]. Thus, a systematic diagnostic approach to these patients is necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, attention to the quality of the breathing discomfort often provides clues to the underlying diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chest tightness may be indicative of bronchospasm",
"     </li>",
"     <li>",
"      A sensation of rapid, shallow breathing may correspond to interstitial disease",
"     </li>",
"     <li>",
"      A sense of heavy breathing is typical of deconditioning",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The history may reveal other valuable clues. The absence of cigarette smoking argues strongly against a diagnosis of chronic obstructive pulmonary disease. The occupational history may lead to a diagnosis of asbestosis or hypersensitivity pneumonitis. The presence of specific, reproducible inciting events such as exposure to fumes or cold air is common with airways hyperreactivity. However, a known chronic cardiopulmonary disease does not guarantee that the patient's symptoms are due to that condition [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/18\">",
"     18",
"    </a>",
"    ]. The rapidity with which symptoms develop during exercise can also provide useful diagnostic information. For example, patients who develop acute elevations in pulmonary capillary wedge pressure generally develop shortness of breath and wheezing within 50 to 100 feet. In contrast, symptoms of exercise-induced asthma usually are precipitated by more intense activity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1513?source=see_link\">",
"     \"Exercise-induced bronchoconstriction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, the negative predictive value of absent physical findings is higher than the positive predictive value for signs obtained from the examination of patients with chronic dyspnea [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation following the history and physical examination typically includes measurement of hemoglobin concentration or hematocrit (to exclude anemia as a contributing factor to respiratory discomfort), blood glucose, urea nitrogen, creatinine, electrolytes, calcium, phosphorus, and thyroid stimulating hormone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/9/23701?source=see_link\">",
"     \"Respiratory function in thyroid disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2084359\">",
"    <span class=\"h2\">",
"     Pulmonary function testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial assessment of pulmonary function in patients with chronic dyspnea includes spirometry and pulse oximetry during ambulation at a normal pace over approximately 200 meters",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    up two to three flights of stairs.",
"   </p>",
"   <p>",
"    Spirometry provides data on airflow obstruction and with a flow-volume loop can detect and differentiate upper and lower respiratory tract obstruction. When intrathoracic airflow limitation is noted or when a diagnosis of asthma is suspected, postbronchodilator spirometry identifies reversibility of airflow limitation suggestive of asthma. A decrease in the forced vital capacity can suggest an underlying \"restrictive\" abnormality that could be confirmed with measurement of lung volumes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5607?source=see_link\">",
"     \"Office spirometry\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22487?source=see_link\">",
"     \"Use of pulmonary function testing in the diagnosis of asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complete pulmonary function testing with assessment of lung volumes and diffusing capacity is generally reserved for individuals in whom interstitial fibrosis or ventilatory muscle weakness are suspected, the spirometry results are abnormal, or in individuals who have low baseline oxygen saturation (eg, &le;95 percent) or a significant decline in oxygen saturation during exercise (eg, &ge;5 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=see_link\">",
"     \"Diffusing capacity for carbon monoxide\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchoprovocation testing is typically obtained in patients with recurrent, episodic dyspnea suggestive of asthma, who have normal or near normal spirometry. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=see_link\">",
"     \"Bronchoprovocation testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Supplemental tests, such as maximal inspiratory and expiratory pressures at the mouth and maximal voluntary ventilation in one minute are typically obtained when respiratory muscle weakness is suspected based on physical examination and analysis of spirometric and lung volume results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35142?source=see_link&amp;anchor=H7#H7\">",
"     \"Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation\", section on 'Evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11560?source=see_link\">",
"     \"Tests of respiratory muscle strength\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2084352\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiograph may provide evidence of hyperinflation and bullous disease suggestive of obstructive lung disease, or changes in interstitial markings consistent with inflammation or interstitial fluid. Abnormalities of heart size may indicate valvular disease or other cardiac dysfunction.",
"   </p>",
"   <p>",
"    Computed tomography (CT) of the chest usually is not indicated in the initial evaluation of patients with dyspnea, but can be valuable in three circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A small percentage of patients with pulmonary fibrosis may have a normal chest radiograph on presentation; CT scan clearly is more sensitive for detecting mild degrees of alveolitis, particularly when high resolution images are obtained [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/37,38\">",
"       37,38",
"      </a>",
"      ]. Thus, patients with crackles on physical examination or reduced lung volumes on pulmonary function testing should have CT scans if the chest radiograph is normal. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"       \"High resolution computed tomography of the lungs\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A minority of patients with a history of cigarette smoking, normal spirometry, and normal chest radiographs have extensive emphysema on high-resolution CT scan [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/39\">",
"       39",
"      </a>",
"      ]. These patients generally demonstrate oxygen desaturation with exercise and have a low diffusing capacity.",
"     </li>",
"     <li>",
"      In patients in whom chronic thromboembolic disease is a consideration due to elevation of pulmonary artery pressure on an echocardiogram or oxygen desaturation during exercise, a computed tomography pulmonary angiogram is obtained. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=see_link&amp;anchor=H18#H18\">",
"       \"Principles of computed tomography of the chest\", section on 'CT angiography'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=see_link\">",
"       \"Diagnosis of acute pulmonary embolism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2084203\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is generally performed in patients in whom the heart is enlarged on chest radiograph or when left ventricular heart failure or pulmonary hypertension are suspected on the basis of clinical findings, brain natriuretic peptide (BNP) levels, chest radiograph findings, or oxygen desaturation with exertion. Color flow Doppler echocardiography is used for patients in whom chronic thromboembolic disease, pulmonary hypertension, or diastolic dysfunction are being considered. Among older adults with unexplained chronic dyspnea after an initial evaluation (eg, history, physical examination, pulmonary function tests, and a chest radiograph), nearly two-thirds have evidence of diastolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/40\">",
"     40",
"    </a>",
"    ], which can manifest as dyspnea with relatively minimal exertion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/60/33735?source=see_link\">",
"     \"Echocardiographic evaluation of left ventricular diastolic function\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=see_link\">",
"     \"Principles of Doppler echocardiography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20567?source=see_link\">",
"     \"Echocardiographic evaluation of the pulmonic valve and pulmonary artery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cardiopulmonary exercise testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiopulmonary exercise testing is indicated when the etiology of a patient's dyspnea remains unclear after the initial evaluation described above, or when it seems out of proportion to the severity of the patient's known cardiac or pulmonary disease. This testing, during which a range of physiologic parameters is monitored, allows one to determine if the patient's dyspnea is more likely due to cardiovascular or respiratory system abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=see_link\">",
"     \"Functional exercise testing: Ventilatory gas analysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=see_link\">",
"     \"Exercise physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiopulmonary exercise testing is particularly helpful in establishing the diagnosis of deconditioning and can yield clues about the presence of primary hyperventilation syndromes. The technique also detects patients with a low threshold for respiratory discomfort; these individuals terminate the test at mild workloads because of dyspnea but have no evidence of cardiopulmonary abnormality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     BEHAVIORAL CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A symptom is the end result of a sequence of events that begins with stimulation of one or more receptors, leads to the transmission of neural information from those receptors to the brain, and ultimately involves the processing of that information so that it becomes a perception. An individual's education, experience, and behavioral style are important in shaping the ultimate perception of a given stimulus [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The global rating that a patient gives for dyspnea may reflect both sensory and emotional (ie, affective) elements. In a study of laboratory-induced dyspnea, air hunger was associated with greater unpleasantness for a given level of sensory intensity than was the sense of respiratory work or effort [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/24\">",
"     24",
"    </a>",
"    ]. The context in which a sensation occurs may alter the affective component of the intensity and needs to be considered when assessing the patient.",
"   </p>",
"   <p>",
"    For a given physiologic derangement, eg, a drop in FEV",
"    <sub>",
"     1",
"    </sub>",
"    or PaO",
"    <sub>",
"     2",
"    </sub>",
"    , there is a wide range of perceptual responses among individuals. Anxiety, anger, pain, and depression may be associated with dyspnea intensity out of proportion to the physiologic impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16553/abstract/43-46\">",
"     43-46",
"    </a>",
"    ]. Increased ventilation associated with anxiety, anger, or pain may push an individual with a limited pulmonary reserve at baseline closer to his or her ventilatory limits and increase respiratory discomfort for any given activity.",
"   </p>",
"   <p>",
"    Patients with hyperventilation syndrome typically experience a sensation of an air hunger or an inability to take a deep breath in the absence of cardiopulmonary disease. These individuals may have panic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anxiety disorders, and on examination are often observed to breathe with very large tidal volumes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37703?source=see_link\">",
"     \"Hyperventilation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/46/6883?source=see_link\">",
"       \"Patient information: Shortness of breath (dyspnea) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/50/28450?source=see_link\">",
"       \"Patient information: Shortness of breath (dyspnea) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyspnea can be the first manifestation of a variety of cardiopulmonary disorders. We recommend the following approach when evaluating a patient with dyspnea of unclear etiology or dyspnea out of proportion to known physiologic abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When developing a differential diagnosis, use a construct that distinguishes respiratory system dyspnea from cardiovascular dyspnea. It is not uncommon for a patient to have more than one problem contributing to the breathing discomfort. The most common causes of chronic dyspnea are asthma, COPD, interstitial lung disease, and cardiomyopathy, but deconditioning is often a major contributing factor in patients with chronic lung disease. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inquire about the quality of the patient's breathing discomfort and attempt to ascertain whether the individual has more than one type of discomfort under different conditions. Use of dyspnea questionnaires can be helpful in eliciting this information from patients with chronic dyspnea. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Language of dyspnea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plasma brain natriuretic peptide (BNP) levels may be helpful in establishing or excluding the diagnosis of heart failure as a cause of acute dyspnea. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Evaluation of acute dyspnea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history and physical examination lead to accurate diagnoses in patients with dyspnea in approximately two-thirds of cases; chest radiography and pulmonary function testing should be the first tests obtained in the majority of cases in which additional information is required. CT scanning is generally reserved for patients in whom there is a suspicion of interstitial lung disease, occult emphysema, or chronic thromboembolic disease. Echocardiography is useful for evaluating suspected left ventricular dysfunction, pulmonary hypertension, and diastolic dysfunction. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Evaluation of chronic dyspnea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiopulmonary exercise testing is a useful study in patients in whom the cause of their breathing discomfort remains elusive after standard testing, in patients in whom deconditioning is a serious consideration, and in patients who appear to have breathing discomfort out of proportion to their physiologic derangements. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Cardiopulmonary exercise testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/1\">",
"      Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/2\">",
"      Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 1989; 149:2277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/3\">",
"      Martinez FJ, Stanopoulos I, Acero R, et al. Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest 1994; 105:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/4\">",
"      Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989; 140:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/5\">",
"      Banzett RB, Lansing RW, Reid MB, et al. 'Air hunger' arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol 1989; 76:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/6\">",
"      Banzett RB, Lansing RW, Brown R, et al. 'Air hunger' from increased PCO2 persists after complete neuromuscular block in humans. Respir Physiol 1990; 81:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/7\">",
"      Brack T, Jubran A, Tobin MJ. Dyspnea and decreased variability of breathing in patients with restrictive lung disease. Am J Respir Crit Care Med 2002; 165:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/8\">",
"      Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990; 142:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/9\">",
"      Elliott MW, Adams L, Cockcroft A, et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991; 144:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/10\">",
"      Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996; 154:1357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/11\">",
"      O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/12\">",
"      Moy ML, Lantin ML, Harver A, Schwartzstein RM. Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol. Am J Respir Crit Care Med 1998; 158:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/13\">",
"      Killian KJ, Gandevia SC, Summers E, Campbell EJ. Effect of increased lung volume on perception of breathlessness, effort, and tension. J Appl Physiol 1984; 57:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/14\">",
"      Taguchi O, Kikuchi Y, Hida W, et al. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991; 71:2183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/15\">",
"      Moy ML, Woodrow Weiss J, Sparrow D, et al. Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 2000; 162:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/16\">",
"      Clark AL, Piepoli M, Coats AJ. Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors. Eur J Clin Invest 1995; 25:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/17\">",
"      Clark A, Volterrani M, Swan JW, et al. Leg blood flow, metabolism and exercise capacity in chronic stable heart failure. Int J Cardiol 1996; 55:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/18\">",
"      Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/19\">",
"      Melzack R, Torgerson WS. On the language of pain. Anesthesiology 1971; 34:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/20\">",
"      Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/21\">",
"      Hunter M, Philips C. The experience of headache pain--an assessment of the qualities of tension headache pain. Pain 1981; 10:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/22\">",
"      Melzack R, Terrence C, Fromm G, Amsel R. Trigeminal neuralgia and atypical facial pain: use of the McGill Pain Questionnaire for discrimination and diagnosis. Pain 1986; 27:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/23\">",
"      Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language. Eur Respir J 2005; 25:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/24\">",
"      Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008; 177:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/25\">",
"      Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010; 65:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/26\">",
"      Williams M, Cafarella P, Olds T, et al. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest 2008; 134:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/27\">",
"      Gui P, Ebihara S, Kanezaki M, et al. Gender differences in perceptions of urge to cough and dyspnea induced by citric acid in healthy never smokers. Chest 2010; 138:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/28\">",
"      Hardie GE, Janson S, Gold WM, et al. Ethnic differences: word descriptors used by African-American and white asthma patients during induced bronchoconstriction. Chest 2000; 117:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/29\">",
"      Phankingthongkum S, Daengsuwan T, Visitsunthorn N, et al. How do Thai children and adolescents describe asthma symptoms? Pediatr Allergy Immunol 2002; 13:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/30\">",
"      Han J, Zhu Y, Li S, et al. The language of medically unexplained dyspnea. Chest 2008; 133:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/31\">",
"      Manning HL, Shea SA, Schwartzstein RM, et al. Reduced tidal volume increases 'air hunger' at fixed PCO2 in ventilated quadriplegics. Respir Physiol 1992; 90:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/32\">",
"      Binks AP, Moosavi SH, Banzett RB, Schwartzstein RM. \"Tightness\" sensation of asthma does not arise from the work of breathing. Am J Respir Crit Care Med 2002; 165:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/33\">",
"      Lam LL, Cameron PA, Schneider HG, et al. Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting. Ann Intern Med 2010; 153:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/34\">",
"      Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/35\">",
"      Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation 2002; 105:2328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/36\">",
"      Zanobetti M, Poggioni C, Pini R. Can chest ultrasonography replace standard chest radiography for evaluation of acute dyspnea in the ED? Chest 2011; 139:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/37\">",
"      Epler GR, McLoud TC, Gaensler EA, et al. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/38\">",
"      Wells AU, Hansell DM, Rubens MB, et al. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/39\">",
"      Klein JS, Gamsu G, Webb WR, et al. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology 1992; 182:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/40\">",
"      Penicka M, Bartunek J, Trakalova H, et al. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis. J Am Coll Cardiol 2010; 55:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/41\">",
"      Rosser R, Guz A. Psychological approaches to breathlessness and its treatment. J Psychosom Res 1981; 25:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/42\">",
"      Bredin M, Corner J, Krishnasamy M, et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999; 318:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/43\">",
"      Burns BH, Howell JB. Disproportionately severe breathlessness in chronic bronchitis. Q J Med 1969; 38:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/44\">",
"      Dales RE, Spitzer WO, Schechter MT, Suissa S. The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis 1989; 139:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/45\">",
"      Nishino T, Shimoyama N, Ide T, Isono S. Experimental pain augments experimental dyspnea, but not vice versa in human volunteers. Anesthesiology 1999; 91:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16553/abstract/46\">",
"      Livermore N, Butler JE, Sharpe L, et al. Panic attacks and perception of inspiratory resistive loads in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178:7.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1436 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-197.136.42.3-D08D6ABB4A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16553=[""].join("\n");
var outline_f16_10_16553=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Respiratory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Controller",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Ventilatory pump",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Gas exchanger",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Heart failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Deconditioning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LANGUAGE OF DYSPNEA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Questionnaires",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Using questionnaires",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      EVALUATION OF ACUTE DYSPNEA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Plasma BNP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H435480019\">",
"      Chest ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      EVALUATION OF CHRONIC DYSPNEA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2084359\">",
"      Pulmonary function testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2084352\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2084203\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cardiopulmonary exercise testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      BEHAVIORAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1436\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1436|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/28/40397\" title=\"figure 1\">",
"      BNP levels etiology dyspnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1436|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/4/32843\" title=\"table 1\">",
"      Dyspnea patient questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/58/32683\" title=\"table 2\">",
"      Dyspnea qualities disease state",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/1/5147\" title=\"table 3\">",
"      Causes of acute dyspnea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=related_link\">",
"      Bronchoprovocation testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/52/19273?source=related_link\">",
"      Cardiac tamponade",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=related_link\">",
"      Control of ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6042?source=related_link\">",
"      Diagnosis of acute pulmonary embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=related_link\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36454?source=related_link\">",
"      Dynamic hyperinflation in patients with COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/60/33735?source=related_link\">",
"      Echocardiographic evaluation of left ventricular diastolic function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20567?source=related_link\">",
"      Echocardiographic evaluation of the pulmonic valve and pulmonary artery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/16/28938?source=related_link\">",
"      Evaluation of the adult with dyspnea in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/35/25144?source=related_link\">",
"      Exercise physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1513?source=related_link\">",
"      Exercise-induced bronchoconstriction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=related_link\">",
"      Functional exercise testing: Ventilatory gas analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37703?source=related_link\">",
"      Hyperventilation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=related_link\">",
"      Natriuretic peptide measurement in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/30/5607?source=related_link\">",
"      Office spirometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/50/28450?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/46/6883?source=related_link\">",
"      Patient information: Shortness of breath (dyspnea) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/40/8839?source=related_link\">",
"      Physiology of dyspnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=related_link\">",
"      Principles of Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=related_link\">",
"      Principles of computed tomography of the chest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/9/23701?source=related_link\">",
"      Respiratory function in thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/20/35142?source=related_link\">",
"      Respiratory muscle weakness due to neuromuscular disease: Clinical manifestations and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/29/23001?source=related_link\">",
"      Structure and function of normal human hemoglobins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11560?source=related_link\">",
"      Tests of respiratory muscle strength",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/61/22487?source=related_link\">",
"      Use of pulmonary function testing in the diagnosis of asthma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16554="Probiotics for gastrointestinal diseases";
var content_f16_10_16554=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Probiotics for gastrointestinal diseases",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16554/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16554/contributors\">",
"     R Balfour Sartor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16554/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16554/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/10/16554/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/10/16554/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/10/16554/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intestinal tract is host to a vast ecology of microbes, which are necessary for health, but also have the potential to contribute to the development of diseases by a variety of mechanisms. Perturbations in intestinal epithelial barrier function or innate immune bacterial killing, for example, can lead to an inflammatory response caused by increased uptake of bacterial and food antigens that stimulate the mucosal immune system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=see_link\">",
"     \"Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interactions between intestinal microbes and the host are the subject of intensive ongoing research since they may influence a variety of diseases. Part of this research involves the deliberate manipulation of the intestinal microflora with a therapeutic intention. The greatest experience has been in the inflammatory bowel diseases, ulcerative colitis, Crohn's disease, and pouchitis, although clinical trials are emerging in several other conditions.",
"   </p>",
"   <p>",
"    There are three general methods by which the intestinal microflora can be altered: administration of antibiotics, prebiotics (ie, dietary components that promote the growth and metabolic activity of beneficial bacteria), probiotics (ie, beneficial bacteria), or fecal transplant (bacteriotherapy). Combination of these methods is also possible (synbiotics). Interest in these approaches has extended well beyond the clinical sciences since a role for intestinal microbes in health and disease has been recognized in alternative and complementary forms of medicine for many years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/3\">",
"     3",
"    </a>",
"    ]. In a case control study, 51 percent of ulcerative colitis patients and 43 percent of patients with Crohn&rsquo;s disease used probiotics compared with 21 percent of healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/4\">",
"     4",
"    </a>",
"    ]. In comparison, systematic evaluation of the efficacy of probiotics is relatively recent. This topic review focuses on clinical trials of probiotics in gastrointestinal diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Probiotics are microorganisms that have beneficial properties for the host. Most commercial products have been derived from food sources, especially cultured milk products. The list of such microorganisms continues to grow and includes strains of lactic acid bacilli (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    and",
"    <em>",
"     Bifidobacterium",
"    </em>",
"    ), a nonpathogenic strain of",
"    <em>",
"     Escherichia coli",
"    </em>",
"    (eg,",
"    <em>",
"     E. coli Nissle 1917",
"    </em>",
"    ),",
"    <em>",
"     Clostridium butyricum, Streptococcus salivarius",
"    </em>",
"    , and",
"    <em>",
"    </em>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"     Saccharomyces boulardii",
"    </a>",
"    <em>",
"    </em>",
"    (a nonpathogenic strain of yeast). Also under development are strains of bacteria that have been genetically engineered to secrete immunomodulators (such as interleukin-10,r trefoil factors, or defensins, or express altered surface proteins such as lipoteichoic acid), which have the potential to favorably influence the immune system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. More recently, the concept of restoring levels of protective commensal bacterial species that are diminished in certain disorders, such as Crohn's disease, has been advanced [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/7-10\">",
"     7-10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Initial studies of selected probiotic species (given alone or in combination) have suggested potential efficacy in several gastrointestinal illnesses, the best studied of which are the inflammatory bowel diseases (particularly pouchitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/11-20\">",
"     11-20",
"    </a>",
"    ]. Therapeutic benefit has also been suggested in several other disorders, including antibiotic-related diarrhea,",
"    <em>",
"     Clostridium difficile",
"    </em>",
"    toxin-induced colitis, infectious diarrhea, hepatic encephalopathy, irritable bowel syndrome, and allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of the more commonly available probiotics include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      VSL#3 (",
"      <em>",
"       Bifidobacterium breve, B. longum, B. infantis,",
"      </em>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       acidophilus, L. plantarum, L. paracasei, L. bulgaricus, Streptococcus thermophilus",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Align (",
"      <em>",
"       B. infantis",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Culturelle (",
"      <em>",
"       L. rhamnosus GG",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      DanActive (",
"      <em>",
"       L. casei",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Mutaflor (",
"      <em>",
"       E. coli Nissle 1917",
"      </em>",
"      )",
"     </li>",
"     <li>",
"      Florastor (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"       Saccharomyces boulardii",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISMS OF BENEFIT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanisms for the benefits of probiotics are incompletely understood. However, four general benefits have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/17,23\">",
"     17,23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suppression of growth or epithelial",
"      <span class=\"nowrap\">",
"       binding/invasion",
"      </span>",
"      by pathogenic bacteria [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improvement of intestinal barrier function [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/25-27\">",
"       25-27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Modulation of the immune system. Several probiotic species or their products induce protective cytokines, including IL-10 and TGF-beta, and suppress proinflammatory cytokines, such as TNF, in the mucosa of patients with pouchitis, ulcerative colitis, and Crohn's disease, in murine experimental colitis, and in isolated splenocytes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/8,24,26,28-32\">",
"       8,24,26,28-32",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"       Saccharomyces boulardii",
"      </a>",
"      limited the migration of T-helper 1 cells in inflamed colon tissue in a mouse model of inflammatory bowel disease [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Modulation of pain perception. Some",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      strains appear to induce expression of micro-opioid and cannabinoid receptors in intestinal epithelial cells and mediate analgesic functions in the gut in a manner similar to the effects of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Probiotics differ in their ability to resist gastric acid and bile acids, colonize the intestinal tract, and influence cytokines secreted by intestinal epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/26,28,35-40\">",
"     26,28,35-40",
"    </a>",
"    ]. Thus, not all probiotics are alike; as a result, benefits observed clinically with one species or with a combination of species are not necessarily generalizable to another.",
"   </p>",
"   <p>",
"    Although yogurt is commonly recommended as a source of probiotics, not all of the live cultures contained in yogurt survive well in an acidic environment nor do they colonize the microbiota efficiently [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. In addition, some yogurt preparations in the United States are pasteurized, thereby killing the bacteria. Furthermore, the residual lactose contained in yogurt can increase symptoms in patients with lactose intolerance, including those who develop secondary lactose intolerance due to an antecedent gastroenteritis (a setting in which probiotics have been recommended). Fermented dairy beverages containing much higher concentrations of live cultures than yogurt or cultures that are relatively resistant to gastric acid are also available.",
"   </p>",
"   <p>",
"    An interesting observation indicates that it may not be necessary to administer living organisms to achieve a benefit. Secreted proteins and DNA of one probiotic preparation (VSL#3, Nature's Pharmaceuticals, Inc.) blocked cytokine activation and prevented apoptosis of epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. The effects depended upon the specific DNA from the different bacterial species that were components of the preparation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/43\">",
"     43",
"    </a>",
"    ]. Non-methylated DNA from VSL#3 as well as other randomly selected",
"    <em>",
"     E. coli",
"    </em>",
"    strains suppressed experimental colitis in several animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/45\">",
"     45",
"    </a>",
"    ]. These therapeutic effects are mediated through toll-like receptor 9 and with induction of type 1 interferons",
"    <span class=\"nowrap\">",
"     alpha/beta",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/46\">",
"     46",
"    </a>",
"    ]. Defined molecular weight proteins from other probiotic species, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     GG",
"    </em>",
"    , can also inhibit proinflammatory signaling and inflammatory cytokine-induced apoptosis in colonic epithelial cells through an epidermal growth factor receptor (EGFR)-dependent mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], while secreted products from a variety of species can inhibit cytokine production [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies demonstrate that products of endogenous commensal microbiota can have beneficial effects, creating opportunities for therapeutic manipulation beyond the traditional",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     and Bifidobacterium",
"    </em>",
"    species. For example,",
"    <em>",
"     Faecalibacterium prausnitzii",
"    </em>",
"    , which is decreased in Crohn&rsquo;s disease, secretes yet to be defined products that suppress experimental colitis and proinflammatory cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/8\">",
"     8",
"    </a>",
"    ], and polysaccharide A of",
"    <em>",
"     Bacteroides fragilis",
"    </em>",
"    stimulates regulatory T cells in a TLR2, IL-10-dependent fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/47\">",
"     47",
"    </a>",
"    ]. Clostridium species comprising Groups IV and XIVA, which are selectively decreased in active IBD patients, can induce IL-10 producing immunosuppressive IL-10 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/10\">",
"     10",
"    </a>",
"    ]. This approach will likely be available for therapeutic use in the foreseeable future.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10298057\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL INFLAMMATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pouchitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the surgical treatment of ulcerative colitis (UC) and familial adenomatous polyposis, proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the favored alternative to proctocolectomy with permanent ileostomy since it preserves intestinal continuity and sphincter function and removes almost all of the colorectal mucosa. This procedure consists of total abdominal colectomy and the construction of an ileal pouch that is anastomosed to the anus.",
"   </p>",
"   <p>",
"    The most frequently observed long-term complication of IPAA is acute",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chronic inflammation of the ileal reservoir, called pouchitis. Symptoms of pouchitis include increased stool frequency, urgency, hematochezia, abdominal pain, fever, and extraintestinal manifestations of inflammatory bowel diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32759?source=see_link\">",
"     \"Pouchitis\"",
"    </a>",
"    .) Pouchitis affects approximately 20 percent of ulcerative colitis patients in the first year after creation of the IPAA and 50 percent of patients after five years, but less than 1 percent of patients with colectomies to treat familial polyposis.",
"   </p>",
"   <p>",
"    Detailed studies of the microflora in patients with pouchitis have demonstrated unique patterns, including the persistence of",
"    <em>",
"     Fusobacteria",
"    </em>",
"    and enteric species, increased",
"    <em>",
"     Clostridium perfringens",
"    </em>",
"    , and the absence of",
"    <em>",
"     Streptococcus",
"    </em>",
"    species in the inflamed pouch [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. These observations and a high rate of response to various antibiotics support a role for bacteria in the pathogenesis of pouchitis and provide a rationale for clinical trials aimed at altering the microflora with probiotics.",
"   </p>",
"   <p>",
"    Small controlled trials have suggested that at least one probiotic preparation (VSL#3) containing 5 X 10(11) per gram of four",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    species, three",
"    <em>",
"     Bifidobacterium",
"    </em>",
"    species, and one strain of",
"    <em>",
"     Streptococcus",
"    </em>",
"    salivarius subspecies thermophilus may be effective in prevention of recurrent pouchitis after antibiotic induction of remission.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized, placebo-controlled trial included 40 patients with a history of chronic, relapsing pouchitis who were placed into clinical and endoscopic remission with broad spectrum antibiotics [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/50\">",
"       50",
"      </a>",
"      ]. Patients were randomly assigned to VSL#3 6",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      or placebo. After nine months of daily treatment, significantly fewer patients in the probiotic group had experienced a relapse (15 versus 100 percent). Within three months of stopping treatment, all patients in the VSL#3 group had relapsed. Likewise, fecal",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       lactobacillus",
"      </a>",
"      and",
"      <em>",
"       bifidobacteria",
"      </em>",
"      concentrations returned to pretreatment levels within one month after therapy was discontinued, indicating that permanent colonization with the probiotic species did not occur.",
"     </li>",
"     <li>",
"      A second study from the same group and investigators in London included 36 patients with recurrent or refractory pouchitis who had required antibiotics at least twice in the previous year [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/51\">",
"       51",
"      </a>",
"      ]. After achieving remission, patients were randomly assigned to VSL#3 or placebo once daily for one year. Significantly more patients in the probiotic group remained in remission (85 versus 6 percent). Patients randomized to VSL#3 also had significantly better quality of life.",
"     </li>",
"     <li>",
"      A third study from the same group included 40 consecutive patients who underwent IPAA for ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/52\">",
"       52",
"      </a>",
"      ]. Patients were randomly assigned to receive VSL#3 3",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      or placebo immediately after ileostomy closure for one year. Patients receiving the probiotic had significantly fewer episodes of pouchitis (10 versus 40 percent). Probiotic treatment was also associated with significant improvement in quality of life compared with placebo.",
"     </li>",
"     <li>",
"      Somewhat different conclusions were reached in an observational study in the United States that involved 31 patients with antibiotic-dependent pouchitis who were treated with VSL#3 after achieving remission with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/53\">",
"       53",
"      </a>",
"      ]. After eight months, only a minority of patients remained on probiotic therapy and in symptomatic remission (most having stopped it due to recurrence of symptoms or adverse effects).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No benefit from another probiotic (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     rhamnosus GG",
"    </em>",
"    ) was found in another, albeit small, controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/54\">",
"     54",
"    </a>",
"    ]. Furthermore, only 40 percent of patients who received the probiotic became colonized. A systematic review concluded that VSL#3 was more effective than placebo for preventing relapse of chronic pouchitis and preventing onset of pouchitis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Ulcerative colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although various probiotic species have shown promise in the treatment of ulcerative colitis, given the small number of patients in these studies and the risks associated with probiotics, two systematic reviews have concluded that there is insufficient evidence to support the use of probiotics for the induction or maintenance of remission in ulcerative colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. However, some studies with probiotics used as adjunctive therapy were not included in these reviews.",
"   </p>",
"   <p>",
"    The following observations were made in randomized trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       E. coli 1917 Nissle",
"      </em>",
"      was as effective as low dose 5-ASA in preventing relapse of ulcerative colitis in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/58,59\">",
"       58,59",
"      </a>",
"      ] and in an open label trial in children [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/60\">",
"       60",
"      </a>",
"      ]. Rectal administration of",
"      <em>",
"       E. coli 1917 Nissle",
"      </em>",
"      enemas had equivocal results [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       GG",
"      </em>",
"      appeared to be more effective than standard treatment involving mesalazine in prolonging relapse-free time but did not influence relapse rates in patients with quiescent ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The combination of a prebiotic and a probiotic (",
"      <em>",
"       Bifidobacterium longum",
"      </em>",
"      ) was associated with improvement in histologic scores and measures of immune activation in a one-month randomized controlled trial [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The combination of VSL#3 plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/53/8021?source=see_link\">",
"       balsalazide",
"      </a>",
"      was slightly more effective than balsalazide or mesalazine alone in a randomized trial of patients with acute mild-to-moderate ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/64\">",
"       64",
"      </a>",
"      ]. A randomized trial involving 29 children with ulcerative colitis found that VSL#3 was more effective than placebo in maintaining remission (73 versus 21 percent at one year) when given in conjunction with steroid induction and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/44/22215?source=see_link\">",
"       mesalamine",
"      </a>",
"      maintenance treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Emerging evidence suggests that VSL#3 can induce remission and reduce disease activity in patients with",
"      <span class=\"nowrap\">",
"       mild/moderate",
"      </span>",
"      active ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/66-69\">",
"       66-69",
"      </a>",
"      ]. A randomized trial of 77 patients found that VSL#3 was more effective than placebo in improving the ulcerative colitis disease activity index (UCDAI) by 50 percent at six weeks (33 versus 10 percent) and inducing remission at 12 weeks (43 versus 16 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/66\">",
"       66",
"      </a>",
"      ]. A second randomized trial examined 144 patients who were receiving a 5-ASA,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      ,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/69\">",
"       69",
"      </a>",
"      ]. The trial similarly found that patients who received VSL#3 were more likely to have at least a 50 percent decrease in the UCDAI after eight weeks compared with patients who received placebo (63 versus 41 percent). Remission rates were also higher in the VSL#3 group (48 versus 32 percent). However, histologic scores were not significantly improved with VSL#3 therapy.",
"     </li>",
"     <li>",
"      A small, double-blind, placebo-controlled trial showed no significant difference in the rates of maintenance of remission in patients with left-sided ulcerative colitis randomized to 52 weeks of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       basilicus La-5",
"      </em>",
"      and",
"      <em>",
"       Bifidobacterium animalis subsp. lactis Bb-12",
"      </em>",
"      or placebo (relapse rate 75 versus 92 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/70\">",
"       70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another small, double-blind, placebo-controlled study reported significantly lower clinical and endoscopic disease activity in pediatric patients with ulcerative colitis treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       reuteri",
"      </em>",
"      AATCC 55730 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Crohn's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical trials of probiotics in Crohn's disease have shown mixed results. The reasons for the heterogeneity are unclear, but could be due to several factors such as the specific probiotics (and doses) used, differences in study duration, characteristics of the included patients (eg, location of disease), and endpoints that were measured. Likewise, use of probiotics in prevention of postoperative recurrence of Crohn's disease has been unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the aggregate, the available data do",
"    <strong>",
"     not",
"    </strong>",
"    support clinical effectiveness of probiotic therapy for either induction or maintenance of remission in patients with Crohn's disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/73-75\">",
"     73-75",
"    </a>",
"    ]. Whether certain patient subgroups might benefit remains to be determined. A report of clinical improvement with combination of a probiotic,",
"    <em>",
"     Bifidobacterium longum",
"    </em>",
"    , and a prebiotic [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/76\">",
"     76",
"    </a>",
"    ]",
"    <strong>",
"    </strong>",
"    suggested the possibility of using a symbiotic approach to treating Crohn's disease, although previous reports with other agents were less positive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10298117\">",
"    <span class=\"h2\">",
"     Diverticular colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infrequently, patients with diverticular disease develop a segmental colitis, most commonly in the sigmoid colon, which can occasionally be symptomatic. Combination therapy with VSL#3 and oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"     beclomethasone",
"    </a>",
"    dipropionate (a locally acting corticosteroid not available in the United States) was beneficial in a case series. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20324?source=see_link\">",
"     \"Diverticular colitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10298270\">",
"    <span class=\"h2\">",
"     Radiation enteritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of four randomized controlled trials of probiotics in radiation induced diarrhea did not detect an overall benefit despite significant effects in some of the individual studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/77\">",
"     77",
"    </a>",
"    ]. Three studies of 632 subjects explored prophylactic administration (pretreatment) and one study examined treatment. Basic research indicates that intestinal bacteria contribute to radiation-induced injury and repair, so this therapeutic application is open to investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10298144\">",
"    <span class=\"h1\">",
"     DIARRHEAL ILLNESSES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Antibiotic-associated diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large, well-conducted studies are needed before probiotics can be recommended for routine prevention of antibiotic-associated diarrhea.",
"   </p>",
"   <p>",
"    While multiple studies have evaluated a variety of probiotics in the treatment and prevention of antibiotic-associated diarrhea, many were small, used different endpoints, and had serious methodological problems that limited comparisons among them. Systematic reviews suggest that probiotics (including various bacterial species and the yeast",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"     Saccharomyces boulardii",
"    </a>",
"    ) are effective in reducing the incidence of diarrhea in patients who are taking antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/79-86\">",
"     79-86",
"    </a>",
"    ]. However, discordant data have been published and there is little detailed information regarding the optimal dose or timing of supplementation or the effects on subgroups of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the largest systematic reviews from 2012 identified 82 randomized trials of probiotics for the prevention of antibiotic-associated diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/85\">",
"     85",
"    </a>",
"    ]. The majority of trials (69 percent) used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     ,",
"    </em>",
"    either alone or in combination with other organisms. An exclusively yeast-based probiotic (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"     Saccharomyces boulardii",
"    </a>",
"    <em>",
"    </em>",
"    or",
"    <em>",
"     Hansen",
"    </em>",
"    CBS 5926) was used in 16 trials (20 percent). A meta-analysis was performed using the 63 trials (11,811 participants) that reported the number of participants with diarrhea and the number of participants randomized to each treatment group. Participants assigned to probiotics had a 42 percent lower risk of developing antibiotic-associated diarrhea than participants in the control groups (RR 0.58; 95% CI 0.50-0.68), translating to a number needed to treat to prevent one case of antibiotic-associated diarrhea of 13.",
"   </p>",
"   <p>",
"    Among the 17 trials that used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    alone, there was a 36 percent decreased risk of antibiotic-associated diarrhea (RR 0.64; 95% CI 0.47-0.86), whereas the risk was decreased 52 percent (RR 0.48; 95% CI 0.35-0.65) among the 15 trials that used",
"    <em>",
"     Saccharomyces",
"    </em>",
"    . Indirect comparisons between the studies did not find a significant difference in the risk of antibiotic-associated diarrhea based upon the specific organism used (",
"    <em>",
"     Bacillus, Bifidobacterium, Enterococcus, Lactobacillus, Saccharomyces,",
"    </em>",
"    or",
"    <em>",
"     Streptococcus",
"    </em>",
"    ). In addition, the risk reduction was similar for children, adults (18 to 65 years), and older adults (&gt;65 years).",
"   </p>",
"   <p>",
"    A randomized trial with 304 children that was not included in the meta-analysis also suggested that probiotics decrease the risk of antibiotic-associated diarrhea. In addition, it suggested that probiotics may shorten the period of diarrhea in patients who have already developed it [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A potential role of probiotics in prevention of",
"    <em>",
"     C. difficile",
"    </em>",
"    diarrhea (CDAD) in patients at high risk for CDAD is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21015?source=see_link\">",
"     \"Clostridium difficile and probiotics\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Infectious diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Probiotics may be considered in adults and children with presumed infectious diarrheal illness. Multiple systematic reviews have demonstrated a modest reduction in the duration of infectious diarrhea with the use of probiotics, although there was heterogeneity among studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/81,89-94\">",
"     81,89-94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data to support the specific type, dose, or duration of probiotic, and the mechanism of protection from specific etiologic agents are limited. It is also unclear whether probiotics reduce important complications of diarrheal illness such as dehydration and malnutrition.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2010 meta-analysis that included 63 randomized controlled trials (using several different probiotic preparations) in adults and children found that probiotics reduced the overall risk of diarrhea lasting four or more days by 59 percent (relative risk 0.41, 95% CI 0.32-0.53) and the mean duration of diarrhea by 25 hours (95% CI 16-34 hours) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/94\">",
"       94",
"      </a>",
"      ]. The two most commonly studied probiotics were",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       GG",
"      </em>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"       Saccharomyces boulardii",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      A 2002 meta-analysis included nine studies that evaluated the efficacy of several strains of lactobacilli in reducing the duration of symptoms in children with acute infectious diarrhea [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/81\">",
"       81",
"      </a>",
"      ]. Probiotics reduced the duration of diarrhea by 0.7 days (95% CI 0.3-1.2) and diarrhea frequency on day two by 1.6 stools per day. A minimum of 10 billion colony-forming units during the first 48 hours was needed to reduce the duration of diarrhea by more than one-half a day.",
"     </li>",
"     <li>",
"      Probiotics may have a role in hastening recovery from acute rotavirus diarrhea in children [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/95-97\">",
"       95-97",
"      </a>",
"      ]. In a double-blind, placebo-controlled trial of 230 children with acute rotavirus diarrhea, VSL#3 significantly decreased stool frequency [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/95\">",
"       95",
"      </a>",
"      ]. In another randomized trial,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       GG",
"      </em>",
"      demonstrated a dose dependent decrease in fecal shedding of rotavirus [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/97\">",
"       97",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The role of probiotics in the prevention of traveler&rsquo;s diarrhea is discussed in detail separately [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/89\">",
"     89",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29145?source=see_link&amp;anchor=H28#H28\">",
"     \"Travelers' diarrhea\", section on 'Other agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10298197\">",
"    <span class=\"h2\">",
"     Collagenous colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collagenous colitis, a subtype of microscopic colitis, is a diarrheal illness characterized by the presence of a thickened subepithelial collagenous plate and lymphocytic infiltrate in the colonic mucosa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/56/27530?source=see_link\">",
"     \"Lymphocytic and collagenous colitis (microscopic colitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A possible benefit of",
"    <em>",
"     E. coli",
"    </em>",
"    strain Nissle 1917 was suggested in an open-label study of 14 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/98\">",
"     98",
"    </a>",
"    ]. The authors hypothesized that the benefit may have been due to an antagonistic effect of the probiotic against strains of Yersinia species. In a second placebo-controlled trial, a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     acidophilus",
"    </em>",
"    and",
"    <em>",
"     Bifidobacterium animalis",
"    </em>",
"    strains had no significant effect on primary end points but were associated with some improvement in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H538059555\">",
"    <span class=\"h2\">",
"     Celiac disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Probiotics can degrade or alter gluten [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/100,101\">",
"     100,101",
"    </a>",
"    ]. However, there is no evidence to support the use of probiotics in patients with celiac disease. In a randomized controlled trial, 22 adults with celiac disease on a gluten containing diet were randomized to treatment with",
"    <em>",
"     Bifidobacterium infantis",
"    </em>",
"    NLS superstrain or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/102\">",
"     102",
"    </a>",
"    ]. Although patients treated with",
"    <em>",
"     Bifidobacterium infantis",
"    </em>",
"    reported a significant improvement in constipation, indigestion, and gastroesophageal reflux as compared with placebo, there was no significant difference in diarrhea, abdominal pain, or celiac serologies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link&amp;anchor=H9#H9\">",
"     \"Diagnosis of celiac disease\", section on 'Serum antibody assays'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=see_link&amp;anchor=H15#H15\">",
"     \"Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults\", section on 'Clinical manifestations'",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H700205307\">",
"    <span class=\"h1\">",
"     CONSTIPATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small, randomized, placebo-controlled trials of probiotics in patients with chronic constipation without irritable bowel syndrome and in normal subjects with a tendency toward infrequent stools suggest improvement in defecation frequency and stool consistency with",
"    <em>",
"     Bifidobacterium lactis DN-173 010, Bifidobacterium lactis BB12,",
"    </em>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     casei Shirota,",
"    </em>",
"    and",
"    <em>",
"     E. coli Nissle 1917",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/103-106\">",
"     103-106",
"    </a>",
"    ]. However, until larger studies are performed, there are insufficient data to recommend probiotics in the management of severe constipation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     IRRITABLE BOWEL SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several controlled trials of probiotics in irritable bowel syndrome (IBS) have been published, many of which can be criticized for methodologic limitations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/98,107-114\">",
"     98,107-114",
"    </a>",
"    ]. All were short-term studies and none has provided clear evidence as to the potential role of probiotic treatment. Furthermore, the magnitude of benefit in studies with positive results was modest, suggesting that the probiotics under consideration are unproven, but have the potential to impact the management of IBS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/75,110,115-117\">",
"     75,110,115-117",
"    </a>",
"    ]. It is possible that a clinically important benefit might be achieved in certain subgroups of patients, particularly those with diarrhea-predominant symptoms in light of data of alterations in the composition of commensal enteric bacterial species in this subset of IBS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/118\">",
"     118",
"    </a>",
"    ]. As in inflammatory bowel disease, a preferred approach may be to correct the altered microbiome in an individual based on observed compositional changes, rather than use a generic exogenous probiotic preparation for all patients.",
"   </p>",
"   <p>",
"    A meta-analysis of 16 randomized controlled trials found important methodologic limitations of most of the studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/110\">",
"     110",
"    </a>",
"    ]. There was some evidence of efficacy for",
"    <em>",
"     Bifidobacterium infantis 35624",
"    </em>",
"    in two appropriately designed studies. The following illustrate the range of findings in some of the largest controlled trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The probiotic",
"      <em>",
"       Bifidobacterium infantis",
"      </em>",
"      was significantly more effective than placebo at four weeks in a controlled trial of 362 patients with IBS [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/109\">",
"       109",
"      </a>",
"      ]. However, the benefit was confined to only one of three doses tested and there was no clear dose-response relationship.",
"     </li>",
"     <li>",
"      In one trial, 77 patients with IBS were randomly assigned to a malted milk drink containing",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       salivarius UCC4331",
"      </em>",
"      or",
"      <em>",
"       Bifidobacterium infantis 35624",
"      </em>",
"      or to a malted milk drink alone [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/111\">",
"       111",
"      </a>",
"      ]. Symptoms were significantly improved at most time points in the group receiving B. infantis. There was a corresponding normalization in the ratio of serum",
"      <span class=\"nowrap\">",
"       IL-10/IL-12",
"      </span>",
"      suggesting that the probiotic may help reduce a proinflammatory state associated with IBS.",
"     </li>",
"     <li>",
"      In a four week trial, 60 patients with IBS were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       plantarum (DSM 9843)",
"      </em>",
"      or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/108\">",
"       108",
"      </a>",
"      ]. Flatulence was significantly reduced in the probiotic group compared with placebo, while abdominal pain was reduced to a similar extent in both groups. Better overall gastrointestinal function was maintained at 12 months in the probiotic group compared with placebo, although there was no difference in bloating.",
"     </li>",
"     <li>",
"      In another four week trial, 50 patients with IBS, according to Rome II criteria, were randomly assigned to a probiotic preparation containing the combination of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       plantarum LPO 1",
"      </em>",
"      and",
"      <em>",
"       Bifidobacterium breve BR",
"      </em>",
"      or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/119\">",
"       119",
"      </a>",
"      ]. Pain and severity scores decreased significantly in the probiotic group after 14 days of treatment.",
"     </li>",
"     <li>",
"      In an eight week trial, 25 patients with diarrhea-predominant IBS were randomly assigned to VSL#3 or placebo twice daily [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/120\">",
"       120",
"      </a>",
"      ]. At the end of the trial, there was no significant difference in colonic transit compared with baseline. However, abdominal bloating was significantly reduced in the probiotic group compared with placebo. No changes in other abdominal symptoms such as pain, gas, or urgency were observed.",
"     </li>",
"     <li>",
"      Improvement in abdominal pain and a trend towards normalization of stool frequency in constipated patients was found in the probiotic treated group in a placebo-controlled trial of 40 patients randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       plantarum 299V",
"      </em>",
"      or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/121\">",
"       121",
"      </a>",
"      ]. By contrast, no benefit was observed in a second placebo-controlled trial [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/122\">",
"       122",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a double-blind crossover trial, 25 patients with IBS were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"       Lactobacillus",
"      </a>",
"      <em>",
"       GG",
"      </em>",
"      or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/107\">",
"       107",
"      </a>",
"      ]. No significant differences were observed in symptoms scores for pain, urgency or bloating. A trend toward reduction in the number of unformed stools was observed in a subgroup with diarrhea predominant symptoms.",
"     </li>",
"     <li>",
"      No overall improvement was observed in a randomized, placebo-controlled trial involving 100 patients with IBS treated with a combination of four probiotic species [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/123\">",
"       123",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a trial with 122 patients with IBS,",
"      <em>",
"       Bifidobacterium bifidum",
"      </em>",
"      <em>",
"       MIMBb75",
"      </em>",
"      was compared with placebo. Patients who received",
"      <em>",
"       B. bifidum MIMBb75",
"      </em>",
"      had a 52 percent overall response rate compared with 21 percent for patients who received placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/124\">",
"       124",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LACTOSE INTOLERANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ingestion of lactase-containing probiotics has the potential to aid lactose digestion in patients with lactose intolerance. Several studies have evaluated the benefit of various probiotics in patients with lactose intolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/112\">",
"     112",
"    </a>",
"    ]. A systematic review of 10 controlled trials found inconsistent results and suggested further studies on specific strains in which a benefit was suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     HEPATIC ENCEPHALOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of probiotics in the treatment of hepatic encephalopathy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4346?source=see_link&amp;anchor=H11#H11\">",
"     \"Hepatic encephalopathy in adults: Treatment\", section on 'Modification of colonic flora (probiotics and prebiotics)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PANCREATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A multicenter, double-blind, placebo-controlled randomized trial of multispecies probiotic preparation and placebo demonstrated that probiotics did not reduce the risk of infectious complications and actually increased mortality from mesenteric ischemia in patients with pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/10/16554/abstract/125,126\">",
"     125,126",
"    </a>",
"    ]. As a result, probiotics are not recommended in predicted severe acute pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SMALL BOWEL BACTERIAL OVERGROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of probiotics in small bowel bacterial overgrowth is unproven. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=see_link\">",
"     \"Treatment of small intestinal bacterial overgrowth\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ALLERGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Probiotics have the potential to reduce intestinal permeability and the generation of proinflammatory cytokines that are elevated in patients with a variety of allergic disorders. The role of probiotics in the treatment of allergic disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31977?source=see_link\">",
"     \"Prebiotics and probiotics for prevention of allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     H. PYLORI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of probiotics in treatment of H. pylori infection is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=see_link\">",
"     \"Treatment regimens for Helicobacter pylori\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?26/62/27618?source=see_link\">",
"       \"Patient information: Probiotics (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several probiotic preparations have promise in preventing or treating various conditions. However, most studies have been small and many have important methodologic limitations, making it difficult to make unequivocal conclusions regarding efficacy, especially when compared with proven therapies. Furthermore, considerable differences exist in composition, doses, and biologic activity between various commercial preparations, so that results with one preparation cannot be applied to all probiotic preparations. Finally, costs to the patient may be considerable since no preparation is FDA approved and most are not reimbursed by insurers. Enthusiasm for probiotics has outpaced the scientific evidence. Large, well designed multicenter controlled clinical trials are needed to clarify the role of specific probiotics in different well-defined patient populations.",
"   </p>",
"   <p>",
"    Because they are generally safe, the decision to use a probiotic rests mostly upon the degree of anticipated benefit, available alternatives, the clarity of the available data in showing a benefit, costs, and patient preferences. No probiotic strategy is currently considered to represent either the standard of care or primary treatment for any of the conditions described above. The following recommendations are based upon the author's overall appraisal of the quality and consistency of the available evidence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pouchitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from small controlled trials suggest a benefit from VSL#3 in the primary and secondary prevention of pouchitis. Thus, it is a reasonable option in addition to standard medical therapy, although long-term efficacy is uncertain. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Pouchitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ulcerative colitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A benefit of probiotics in ulcerative colitis remains unproven, but",
"    <em>",
"     E. coli Nissle 1917",
"    </em>",
"    shows promise in maintaining remission and could be considered as an alternative in patients intolerant or resistant to 5-ASA preparations. No other probiotic preparation has been validated for this indication. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Ulcerative colitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Crohn's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A benefit of probiotics in Crohn's disease remains unproven. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Crohn's disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Antibiotic-associated diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large, well-conducted studies are needed before probiotics can be recommended for routine prevention of antibiotic-associated diarrhea. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Antibiotic-associated diarrhea'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    However, in patients receiving antibiotics who are felt to be at increased risk for",
"    <em>",
"     Clostridium difficile",
"    </em>",
"    associated diarrhea (CDAD), we suggest coadministration of probiotics for prevention of CDAD (",
"    <a class=\"graphic graphic_table graphicRef50560 \" href=\"UTD.htm?19/44/20160\">",
"     table 1",
"    </a>",
"    ) (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21015?source=see_link&amp;anchor=H5#H5\">",
"     \"Clostridium difficile and probiotics\", section on 'Prevention of CDAD'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Infectious diarrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest the use of probiotics in adults and children with presumed infectious diarrheal illness (",
"    <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"     Grade 2B",
"    </a>",
"    ). If probiotics are used, treatment should consist of regimens with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     GG",
"    </em>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/39/25203?source=see_link\">",
"     Saccharomyces boulardii",
"    </a>",
"    . (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Infectious diarrhea'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H700205373\">",
"    <span class=\"h2\">",
"     Constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A few small randomized controlled trials suggest improvement in defecation frequency and stool consistency in patients with chronic constipation. However, larger studies are needed before probiotics can be routinely recommended in the management of severe chronic constipation. (See",
"    <a class=\"local\" href=\"#H700205307\">",
"     'Constipation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Irritable bowel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;More convincing evidence of a benefit of probiotics for IBS is accumulating, although there is still considerable disagreement as to which agent or group of probiotics is most beneficial. A definitive therapeutic role remains unproven and needs to be further investigated in defined patient subsets. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Irritable bowel syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Lactose intolerance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A benefit of probiotics for lactose intolerance remains unproven. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Lactose intolerance'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Hepatic encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial studies were associated with an improvement in hepatic encephalopathy. However, a large meta-analysis has shown no demonstrable benefit with regard to clinically relevant outcomes (eg, mortality and quality of life). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Hepatic encephalopathy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A definitive role of probiotics for allergic conditions remains unproven, although initial results in studies of children with a variety of preparations for atopic dermatitis are promising. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Allergy'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/1\">",
"      Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/2\">",
"      Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 2009; 22:292.",
"     </a>",
"    </li>",
"    <li>",
"     Holt S. Natural Ways to Digestive Health: Interfaces Between Conventional and Alternative Medicine, M Evans and Company, Inc, New York 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/4\">",
"      Hedin CR, Mullard M, Sharratt E, et al. Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2010; 16:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/5\">",
"      Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/6\">",
"      Vandenbroucke K, Hans W, Van Huysse J, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004; 127:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/7\">",
"      Mohamadzadeh M, Pfeiler EA, Brown JB, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/8\">",
"      Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/9\">",
"      Sartor RB. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Proc Natl Acad Sci U S A 2008; 105:16413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/10\">",
"      Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/11\">",
"      Macfarlane GT, Cummings JH. Probiotics, infection and immunity. Curr Opin Infect Dis 2002; 15:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/12\">",
"      B&ouml;hm SK, Kruis W. Probiotics: do they help to control intestinal inflammation? Ann N Y Acad Sci 2006; 1072:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/13\">",
"      Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006; 57 Suppl 9:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/14\">",
"      Ewaschuk JB, Tejpar QZ, Soo I, et al. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep 2006; 8:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/15\">",
"      Hart AL, Stagg AJ, Kamm MA. Use of probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 2003; 36:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/16\">",
"      Famularo G, Mosca L, Minisola G, et al. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease. Curr Pharm Des 2003; 9:1973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/17\">",
"      Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126:1620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/18\">",
"      Fedorak RN, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2008. J Clin Gastroenterol 2008; 42 Suppl 2:S97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/19\">",
"      Isaacs K, Herfarth H. Role of probiotic therapy in IBD. Inflamm Bowel Dis 2008; 14:1597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/20\">",
"      Seksik P, Dray X, Sokol H, Marteau P. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Mol Nutr Food Res 2008; 52:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/21\">",
"      Rowland I, Capurso L, Collins K, et al. Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009. Gut Microbes 2010; 1:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/22\">",
"      Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012; 7:e34938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/23\">",
"      Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008; 14:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/24\">",
"      Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 2009; 9:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/25\">",
"      Seth A, Yan F, Polk DB, Rao RK. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2008; 294:G1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/26\">",
"      Yan F, Cao H, Cover TL, et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/27\">",
"      Yan F, Cao H, Cover TL, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 2011; 121:2242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/28\">",
"      McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/29\">",
"      Pathmakanthan S, Li CK, Cowie J, Hawkey CJ. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol 2004; 19:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/30\">",
"      Borruel N, Carol M, Casellas F, et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002; 51:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/31\">",
"      Lin YP, Thibodeaux CH, Pe&ntilde;a JA, et al. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 2008; 14:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/32\">",
"      Ng SC, Plamondon S, Kamm MA, et al. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Inflamm Bowel Dis 2010; 16:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/33\">",
"      Dalmasso G, Cottrez F, Imbert V, et al. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 2006; 131:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/34\">",
"      Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/35\">",
"      Fujii T, Ohtsuka Y, Lee T, et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr 2006; 43:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/36\">",
"      Riedel CU, Foata F, Philippe D, et al. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol 2006; 12:3729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/37\">",
"      O'Hara AM, O'Regan P, Fanning A, et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 2006; 118:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/38\">",
"      Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002; 8:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/39\">",
"      Madsen KL, Doyle JS, Tavernini MM, et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 2000; 118:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/40\">",
"      Sougioultzis S, Simeonidis S, Bhaskar KR, et al. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 2006; 343:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/41\">",
"      Pedrosa MC, Golner BB, Goldin BR, et al. Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects. Am J Clin Nutr 1995; 61:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/42\">",
"      Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000; 78:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/43\">",
"      Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004; 126:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/44\">",
"      Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277:50959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/45\">",
"      Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/46\">",
"      Katakura K, Lee J, Rachmilewitz D, et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005; 115:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/47\">",
"      Round JL, Lee SM, Li J, et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/48\">",
"      Komanduri S, Gillevet PM, Sikaroodi M, et al. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol 2007; 5:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/49\">",
"      Sokol H, Lay C, Seksik P, Tannock GW. Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis 2008; 14:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/50\">",
"      Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/51\">",
"      Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/52\">",
"      Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/53\">",
"      Shen B, Brzezinski A, Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005; 22:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/54\">",
"      Kuisma J, Mentula S, Jarvinen H, et al. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003; 17:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/55\">",
"      Holubar SD, Cima RR, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 2010; :CD001176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/56\">",
"      Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; :CD005573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/57\">",
"      Naidoo K, Gordon M, Fagbemi AO, et al. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2011; :CD007443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/58\">",
"      Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/59\">",
"      Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53:1617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/60\">",
"      Henker J, M&uuml;ller S, Laass MW, et al. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol 2008; 46:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/61\">",
"      Matthes H, Krummenerl T, Giensch M, et al. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med 2010; 10:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/62\">",
"      Zocco MA, dal Verme LZ, Cremonini F, et al. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 2006; 23:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/63\">",
"      Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005; 54:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/64\">",
"      Tursi A, Brandimarte G, Giorgetti GM, et al. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 2004; 10:PI126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/65\">",
"      Miele E, Pascarella F, Giannetti E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/66\">",
"      Sood A, Midha V, Makharia GK, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009; 7:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/67\">",
"      Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/68\">",
"      Huynh HQ, deBruyn J, Guan L, et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm Bowel Dis 2009; 15:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/69\">",
"      Tursi A, Brandimarte G, Papa A, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2010; 105:2218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/70\">",
"      Wildt S, Nordgaard I, Hansen U, et al. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J Crohns Colitis 2011; 5:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/71\">",
"      Oliva S, Di Nardo G, Ferrari F, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012; 35:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/72\">",
"      Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. Aliment Pharmacol Ther 2010; 31:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/73\">",
"      Butterworth AD, Thomas AG, Akobeng AK. Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008; :CD006634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/74\">",
"      Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2006; :CD004826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/75\">",
"      Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/76\">",
"      Steed H, Macfarlane GT, Blackett KL, et al. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease. Aliment Pharmacol Ther 2010; 32:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/77\">",
"      Fuccio L, Guido A, Eusebi LH, et al. Effects of probiotics for the prevention and treatment of radiation-induced diarrhea. J Clin Gastroenterol 2009; 43:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/78\">",
"      Packey CD, Ciorba MA. Microbial influences on the small intestinal response to radiation injury. Curr Opin Gastroenterol 2010; 26:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/79\">",
"      Sazawal S, Hiremath G, Dhingra U, et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006; 6:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/80\">",
"      D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/81\">",
"      Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/82\">",
"      McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/83\">",
"      Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2007; :CD004827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/84\">",
"      Szajewska H, Ruszczyski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/85\">",
"      Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/86\">",
"      Videlock EJ, Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2012; 35:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/87\">",
"      Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012; 107:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/88\">",
"      Chen CC, Kong MS, Lai MW, et al. Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea. Pediatr Infect Dis J 2010; 29:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/89\">",
"      McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007; 5:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/90\">",
"      Szajewska H, Sk&oacute;rka A, Ruszczyski M, Gieruszczak-Biaek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/91\">",
"      Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis 2008; 2008:290769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/92\">",
"      Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst Rev 2010; :CD007401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/93\">",
"      Szajewska H, Sk&oacute;rka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther 2009; 30:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/94\">",
"      Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; :CD003048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/95\">",
"      Dubey AP, Rajeshwari K, Chakravarty A, Famularo G. Use of VSL[sharp]3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol 2008; 42 Suppl 3 Pt 1:S126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/96\">",
"      Teran CG, Teran-Escalera CN, Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis 2009; 13:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/97\">",
"      Fang SB, Lee HC, Hu JJ, et al. Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children. J Trop Pediatr 2009; 55:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/98\">",
"      Tromm A, Niewerth U, Khoury M, et al. The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol 2004; 42:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/99\">",
"      Wildt S, Munck LK, Vinter-Jensen L, et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflamm Bowel Dis 2006; 12:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/100\">",
"      De Angelis M, Rizzello CG, Fasano A, et al. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue. Biochim Biophys Acta 2006; 1762:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/101\">",
"      Di Cagno R, Barbato M, Di Camillo C, et al. Gluten-free sourdough wheat baked goods appear safe for young celiac patients: a pilot study. J Pediatr Gastroenterol Nutr 2010; 51:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/102\">",
"      Smecuol E, Hwang HJ, Sugai E, et al. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. J Clin Gastroenterol 2013; 47:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/103\">",
"      Koebnick C, Wagner I, Leitzmann P, et al. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003; 17:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/104\">",
"      Yang YX, He M, Hu G, et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 2008; 14:6237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/105\">",
"      Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J Gastroenterol 2010; 16:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/106\">",
"      Nishida S, Gotou M, Akutsu S, et al. Effect of yogurt containing Bifidobacterium lactis BB-12 on improvement of defecation and fecal microflora of healthy female adults. Milk Science 2004; 53:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/107\">",
"      O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000; 32:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/108\">",
"      Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/109\">",
"      Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101:1581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/110\">",
"      Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 2009; 104:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/111\">",
"      O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/112\">",
"      Levri KM, Ketvertis K, Deramo M, et al. Do probiotics reduce adult lactose intolerance? A systematic review. J Fam Pract 2005; 54:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/113\">",
"      Francavilla R, Miniello V, Magist&agrave; AM, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 2010; 126:e1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/114\">",
"      Ki Cha B, Mun Jung S, Hwan Choi C, et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 2012; 46:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/115\">",
"      Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/116\">",
"      Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol 2008; 42 Suppl 3 Pt 1:S123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/117\">",
"      McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14:2650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/118\">",
"      Ringel Y, Carroll IM. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am 2009; 19:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/119\">",
"      Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004; 38:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/120\">",
"      Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003; 17:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/121\">",
"      Carroll IM, Ringel-Kulka T, Keku TO, et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011; 301:G799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/122\">",
"      Sen S, Mullan MM, Parker TJ, et al. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002; 47:2615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/123\">",
"      Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008; 32:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/124\">",
"      Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/125\">",
"      Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/10/16554/abstract/126\">",
"      Capurso G, Marignani M, Piciucchi M, et al. Probiotics and severe acute pancreatitis. J Clin Gastroenterol 2008; 42 Suppl 3 Pt 1:S148.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2603 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-4BCC47CC64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16554=[""].join("\n");
var outline_f16_10_16554=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISMS OF BENEFIT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10298057\">",
"      GASTROINTESTINAL INFLAMMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pouchitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10298117\">",
"      Diverticular colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10298270\">",
"      Radiation enteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10298144\">",
"      DIARRHEAL ILLNESSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Antibiotic-associated diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Infectious diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10298197\">",
"      Collagenous colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H538059555\">",
"      Celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H700205307\">",
"      CONSTIPATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      IRRITABLE BOWEL SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LACTOSE INTOLERANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      HEPATIC ENCEPHALOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PANCREATITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SMALL BOWEL BACTERIAL OVERGROWTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ALLERGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      H. PYLORI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pouchitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ulcerative colitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Antibiotic-associated diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Infectious diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H700205373\">",
"      Constipation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Irritable bowel syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Lactose intolerance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Hepatic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2603\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2603|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/44/20160\" title=\"table 1\">",
"      Probiotic regimens",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/33/21015?source=related_link\">",
"      Clostridium difficile and probiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=related_link\">",
"      Diagnosis of celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20324?source=related_link\">",
"      Diverticular colitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4346?source=related_link\">",
"      Hepatic encephalopathy in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27401?source=related_link\">",
"      Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/56/27530?source=related_link\">",
"      Lymphocytic and collagenous colitis (microscopic colitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40650?source=related_link\">",
"      Pathogenesis, epidemiology, and clinical manifestations of celiac disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?26/62/27618?source=related_link\">",
"      Patient information: Probiotics (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32759?source=related_link\">",
"      Pouchitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31977?source=related_link\">",
"      Prebiotics and probiotics for prevention of allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/29/29145?source=related_link\">",
"      Travelers' diarrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=related_link\">",
"      Treatment of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23049?source=related_link\">",
"      Treatment regimens for Helicobacter pylori",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_10_16555="Pediatric RIFLE Classification of AKI";
var content_f16_10_16555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pediatric RIFLE Classification of acute kidney injury",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        pRIFLE stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Estimated creatinine clearance (eCCl)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Urine output",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        R = Risk for renal dysfunction",
"       </td>",
"       <td>",
"        eCCl decreased by 25 percent",
"       </td>",
"       <td>",
"        &lt;0.5 mL/kg per hour for 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        I = Injury to the kidney",
"       </td>",
"       <td>",
"        eCCl decreased by 50 percent",
"       </td>",
"       <td>",
"        &lt;0.5 mL/kg per hour for 16 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        F = Failure of kidney function",
"       </td>",
"       <td>",
"        eCCl decreased by 75 percent or eCCl &lt;35 mL/min per 1.73 m",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"       <td>",
"        &lt;0.3 mL/kg per hour for 24 hours or anuria for 12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L = Loss of kidney function",
"       </td>",
"       <td>",
"        Persistent failure &gt;4 weeks",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        E = End-stage renal disease",
"       </td>",
"       <td>",
"        Persistent failure &gt;3 months",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16555=[""].join("\n");
var outline_f16_10_16555=null;
var title_f16_10_16556="Healthy weight exercise tips";
var content_f16_10_16556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tips for maintaining a healthy weight: exercise",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Exercise Phase I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Begin decreasing time spent in sedentary activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Identify how many hours per day your family",
"spends in sedentary activities such as watching TV, playing video",
"games, and surfing the internet and make efforts to decrease this time",
"every day this week. Explore ways to be physically active on a daily",
"basis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Exercise Phase II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Decrease sedentary time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Limit television, video games and computer time to no more than 1 hour per day. Limiting sedentary time will encourage children to choose other activities, most of which will generate increased physical activity. Buy active toys rather than computer games or videotapes. Define indoor areas for physical play such as \"Nerf\" balls, bouncy balls or scooter toys.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Incorporate physical activity into daily routines.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Walk or ride bike to school. Play outdoors, in the gym or on the playground for 30 minutes before homework every day. Walk with friends instead of talking to them on the telephone.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Accumulate 1 hour of physical activity during the day.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Both children and adults should be active for 1 hour every day. This activity can be accumulated throughout the day. Consider purchasing a pedometer ($10 - $15) and join the 10,000 steps a day program.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Be physically active as a family.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plan family activities for the weekend such as bike riding, hiking; trips to the zoo, museum or library; and house or yard projects. Take family walks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Consider participating in organized sports or physical activities.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Get involved in team sports or marching band at school. Take classes in activities that you enjoy such as dance, martial arts, swimming or tennis; or buy an aerobics tape and exercise at home.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16556=[""].join("\n");
var outline_f16_10_16556=null;
var title_f16_10_16557="Mesothelioma prognostic groups";
var content_f16_10_16557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74485&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prognostic indices of survival for advanced mesothelioma in EORTC* studies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"5\" rowspan=\"1\">",
"        EORTC",
"studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"1\" rowspan=\"1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle2\">",
"        Response (percent)",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"3\" rowspan=\"1\">",
"        MST (months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"1\">",
"        Mitoxantrone",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        7.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"1\">",
"        Epirubicin",
"       </td>",
"       <td>",
"        13.5",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        8.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"1\">",
"        Etoposide (IV)",
"       </td>",
"       <td>",
"        4.2",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        6.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"1\">",
"        Etoposide (PO)",
"       </td>",
"       <td>",
"        7.3",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        8.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paclitaxel",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        9.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"5\" rowspan=\"1\">",
"        Poor",
"prognostic factors in multivariate analysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2\">",
"        Variable",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"3\" rowspan=\"1\">",
"        MST (months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Performance status (PS)",
"        <br/>",
"       </td>",
"       <td>",
"        Good (0)",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        10.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poor (1-2)",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        7.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        WBC count",
"        <br/>",
"       </td>",
"       <td>",
"        High (&gt;8.3)",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        6",
"        <br/>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low (&lt;8.3)",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        10.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Hemoglobin (HGB)",
"        <br/>",
"       </td>",
"       <td>",
"        High (&gt;1 g/dL)",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        7.3",
"        <br/>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low (&lt;1 g/dL)",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        9.6",
"        <br/>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Histologic diagnosis",
"        <br/>",
"       </td>",
"       <td>",
"        Definite",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        9.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Possible",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Sarcomatous subtype",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other subtype",
"       </td>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        8.4-9.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"5\" rowspan=\"1\">",
"        EORTC*",
"prognostic groups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\" colspan=\"2\" rowspan=\"1\">",
"        Group",
"characteristics",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"1\">",
"        MST (months)",
"       </td>",
"       <td class=\"subtitle2\">",
"        1 yr OS",
"       </td>",
"       <td class=\"subtitle2\">",
"        2 yr OS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         Low",
"risk",
"        </strong>",
"        (prognostic score &lt;1.27)- Equivalent to",
"having 0-2 poor prognostic factors",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"1\">",
"        10.8",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"1\">",
"        40 percent",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"1\">",
"        14 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\" rowspan=\"1\">",
"        <strong>",
"         High",
"risk",
"        </strong>",
"        (prognostic score &gt;1.27)- Equivalent to",
"having three or more poor prognostic factors",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"1\">",
"        5.5",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"1\">",
"        12 percent",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"1\">",
"        0 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * EORTC: European Organization for Research and Treatment of Cancer; MST: median survival time; WBC: White blood cell count, X 1000/microL.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16557=[""].join("\n");
var outline_f16_10_16557=null;
var title_f16_10_16558="Incidence of gonorrhea by age";
var content_f16_10_16558=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F70456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F70456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Incidence of gonorrhea by age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 276px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2000. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, September 2001.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16558=[""].join("\n");
var outline_f16_10_16558=null;
var title_f16_10_16559="Spider veins ankle PI";
var content_f16_10_16559=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F54276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F54276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Telangiectasias (spider veins) on the lower leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a picture of telangiectasias (spider veins), which are small veins that are swollen. These are also called \"hyphen webs\" or \"thread veins.\"",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick C Alguire, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_10_16559=[""].join("\n");
var outline_f16_10_16559=null;
